Section 60

EurekaMag PDF full texts Chapter 59,289


Shi, L.; Kojonazarov, B.; Elgheznawy, A.; Popp, R.üd.; Dahal, B.K.; Böhm, M.; Pullamsetti, S.S.; Ghofrani, H.-A.; Gödecke, A.; Jungmann, A.; Katus, H.A.; Müller, O.J.; Schermuly, R.T.; Fisslthaler, B.; Seeger, W.; Fleming, I. 2016: MiR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach. Cardiovascular Research 111(3): 184-193
Li, R.; Wu, S.; Chen, X.; Xu, H.; Teng, P.; Li, W. 2016: MiR-223/FBW7 axis regulates doxorubicin sensitivity through epithelial mesenchymal transition in non-small cell lung cancer. American Journal of Translational Research 8(6): 2512-2524
Shen, B.; Pan, Q.; Yang, Y.; Gao, Y.; Liu, X.; Li, W.; Han, Y.; Yuan, X.; Qu, Y.; Zhao, Z. 2017: MiR-224 Affects Mammary Epithelial Cell Apoptosis and Triglyceride Production by Downregulating ACADM and ALDH2 Genes. Dna and Cell Biology 36(1): 26-33
Di, Y.; Zhang, D.; Hu, T.; Li, D. 2015: MiR-23 regulate the pathogenesis of patients with coronary artery disease. International Journal of Clinical and Experimental Medicine 8(7): 11759-11769
Nie, M.; Yu, S.; Peng, S.; Fang, Y.; Wang, H.; Yang, X. 2015: MiR-23a and miR-27a promote human granulosa cell apoptosis by targeting SMAD5. Biology of Reproduction 93(4): 98
Lin, R.; Sampson, J.H.; Li, Q.-J.; Zhu, B. 2015: MiR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment. Oncoimmunology 4(3): E990803
Gindin, Y.; Jiang, Y.; Francis, P.; Walker, R.L.; Abaan, O.D.; Zhu, Y.J.; Meltzer, P.S. 2015: MiR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1. Frontiers in Genetics 6: 233
Peng, F.; Zhang, H.; Du, Y.; Tan, P. 2015: MiR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist. Oncology Reports 33(2): 942-950
Wang, G.; Li, B.; Fu, Y.; He, M.; Wang, J.; Shen, P.; Bai, L. 2015: MiR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(6): 4715-4721
Campos-Viguri, G.E.; Jiménez-Wences, H.; Peralta-Zaragoza, O.; Torres-Altamirano, G.; Soto-Flores, D.G.; Hernández-Sotelo, D.; Alarcón-Romero, L.D.C.; Jiménez-López, M.A.; Illades-Aguiar, B.; Fernández-Tilapa, G. 2015: MiR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer. Infectious Agents and Cancer 10: 42
Sun, L.; Liu, A.; Zhang, J.; Ji, W.; Li, Y.; Yang, X.; Wu, Z.; Guo, J. 2018: MiR-23b improves cognitive impairments in traumatic brain injury by targeting ATG12-mediated neuronal autophagy. Behavioural Brain Research 340: 126-136
Liu, H.; Hao, W.; Wang, X.; Su, H. 2016: MiR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells. Journal of Toxicological Sciences 41(2): 185-193
Zhao, S.; Li, T.; Li, J.; Lu, Q.; Han, C.; Wang, N.; Qiu, Q.; Cao, H.; Xu, X.; Chen, H.; Zheng, Z. 2016: MiR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway. Diabetologia 59(3): 644-654
Cho, S.; Wu, C.-J.; Yasuda, T.; Cruz, L.O.; Khan, A.A.; Lin, L.-L.; Nguyen, D.T.; Miller, M.; Lee, H.-M.; Kuo, M.-L.; Broide, D.H.; Rajewsky, K.; Rudensky, A.Y.; Lu, L.-F. 2016: MiR-23∼27∼24 clusters control effector T cell differentiation and function. Journal of Experimental Medicine 213(2): 235-249
Fordham, J.B.; Naqvi, A.R.; Nares, S. 2015: MiR-24 Regulates Macrophage Polarization and Plasticity. Journal of Clinical and Cellular Immunology 6(5)
Xiang, Y. 2015: MiR-24 in diabetes. Oncotarget 6(19): 16816-16817
Zhao, J.; Hu, C.; Chi, J.; Li, J.; Peng, C.; Yun, X.; Li, D.; Yu, Y.; Li, Y.; Gao, M.; Zheng, X. 2016: MiR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7. Oncology Reports 36(2): 1143-1149
Lynch, S.M.; McKenna, M.M.; Walsh, C.P.; McKenna, D.J. 2016: MiR-24 regulates CDKN1B/p27 expression in prostate cancer. Prostate 76(7): 637-648
Naqvi, A.R.; Fordham, J.B.; Nares, S. 2015: MiR-24, miR-30b, and miR-142-3p regulate phagocytosis in myeloid inflammatory cells. Journal of Immunology 194(4): 1916-1927
Manvati, S.; Mangalhara, K.C.; Kalaiarasan, P.; Srivastava, N.; Bamezai, R.N.K. 2015: MiR-24-2 regulates genes in survival pathway and demonstrates potential in reducing cellular viability in combination with docetaxel. Gene 567(2): 217-224
Li, Q.; Wang, N.; Wei, H.; Li, C.; Wu, J.; Yang, G. 2016: MiR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6. Digestive Diseases and Sciences 61(12): 3486-3497
Zhang, M-Xue.; Zhang, J.; Zhang, H.; Tang, H. 2016: MiR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway. Plos one 11(6): E0158433
Zoni, E.; van der Horst, G.; van de Merbel, A.F.; Chen, L.; Rane, J.K.; Pelger, R.C.M.; Collins, A.T.; Visakorpi, T.; Snaar-Jagalska, B.E.; Maitland, N.J.; van der Pluijm, G. 2015: MiR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression. Cancer Research 75(11): 2326-2336
Huang, F.; Zhang, L.; Long, Z.; Chen, Z.; Hou, X.; Wang, C.; Peng, H.; Wang, J.; Li, J.; Duan, R.; Xia, K.; Chuang, D.-M.; Tang, B.; Jiang, H. 2014: MiR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3. Febs Letters 588(24): 4791-4798
He, Z.; Liu, Y.; Xiao, B.; Qian, X. 2015: MiR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression. Biochemical and Biophysical Research Communications 457(3): 235-241
Qiu, G.; Fang, B.; Xin, G.; Wei, Q.; Yuan, X.; Wu, D. 2015: MiR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma Hela cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31(1): 40-43
Peng, G.; Yuan, X.; Yuan, J.; Liu, Q.; Dai, M.; Shen, C.; Ma, J.; Liao, Y.; Jiang, W. 2015: MiR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL. Molecular and Cellular Biochemistry 409(1-2): 103-111
Zhang, J.; Gong, X.; Tian, K.; Chen, D.; Sun, J.; Wang, G.; Guo, M. 2015: MiR-25 promotes glioma cell proliferation by targeting CDKN1C. Biomedicine and PharmacoTherapy 71: 7-14
Wu, T.; Chen, W.; Kong, D.; Li, X.; Lu, H.; Liu, S.; Wang, J.; Du, L.; Kong, Q.; Huang, X.; Lu, Z. 2015: MiR-25 targets the modulator of apoptosis 1 gene in lung cancer. Carcinogenesis 36(8): 925-935
Zoni, E.; Kruithof-de Julio, M.; van der Pluijm, G. 2015: MiR-25, integrin and cancer invasiveness. Oncoscience 2(8): 663-664
Song, J.; Li, Y. 2017: MiR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells. Cancer Science 108(1): 23-31
Xu, S.; Wang, T.; Yang, Z.; Li, Y.; Li, W.; Wang, T.; Wang, S.; Jia, L.; Zhang, S.; Li, S. 2016: MiR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13. Oncotarget 7(29): 45687-45701
Wang, P.; Lv, L. 2016: MiR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach. Oncotarget 7(49): 81367-81376
Sun, T.-Y.; Xie, H.-J.; He, H.; Li, Z.; Kong, L.-F. 2016: MiR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression. American Journal of Translational Research 8(2): 1037-1046
Wang, G.; Sun, Y.; He, Y.; Ji, C.; Hu, B.; Sun, Y. 2015: MiR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2. Genetic Testing and Molecular Biomarkers 19(1): 30-36
Zhou, J.; Ju, W-Qiang.; Yuan, X-Peng.; Zhu, X-Feng.; Wang, D-Ping.; He, X-Shun. 2016: MiR-26a regulates mouse hepatocyte proliferation via directly targeting the 3' untranslated region of CCND2 and CCNE2. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 15(1): 65-72
Liang, H.; Liu, S.; Chen, Y.; Bai, X.; Liu, L.; Dong, Y.; Hu, M.; Su, X.; Chen, Y.; Huangfu, L.; Li, X.; Gu, Y.; Shan, H. 2016: MiR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among mi RNAs in IPF. Journal of Molecular Medicine 94(6): 655-665
Liu, P.; Tang, H.; Chen, B.; He, Z.; Deng, M.; Wu, M.; Liu, X.; Yang, L.; Ye, F.; Xie, X. 2015: MiR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer. Cancer Letters 357(1): 384-392
Chang, L.; Li, K.; Guo, T. 2017: MiR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 19(6): 695-703
Jin, Q.; Li, X.J.; Cao, P.G. 2016: MiR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2. Iranian Journal of Basic Medical Sciences 19(8): 851-857
Du, J.-Y.; Wang, L.-F.; Wang, Q.; Yu, L.-D. 2015: MiR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells. Oncology Reports 33(4): 1890-1898
Cao, J.; Guo, T.; Dong, Q.; Zhang, J.; Li, Y. 2015: MiR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanism. Oncology Reports 33(2): 974-980
Wang, Q.; Xu, C.; Zhao, Y.; Xu, Z.; Zhang, Y.; Jiang, J.; Yan, B.; Gu, D.; Wu, M.; Wang, Y.; Liu, H. 2016: MiR-26b-3p Regulates Human Umbilical Cord-Derived Mesenchymal Stem Cell Proliferation by Targeting Estrogen Receptor. Stem Cells and Development 25(5): 415-426
Lozano-Velasco, E.; Galiano-Torres, J.; Jodar-Garcia, A.; Aranega, A.E.; Franco, D. 2015: MiR-27 and miR-125 Distinctly Regulate Muscle-Enriched Transcription Factors in Cardiac and Skeletal Myocytes. Biomed Research International 2015: 391306
Chen, S.-Z.; Xu, X.; Ning, L.-F.; Jiang, W.-Y.; Xing, C.; Tang, Q.-Q.; Huang, H.-Y. 2015: MiR-27 impairs the adipogenic lineage commitment via targeting lysyl oxidase. Obesity 23(12): 2445-2453
Tanaka, K.; Miyata, H.; Sugimura, K.; Fukuda, S.; Kanemura, T.; Yamashita, K.; Miyazaki, Y.; Takahashi, T.; Kurokawa, Y.; Yamasaki, M.; Wada, H.; Nakajima, K.; Takiguchi, S.; Mori, M.; Doki, Y. 2015: MiR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts. Carcinogenesis 36(8): 894-903
Ahmadian-Elmi, M.; Bidmeshki Pour, A.; Naghavian, R.; Ghaedi, K.; Tanhaei, S.; Izadi, T.; Nasr-Esfahani, M.H. 2016: MiR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis. Immunogenetics 68(1): 43-54
Salah, Z.; Arafeh, R.; Maximov, V.; Galasso, M.; Khawaled, S.; Abou-Sharieha, S.; Volinia, S.; Jones, K.B.; Croce, C.M.; Aqeilan, R.I. 2015: MiR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Oncotarget 6(7): 4920-4935
Kim, J.; Fiesel, F.C.; Belmonte, K.C.; Hudec, R.; Wang, W.-X.; Kim, C.; Nelson, P.T.; Springer, W.; Kim, J. 2016: MiR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Molecular Neurodegeneration 11(1): 55
Peng, H.; Wang, X.; Zhang, P.; Sun, T.; Ren, X.; Xia, Z. 2015: MiR-27a promotes cell proliferation and metastasis in renal cell carcinoma. International Journal of Clinical and Experimental Pathology 8(2): 2259-2266
Zhou, S.; Huang, Q.; Zheng, S.; Lin, K.; You, J.; Zhang, X. 2016: MiR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(5): 6837-6845
Yuan, L.; Zhang, T.-t.; Ren, Y. 2015: MiR-27a rs895819 polymorphism and risk of cancer in Chinese population: a meta-analysis. Journal of Evidence-Based Medicine 8(2): 75-83
Zhao, W.; Zhang, X.; Liu, J.; Sun, B.; Tang, H.; Zhang, H. 2016: MiR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7. Oncology Reports 36(6): 3691-3699
Zhao, X.; Song, X.; Bai, X.; Fei, N.; Huang, Y.; Zhao, Z.; Du, Q.; Zhang, H.; Zhang, L.; Tong, D. 2016: MiR-27b attenuates apoptosis induced by transmissible gastroenteritis virus (TGEV) infection via targeting runt-related transcription factor 1 (RUNX1). Peerj 4: E1635
Goedeke, L.; Rotllan, N.; Ramírez, C.M.; Aranda, J.F.; Canfrán-Duque, A.; Araldi, E.; Fernández-Hernando, A.; Langhi, C.; de Cabo, R.; Baldán, Án.; Suárez, Y.; Fernández-Hernando, C. 2015: MiR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice. Atherosclerosis 243(2): 499-509
Feng, Q.; Wu, X.; Li, F.; Ning, B.; Lu, X.; Zhang, Y.; Pan, Y.; Guan, W. 2017: MiR-27b inhibits gastric cancer metastasis by targeting NR2F2. Protein and Cell 8(2): 114-122
Yao, J.; Deng, B.; Zheng, L.; Dou, L.; Guo, Y.; Guo, K. 2016: MiR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition. Oncology Reports 35(3): 1645-1651
Zhou, X.; Zuo, S.; Xin, W. 2015: MiR-27b overexpression improves mitochondrial function in a Sirt1-dependent manner. Journal of Physiology and Biochemistry 71(4): 753-762
Poon, V.Y.; Gu, M.; Ji, F.; VanDongen, A.M.; Fivaz, M. 2016: MiR-27b shapes the presynaptic transcriptome and influences neurotransmission by silencing the polycomb group protein Bmi1. Bmc Genomics 17(1): 777
Tao, J.; Zhi, X.; Zhang, X.; Fu, M.; Huang, H.; Fan, Y.; Guan, W.; Zou, C. 2015: MiR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. Journal of Experimental and Clinical Cancer Research: Cr 34: 139
Li, Q.; Johnston, N.; Zheng, X.; Wang, H.; Zhang, X.; Gao, D.; Min, W. 2016: MiR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion. Oncotarget 7(33): 53735-53750
Li, S.-P.; Liu, B.; Song, B.; Wang, C.-X.; Zhou, Y.-C. 2015: MiR-28 promotes cardiac ischemia by targeting mitochondrial aldehyde dehydrogenase 2 (ALDH2) in mus musculus cardiac myocytes. European Review for Medical and Pharmacological Sciences 19(5): 752-758
Bai, X.T.; Nicot, C. 2015: MiR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection. Journal of Biological Chemistry 290(9): 5381-5390
Liu, J.; Liu, Y.; Sun, Y.-N.; Li, S.; Liu, X.-Q.; Li, J.; Li, C.-M.; Tian, W.; Zhou, Y.-T.; Shang, X.-M. 2015: MiR-28-5p Involved in LXR-ABCA1 Pathway is Increased in the Plasma of Unstable Angina Patients. Heart Lung and Circulation 24(7): 724-730
Wang, C.; Wu, C.; Yang, Q.; Ding, M.; Zhong, J.; Zhang, C.-Y.; Ge, J.; Wang, J.; Zhang, C. 2016: MiR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B. Oncotarget 7(45): 73888-73902
Zhou, S-Lai.; Hu, Z-Qiang.; Zhou, Z-Jun.; Dai, Z.; Wang, Z.; Cao, Y.; Fan, J.; Huang, X-Wu.; Zhou, J. 2016: MiR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis. Hepatology 63(5): 1560-1575
Fischer, S.; Paul, A.J.; Wagner, A.; Mathias, S.; Geiss, M.; Schandock, F.; Domnowski, M.; Zimmermann, J.ör.; Handrick, R.é; Hesse, F.; Otte, K. 2015: MiR-2861 as novel HDAC5 inhibitor in CHO cells enhances productivity while maintaining product quality. Biotechnology and Bioengineering 112(10): 2142-2153
Diomede, F.; Merciaro, I.; Martinotti, S.; Cavalcanti, M.; Caputi, S.; Mazzon, E.; Trubiani, O. 2016: miR-2861 is involved in osteogenic commitment of human periodontal ligament stem cells grown onto 3D scaffold. Journal of Biological Regulators and Homeostatic Agents 30(4): -
Vanden Oever, M.; Muldoon, D.; Mathews, W.; McElmurry, R.; Tolar, J. 2016: MiR-29 Regulates Type VIi Collagen in Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology 136(10): 2013-2021
Cui, Y.; Li, T.; Yang, D.; Li, S.; Le, W. 2016: MiR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCs. Oncotarget 7(40): 64932-64941
Cao, Y.; Guo, W-Ting.; Tian, S.; He, X.; Wang, X-Wen.; Liu, X.; Gu, K-Li.; Ma, X.; Huang, D.; Hu, L.; Cai, Y.; Zhang, H.; Wang, Y.; Gao, P. 2015: MiR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency. EMBO Journal 34(5): 609-623
Wang, L.; Bo, X.; Zheng, Q.; Xiao, X.; Wu, L.; Li, B. 2016: MiR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma. Febs Letters 590(23): 4252-4262
Xu, C.; Li, S.; Chen, T.; Hu, H.; Ding, C.; Xu, Z.; Chen, J.; Liu, Z.; Lei, Z.; Zhang, H.-T.; Li, C.; Zhao, J. 2016: MiR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer. Oncology Reports 35(1): 497-503
Sun, Y.; Zhao, J.; Yin, X.; Yuan, X.; Guo, J.; Bi, J. 2016: MiR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma. Cell Proliferation 49(5): 636-643
Wu, S.-Q.; Zhang, L.-H.; Huang, H.-B.; Li, Y.-P.; Niu, W.-Y.; Zhan, R. 2016: MiR-299-5p promotes cell growth and regulates G1/S transition by targeting p21Cip1/Waf1 in acute promyelocytic leukemia. Oncology Letters 12(1): 741-747
Tian, R.; Zheng, Z.; Huang, R.; Jiao, Y.; Du, X. 2015: MiR-29a Participated in Nacre Formation and Immune Response by Targeting Y2R in Pinctada martensii. International Journal of Molecular Sciences 16(12): 29436-29445
Liu, C.; Duan, P.; Li, B.; Huang, C.; Jing, Y.; Yan, W. 2015: MiR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1. Oncology Letters 9(1): 96-102
Rosca, A.; Anton, G.; Botezatu, A.; Temereanca, A.; Ene, L.; Achim, C.; Ruta, S. 2016: MiR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients. Journal of Medical Virology 88(12): 2132-2137
Stary, C.M.; Sun, X.; Ouyang, Y.; Li, L.; Giffard, R.G. 2016: MiR-29a differentially regulates cell survival in astrocytes from cornu ammonis 1 and dentate gyrus by targeting VDAC1. Mitochondrion 30: 248-254
Hu, W.; Dooley, J.; Chung, S.S.; Chandramohan, D.; Cimmino, L.; Mukherjee, S.; Mason, C.E.; de Strooper, B.; Liston, A.; Park, C.Y. 2015: MiR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a. Blood 125(14): 2206-2216
Li, C.; Zhang, P.; Gu, J. 2015: MiR-29a modulates tumor necrosis factor-α-induced osteogenic inhibition by targeting Wnt antagonists. Development Growth and Differentiation 57(3): 264-273
Han, C.; Chen, X.; Zhuang, R.; Xu, M.; Liu, S.; Li, Q. 2015: MiR-29a promotes myocardial cell apoptosis induced by high glucose through down-regulating IGF-1. International Journal of Clinical and Experimental Medicine 8(8): 14352-14362
Wang, S.; Zan, J.; Wu, M.; Zhao, W.; Li, Z.; Pan, Y.; Sun, Z.; Zhu, J. 2015: MiR-29a promotes scavenger receptor a expression by targeting QKi (quaking) during monocyte-macrophage differentiation. Biochemical and Biophysical Research Communications 464(1): 1-6
Zhang, Y.; Li, Y.H.; Liu, C.; Nie, C.-J.; Zhang, X.-H.; Zheng, C.-Y.; Jiang, W.; Yin, W.-N.; Ren, M.-H.; Jin, Y.-X.; Liu, S.-F.; Zheng, B.; Wen, J.-K. 2017: MiR-29a regulates vascular neointimal hyperplasia by targeting YY1. Cell Proliferation 50(3)
Li, R.; Liu, J.; Li, Q.; Chen, G.; Yu, X. 2016: MiR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(3): 3987-3996
Fu, Q.; Qin, T.; Chen, L.; Liu, C-Jiang.; Zhang, X.; Wang, Y-Zhu.; Hu, M-Xing.; Chu, H-Yuan.; Zhang, H-Wei. 2016: MiR-29a up-regulation in AR42J cells contributes to apoptosis via targeting TNFRSF1A gene. World Journal of Gastroenterology 22(20): 4881-4890
Qiu, F.; Sun, R.; Deng, N.; Guo, T.; Cao, Y.; Yu, Y.; Wang, X.; Zou, B.; Zhang, S.; Jing, T.; Ling, T.; Xie, J.; Zhang, Q. 2015: MiR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression. Plos one 10(3): E0120969
Langsch, S.; Baumgartner, U.; Haemmig, S.; Schlup, C.; Schäfer, S.C.; Berezowska, S.; Rieger, G.; Dorn, P.; Tschan, M.P.; Vassella, E. 2016: MiR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers. Cancer Research 76(14): 4160-4169
Chen, D-dian.; Feng, L-chun.; Ye, R.; He, Y-qi.; Wang, Y-di. 2015: MiR-29b Reduces Cisplatin Resistance of Gastric Cancer Cell by Targeting PI3K/Akt Pathway. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 37(5): 514-519
Yang, Y.; Pan, Q.; Sun, B.; Yang, R.; Fang, X.; Liu, X.; Yu, X.; Zhao, Z. 2016: MiR-29b Targets LPL and TDG Genes and Regulates Apoptosis and Triglyceride Production in MECs. Dna and Cell Biology 35(12): 758-765
Gigante, M.; Pontrelli, P.; Herr, W.; Gigante, M.; D'Avenia, M.; Zaza, G.; Cavalcanti, E.; Accetturo, M.; Lucarelli, G.; Carrieri, G.; Battaglia, M.; Storkus, W.J.; Gesualdo, L.; Ranieri, E. 2016: MiR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction. Journal of Translational Medicine 14: 84
Chung, H.J.; Choi, Y.E.; Kim, E.S.; Han, Y.-H.; Park, M.-J.; Bae, I.H. 2015: MiR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2. Oncotarget 6(21): 18429-18444
Zhao, H.; Wilkie, T.; Deol, Y.; Sneh, A.; Ganju, A.; Basree, M.; Nasser, M.W.; Ganju, R.K. 2015: MiR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Molecular Cancer 14: 11
Qi, Y.; Li, X.; Zhao, S. 2015: MiR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2. Neoplasma 62(3): 384-390
Xue, T.; Wei, L.; Zha, D.-J.; Qiu, J.-H.; Chen, F.-Q.; Qiao, L.; Qiu, Y. 2016: MiR-29b overexpression induces cochlear hair cell apoptosis through the regulation of SIRT1/PGC-1α signaling: Implications for age-related hearing loss. International Journal of Molecular Medicine 38(5): 1387-1394
Pan, T.; Song, W.; Gao, H.; Li, T.; Cao, X.; Zhong, S.; Wang, Y. 2016: MiR-29b-Loaded Gold Nanoparticles Targeting to the Endoplasmic Reticulum for Synergistic Promotion of Osteogenic Differentiation. Acs Applied Materials and Interfaces 8(30): 19217-19227
Xiao, S.; Yang, Z.; Qiu, X.; Lv, R.; Liu, J.; Wu, M.; Liao, Y.; Liu, Q. 2016: MiR-29c contribute to glioma cells temozolomide sensitivity by targeting O6-methylguanine-DNA methyltransferases indirectely. Oncotarget 7(31): 50229-50238
Solé, C.; Cortés-Hernández, J.; Felip, M.L.; Vidal, M.; Ordi-Ros, J. 2015: MiR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 30(9): 1488-1496
Chuang, T-Der.; Pearce, W.J.; Khorram, O. 2015: MiR-29c induction contributes to downregulation of vascular extracellular matrix proteins by glucocorticoids. American Journal of Physiology. Cell Physiology 309(2): C117-C125
Long, M.; Wan, X.; La, X.; Gong, X.; Cai, X. 2015: MiR-29c is downregulated in the ectopic endometrium and exerts its effects on endometrial cell proliferation, apoptosis and invasion by targeting c-Jun. International Journal of Molecular Medicine 35(4): 1119-1125
Zong, Y.; Yu, P.; Cheng, H.; Wang, H.; Wang, X.; Liang, C.; Zhu, H.; Qin, Y.; Qin, C. 2015: MiR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer's disease. Brain Research 1624: 95-102
Zou, Y.; Li, J.; Chen, Z.; Li, X.; Zheng, S.; Yi, D.; Zhong, A.; Chen, J. 2015: MiR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients. Carcinogenesis 36(6): 676-684
Licholai, S.; Szczeklik, W.; Sanak, M. 2016: MiR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery. Microrna 5(2): 124-131
Shang, J.; Yao, Y.; Fan, X.; Shangguan, L.; Li, J.; Liu, H.; Zhou, Y. 2016: MiR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways. Biochimica et Biophysica Acta 1863(4): 520-532
Xu, H.; Sun, J.; Shi, C.; Sun, C.; Yu, L.; Wen, Y.; Zhao, S.; Liu, J.; Xu, J.; Li, H.; An, T.; Zhou, X.; Ren, L.; Wang, Q.; Yu, S. 2015: MiR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3B. Neuroscience Letters 590: 40-46
Amodio, N.; Rossi, M.; Raimondi, L.; Pitari, M.R.; Botta, C.; Tagliaferri, P.; Tassone, P. 2015: MiR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget 6(15): 12837-12861
Peck, B.C.E.; Sincavage, J.; Feinstein, S.; Mah, A.T.; Simmons, J.G.; Lund, P.Kay.; Sethupathy, P. 2016: MiR-30 Family Controls Proliferation and Differentiation of Intestinal Epithelial Cell Models by Directing a Broad Gene Expression Program That Includes SOX9 and the Ubiquitin Ligase Pathway. Journal of Biological Chemistry 291(31): 15975-15984
Guess, M.G.; Barthel, K.K.B.; Harrison, B.C.; Leinwand, L.A. 2015: MiR-30 family micro RNAs regulate myogenic differentiation and provide negative feedback on the microRNA pathway. Plos one 10(2): E0118229
Tsukasa, K.; Ding, Q.; Miyazaki, Y.; Matsubara, S.; Natsugoe, S.; Takao, S. 2016: MiR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. Human Cell 29(3): 130-137
Wang, J.; Jiao, Y.; Cui, L.; Jiang, L. 2017: MiR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway. Bioscience Biotechnology and Biochemistry 81(1): 119-126
Che, S.; Sun, T.; Wang, J.; Jiao, Y.; Wang, C.; Meng, Q.; Qi, W.; Yan, Z. 2015: MiR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(9): 6805-6811
Hu, F.; Wang, M.; Xiao, T.; Yin, B.; He, L.; Meng, W.; Dong, M.; Liu, F. 2015: MiR-30 promotes thermogenesis and the development of beige fat by targeting RIP140. Diabetes 64(6): 2056-2068
Zhang, B-Wen.; Cai, H-Fang.; Wei, X-Feng.; Sun, J-Jie.; Lan, X-Yong.; Lei, C-Zhao.; Lin, F-Peng.; Qi, X-Lei.; Plath, M.; Chen, H. 2016: MiR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL. International journal of molecular sciences 17(2)
Sousa, J.F.; Nam, K.Taek.; Petersen, C.P.; Lee, H-Joon.; Yang, H-Kwang.; Kim, W.Ho.; Goldenring, J.R. 2016: MiR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach. Gut 65(6): 914-924
Wang, L.; Yu, P. 2016: MiR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53. Oncology Reports 36(6): 3225-3232
Damodaran, C.; Das, T.P.; Papu John, A.M.S.; Suman, S.; Kolluru, V.; Morris, T.J.; Faber, E.N.; Rai, S.N.; Messer, J.C.; Alatassi, H.; Ankem, M.K. 2016: MiR-301a expression: a prognostic marker for prostate cancer. Urologic Oncology 34(8): 336.E13
He, C.; Shi, Y.; Wu, R.; Sun, M.; Fang, L.; Wu, W.; Liu, C.; Tang, M.; Li, Z.; Wang, P.; Cong, Y.; Liu, Z. 2016: MiR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD. Gut 65(12): 1938-1950
Li, H.-H.; Lin, S.-L.; Huang, C.-N.; Lu, F.-J.; Chiu, P.-Y.; Huang, W.-N.; Lai, T.-J.; Lin, C.-L. 2016: MiR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling. Journal of Alzheimer's Disease: Jad 50(4): 1083-1098
Parchem, R.J.; Moore, N.; Fish, J.L.; Parchem, J.G.; Braga, T.T.; Shenoy, A.; Oldham, M.C.; Rubenstein, J.L.R.; Schneider, R.A.; Blelloch, R. 2015: MiR-302 Is Required for Timing of Neural Differentiation, Neural Tube Closure, and Embryonic Viability. Cell Reports 12(5): 760-773
Wang, Y.; Zhao, L.; Xiao, Q.; Jiang, L.; He, M.; Bai, X.; Ma, M.; Jiao, X.; Wei, M. 2016: MiR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells. Gynecologic Oncology 141(3): 592-601
Cataldo, A.; Cheung, D.G.; Balsari, A.; Tagliabue, E.; Coppola, V.; Iorio, M.V.; Palmieri, D.; Croce, C.M. 2016: MiR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget 7(1): 786-797
Liu, F.-Y.; Wang, L.-P.; Wang, Q.; Han, P.; Zhuang, W.-P.; Li, M.-J.; Yuan, H. 2016: MiR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer. Cancer Medicine 5(9): 2302-2313
Wang, L.; Yao, J.; Sun, H.; Sun, R.; Chang, S.'e.; Yang, Y.; Song, T.; Huang, C. 2016: MiR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(1): 847-855
Park, D.; Kim, H.; Kim, Y.; Jeoung, D. 2016: MiR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer Drugs. Molecules and Cells 39(4): 299-309
Zou, Z.; Ni, M.; Zhang, J.; Chen, Y.; Ma, H.; Qian, S.; Tang, L.; Tang, J.; Yao, H.; Zhao, C.; Lu, X.; Sun, H.; Qian, J.; Mao, X.; Lu, X.; Liu, Q.; Zen, J.; Wu, H.; Bao, Z.; Lin, S.; Sheng, H.; Li, Y.; Liang, Y.; Chen, Z.; Zong, D. 2016: MiR-30a can inhibit DNA replication by targeting RPA1 thus slowing cancer cell proliferation. Biochemical Journal 473(14): 2131-2139
Sestito, R.; Cianfrocca, R.; Rosanò, L.; Tocci, P.; Semprucci, E.; Di Castro, V.; Caprara, V.; Ferrandina, G.; Sacconi, A.; Blandino, G.; Bagnato, A. 2016: MiR-30a inhibits endothelin a receptor and chemoresistance in ovarian carcinoma. Oncotarget 7(4): 4009-4023
Li, S.-P.; He, J.-D.; Wang, Z.; Yu, Y.; Fu, S.-Y.; Zhang, H.-M.; Zhang, J.-J.; Shen, Z.-Y. 2016: MiR-30b inhibits autophagy to alleviate hepatic ischemia-reperfusion injury via decreasing the Atg12-Atg5 conjugate. World Journal of Gastroenterology 22(18): 4501-4514
Raut, S.K.; Kumar, A.; Singh, G.B.; Nahar, U.; Sharma, V.; Mittal, A.; Sharma, R.; Khullar, M. 2015: MiR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy. Cardiovascular Therapeutics 33(3): 89-97
Raut, S.K.; Singh, G.B.; Rastogi, B.; Saikia, U.N.; Mittal, A.; Dogra, N.; Singh, S.; Prasad, R.; Khullar, M. 2016: MiR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Molecular and Cellular Biochemistry 417(1-2): 191-203
Roy, S.; Benz, F.; Vargas Cardenas, D.; Vucur, M.; Gautheron, J.; Schneider, A.; Hellerbrand, C.; Pottier, N.; Alder, J.; Tacke, F.; Trautwein, C.; Roderburg, C.; Luedde, T. 2015: MiR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis. Journal of Digestive Diseases 16(9): 513-524
Sun, T.; Li, W.; Ling, S. 2016: MiR-30c and semaphorin 3A determine adult neurogenesis by regulating proliferation and differentiation of stem cells in the subventricular zones of mouse. Cell Proliferation 49(3): 270-280
Wu, W.; Zhang, X.; Liao, Y.; Zhang, W.; Cheng, H.; Deng, Z.; Shen, J.; Yuan, Q.; Zhang, Y.; Shen, W. 2015: MiR-30c negatively regulates the migration and invasion by targeting the immediate early response protein 2 in SMMC-7721 and HepG2 cells. American Journal of Cancer Research 5(4): 1435-1446
Ye, Z.; Zhao, L.; Li, J.; Chen, W.; Li, X. 2015: MiR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society 25(9): 1574-1581
Chakrabarti, M.; Klionsky, D.J.; Ray, S.K. 2016: MiR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells. Plos one 11(7): E0158537
Sohn, D.; Peters, D.; Piekorz, R.P.; Budach, W.; Jänicke, R.U. 2016: MiR-30e controls DNA damage-induced stress responses by modulating expression of the CDK inhibitor p21WAF1/CIP1 and caspase-3. Oncotarget 7(13): 15915-15929
Ding, W.; Li, J.; Singh, J.; Alif, R.; Vazquez-Padron, R.I.; Gomes, S.A.; Hare, J.M.; Shehadeh, L.A. 2015: MiR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice. Cardiovascular Research 106(1): 131-142
Chen, Z.; Qiu, H.; Ma, L.; Luo, J.; Sun, S.; Kang, K.; Gou, D.; Loor, J.J. 2016: MiR-30e-5p and miR-15a Synergistically Regulate Fatty Acid Metabolism in Goat Mammary Epithelial Cells via LRP6 and YAP1. International Journal of Molecular Sciences 17(11)
Liu, D.; Dejun, L.; Sun, X.; Xuelin, S.; Ye, P.; Ping, Y. 2015: MiR-31 Overexpression Exacerbates Atherosclerosis by Targeting NOX4 in apoE(-/-) Mice. Clinical Laboratory 61(11): 1617-1624
Wu, D.; Wang, B.; Shang, J.; Song, J.; Zhang, H. 2015: MiR-31 Reduces Cell Growth of Papillary Thyroid Carcinoma by RNA-Binding Protein HuR. Clinical Laboratory 61(11): 1625-1634
Yang, X.; Xu, X.; Zhu, J.; Zhang, S.; Wu, Y.; Wu, Y.; Zhao, K.; Xing, C.; Cao, J.; Zhu, H.; Li, M.; Ye, Z.; Peng, W. 2016: MiR-31 affects colorectal cancer cells by inhibiting autophagy in cancer-associated fibroblasts. Oncotarget 7(48): 79617-79628
Thompson, M.A.; Edmonds, M.D.; Liang, S.; McClintock-Treep, S.; Wang, X.; Li, S.; Eischen, C.M. 2016: MiR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Human Pathology 50: 118-126
Zheng, W.; Liu, Z.; Zhang, W.; Hu, X. 2015: MiR-31 functions as an oncogene in cervical cancer. Archives of Gynecology and Obstetrics 292(5): 1083-1089
Guo, H.; Qi, R.-Q.; Lv, Y.-N.; Wang, H.-X.; Hong, Y.-X.; Zheng, S.; Li, J.-H.; Gao, X.-H.; Chen, H.-D. 2016: MiR-31 is distinctively overexpressed in primary male extramammary Paget's disease. Oncotarget 7(17): 24559-24563
Lu, W.-C.; Liu, C.-J.; Tu, H.-F.; Chung, Y.-T.; Yang, C.-C.; Kao, S.-Y.; Chang, K.-W.; Lin, S.-C. 2016: MiR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma. Oncotarget 7(35): 57254-57267
Cui, X.; Li, Q.; He, Y. 2017: MiR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL. Molecular and Cellular Biochemistry 424(1-2): 195-201
Zhu, D.; Chen, H.; Yang, X.; Chen, W.; Wang, L.; Xu, J.; Yu, L. 2015: MiR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer. Oncotargets and Therapy 8: 1773-1783
Anonymous 2016: MiR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer [Retraction. OncoTargets and therapy 9: 6379
Li, L.; Wu, D. 2016: MiR-32 inhibits proliferation, epithelial-mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells. Oncotargets and Therapy 9: 1489-1498
Wan, L.-Y.; Deng, J.; Xiang, X.-J.; Zhang, L.; Yu, F.; Chen, J.; Sun, Z.; Feng, M.; Xiong, J.-P. 2015: MiR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1. Biochemical and Biophysical Research Communications 457(2): 125-132
Li, X-Qian.; Fang, B.; Tan, W-Fei.; Wang, Z-Lin.; Sun, X-Jia.; Zhang, Z-Li.; Ma, H. 2016: MiR-320a affects spinal cord edema through negatively regulating aquaporin-1 of blood-spinal cord barrier during bimodal stage after ischemia reperfusion injury in rats. BMC neuroscience 17: 10
Yin, Z.; Zhao, Y.; Li, H.; Yan, M.; Zhou, L.; Chen, C.; Wang, D.W. 2016: MiR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway. Aging 8(1): 192-207
Lu, Y.; Wu, D.; Wang, J.; Li, Y.; Chai, X.; Kang, Q. 2016: MiR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3. Biochemical and Biophysical Research Communications 473(4): 1315-1320
Wang, H.; Cao, F.; Li, X.; Miao, H.; E, J.; Xing, J.; Fu, C.-G. 2015: MiR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells. Bmc Cancer 15: 748
Marchand, A.; Atassi, F.; Mougenot, N.; Clergue, M.; Codoni, V.; Berthuin, J.; Proust, C.; Trégouët, D.-A.; Hulot, J.-S.éb.; Lompré, A.-M. 2016: MiR-322 regulates insulin signaling pathway and protects against metabolic syndrome-induced cardiac dysfunction in mice. Biochimica et Biophysica Acta 1862(4): 611-621
Shen, X.; Soibam, B.; Benham, A.; Xu, X.; Chopra, M.; Peng, X.; Yu, W.; Bao, W.; Liang, R.; Azares, A.; Liu, P.; Gunaratne, P.H.; Mercola, M.; Cooney, A.J.; Schwartz, R.J.; Liu, Y. 2016: MiR-322/-503 cluster is expressed in the earliest cardiac progenitor cells and drives cardiomyocyte specification. Proceedings of the National Academy of Sciences of the United States of America 113(34): 9551-9556
Ge, L.; Habiel, D.M.; Hansbro, P.M.; Kim, R.Y.; Gharib, S.A.; Edelman, J.D.; Königshoff, M.; Parimon, T.; Brauer, R.; Huang, Y.; Allen, J.; Jiang, D.; Kurkciyan, A.A.; Mizuno, T.; Stripp, B.R.; Noble, P.W.; Hogaboam, C.M.; Chen, P. 2016: MiR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways. Jci Insight 1(20): E90301
Li, J.; Li, S.; Chen, Z.; Wang, J.; Chen, Y.; Xu, Z.; Jin, M.; Yu, W. 2016: MiR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(10): 13287-13294
Yu, S.; Huang, H.; Deng, G.; Xie, Z.; Ye, Y.; Guo, R.; Cai, X.; Hong, J.; Qian, D.; Zhou, X.; Tao, Z.; Chen, B.; Li, Q. 2015: MiR-326 targets antiapoptotic Bcl-xL and mediates apoptosis in human platelets. Plos one 10(4): E0122784
Cao, J.-X.; Wen, F.; Wang, H.; Liao, P.; Li, J.-J. 2015: MiR-328 Inhibits K562 Cell Proliferation by Up-regulation of C/EBPα Expression. Zhongguo Shi Yan Xue Ye Xue Za Zhi 23(2): 350-355
Liu, X.; Shi, H.; Liu, B.; Li, J.; Liu, Y.; Yu, B. 2015: MiR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer. Acta Biochimica et Biophysica Sinica 47(6): 431-440
Kim, B.-K.; Yoo, H.-I.; Choi, K.; Yoon, S.K. 2015: MiR-330-5p inhibits proliferation and migration of keratinocytes by targeting Pdia3 expression. Febs Journal 282(24): 4692-4702
Kim, Y.; Kim, H.; Park, D.; Jeoung, D. 2015: MiR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3. Molecules and Cells 38(6): 562-572
Yang, B.; Huang, J.; Liu, H.; Guo, W.; Li, G. 2016: MiR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(2): 1771-1779
Wang, K.; Chen, X.; Zhan, Y.; Jiang, W.; Liu, X.; Wang, X.; Wu, B. 2015: MiR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(9): 6875-6882
Chen, X.; Wei, L.; Zhao, S. 2016: MiR-338 inhibits the metastasis of lung cancer by targeting integrin β3. Oncology Reports 36(3): 1467-1474
Chen, J-Song.; Liang, L-Li.; Xu, H-Xu.; Chen, F.; Shen, S-Li.; Chen, W.; Chen, L-Zhou.; Su, Q.; Zhang, L-Juan.; Bi, J.; Zeng, W-Tao.; Li, W.; Ma, N.; Huang, X-Hui. 2016: miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells. Oncotarget (): -
Hong-Yuan, W.; Xiao-Ping, C. 2015: MiR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer. Indian Journal of Cancer 52(Suppl 3): E168-E171
Ma, X.; He, X.; Dong, P.; Xue, D.; Song, D.; Xu, H.; Zhang, X. 2016: MiR-338-5p modulates B cell biological functions by targeting NF-κB1. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32(11): 1475-1480
Weber, C.E.M.; Luo, C.; Hotz-Wagenblatt, A.; Gardyan, A.; Kordaß, T.; Holland-Letz, T.; Osen, W.; Eichmüller, S.B. 2016: MiR-339-3p Is a Tumor Suppressor in Melanoma. Cancer Research 76(12): 3562-3571
Zhou, C.; Lu, Y.; Li, X. 2015: MiR-339-3p inhibits proliferation and metastasis of colorectal cancer. Oncology Letters 10(5): 2842-2848
Shan, W.; Li, J.; Bai, Y.; Lu, X. 2016: MiR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 37(4): 5203-5211
Hou, H.; Kang, Y.; Li, Y.; Zeng, Y.; Ding, G.; Shang, J. 2017: MiR-33a expression sensitizes Lgr5+ HCC-CSCs to doxorubicin via ABCA1. Neoplasma 64(1): 81-91
Zhou, J.; Xu, D.; Xie, H.; Tang, J.; Liu, R.; Li, J.; Wang, S.; Chen, X.; Su, J.; Zhou, X.; Xia, K.; He, Q.; Chen, J.; Xiong, W.; Cao, P.; Cao, K. 2015: MiR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α. Cancer Biology and Therapy 16(6): 846-855
Tian, F.; Wei, H.; Tian, H.; Qiu, Y.; Xu, J. 2016: MiR-33a is downregulated in melanoma cells and modulates cell proliferation by targeting PCTAIRE1. Oncology Letters 11(4): 2741-2746
Liang, C.; Wang, Z.; Li, Y.-Y.; Yu, B.-H.; Zhang, F.; Li, H.-Y. 2015: MiR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(12): 9395-9403
Mi, W.; Shi, Q.; Chen, X.; Wu, T.; Huang, H. 2016: MiR-33a-5p modulates TNF-α-inhibited osteogenic differentiation by targeting SATB2 expression in hBMSCs. Febs Letters 590(3): 396-407
Xiong, X.-P.; Kurthkoti, K.; Chang, K.-Y.; Li, J.-L.; Ren, X.; Ni, J.-Q.; Rana, T.M.; Zhou, R. 2016: MiR-34 Modulates Innate Immunity and Ecdysone Signaling in Drosophila. Plos Pathogens 12(11): E1006034
Navarro, F.; Lieberman, J. 2015: MiR-34 and p53: new Insights into a Complex Functional Relationship. Plos one 10(7): E0132767
Disayabutr, S.; Kim, E.K.; Cha, S.-I.; Green, G.; Naikawadi, R.P.; Jones, K.D.; Golden, J.A.; Schroeder, A.; Matthay, M.A.; Kukreja, J.; Erle, D.J.; Collard, H.R.; Wolters, P.J. 2016: MiR-34 mi RNAs Regulate Cellular Senescence in Type Ii Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis. Plos one 11(6): E0158367
Hou, L-Kun.; Yu, Y.; Xie, Y-Gong.; Wang, J.; Mao, J-Fei.; Zhang, B.; Wang, X.; Cao, X-Chen. 2016: MiR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression. Oncotarget 7(18): 26016-26026
Li, X.; Gong, X.; Chen, J.; Zhang, J.; Sun, J.; Guo, M. 2015: MiR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2. Biochemical and Biophysical Research Communications 460(3): 670-677
Fiore, D.; Donnarumma, E.; Roscigno, G.; Iaboni, M.; Russo, V.; Affinito, A.; Adamo, A.; De Martino, F.; Quintavalle, C.; Romano, G.; Greco, A.; Soini, Y.; Brunetti, A.; Croce, C.M.; Condorelli, G. 2016: MiR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS. Oncotarget 7(15): 19531-19547
Shi, L.; Chen, Z.-G.; Wu, L.-L.; Zheng, J.-J.; Yang, J.-R.; Chen, X.-F.; Chen, Z.-Q.; Liu, C.-L.; Chi, S.-Y.; Zheng, J.-Y.; Huang, H.-X.; Lin, X.-Y.; Zheng, F. 2014: MiR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway. Asian Pacific Journal of Cancer Prevention: Apjcp 15(23): 10439-10444
Huang, D.; Qiu, S.; Ge, R.; He, L.; Li, M.; Li, Y.; Peng, Y. 2015: MiR-340 suppresses glioblastoma multiforme. Oncotarget 6(11): 9257-9270
Crippa, E.; Folini, M.; Pennati, M.; Zaffaroni, N.; Pierotti, M.A.; Gariboldi, M. 2016: MiR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells. Oncotarget 7(14): 18594-18604
Zhao, L.; Zhang, Y. 2015: MiR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Biochemical and Biophysical Research Communications 457(3): 370-377
Tai, M.C.; Kajino, T.; Nakatochi, M.; Arima, C.; Shimada, Y.; Suzuki, M.; Miyoshi, H.; Yatabe, Y.; Yanagisawa, K.; Takahashi, T. 2015: MiR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis 36(12): 1464-1473
Xie, X.; Liu, H.; Wang, M.; Ding, F.; Xiao, H.; Hu, F.; Hu, R.; Mei, J. 2015: MiR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(7): 5031-5038
Yan, X.-C.; Cao, J.; Liang, L.; Wang, L.; Gao, F.; Yang, Z.-Y.; Duan, J.-L.; Chang, T.-F.; Deng, S.-M.; Liu, Y.; Dou, G.-R.; Zhang, J.; Zheng, Q.-J.; Zhang, P.; Han, H. 2016: MiR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling. Journal of the American Heart Association 5(2)
Guo, J.; Lv, J.; Liu, M.; Tang, H. 2015: MiR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy. Journal of Biological Chemistry 290(51): 30342-30350
Su, M.-T.; Tsai, P.-Y.; Tsai, H.-L.; Chen, Y.-C.; Kuo, P.-L. 2017: MiR-346 and miR-582-3p-regulated EG-VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9. Biofactors 43(2): 210-219
Yan, H.-L.; Li, L.; Li, S.-J.; Zhang, H.-S.; Xu, W. 2016: MiR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1. Journal of Biochemical and Molecular Toxicology 30(12): 602-607
Chen, Y.; Rao, Q.; Zhang, H.; Xu, H.; Zhang, C.; Zhuang, Q.; Ye, Z. 2016: MiR-34C Disrupts the Stemness of Purified CD133+ Prostatic Cancer Stem Cells. Urology 96: 177.E1-177.E9
Cui, H.; Ge, J.; Xie, N.; Banerjee, S.; Zhou, Y.; Antony, V.B.; Thannickal, V.J.; Liu, G. 2017: MiR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence. American Journal of Respiratory Cell and Molecular Biology 56(2): 168-178
Adams, B.D.; Wali, V.B.; Cheng, C.J.; Inukai, S.; Booth, C.J.; Agarwal, S.; Rimm, D.L.; Győrffy, B.áz.; Santarpia, L.; Pusztai, L.; Saltzman, W.M.; Slack, F.J. 2016: MiR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer. Cancer Research 76(4): 927-939
Łakomiak, A.; Brzuzan, P.ł; Jakimiuk, E.; Florczyk, M.; Woźny, M. 2016: MiR-34a and bcl-2 expression in whitefish (Coregonus lavaretus) after microcystin-LR exposure. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 193: 47-56
Li, J.; Yu, L.; Shen, Z.; Li, Y.; Chen, B.; Wei, W.; Chen, X.; Wang, Q.; Tong, F.; Lou, H.; Chu, M.; Wei, L. 2016: MiR-34a and its novel target, NLRC5, are associated with HPV16 persistence. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 44: 293-299
Ribeiro, J.; Marinho-Dias, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.ês.; Medeiros, R.; Sousa, H. 2015: MiR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development. Biomed Research International 2015: 304584
Gallardo, E.; Navarro, A.; Carcereny, E.; Jansa, S.; Viñolas, N.; Marrades, R.; Ramirez, J.; Monzo, M. 2016: miR-34a as a prognostic marker of relapse in non-small-cell lung cancer (NSCLC) patients (p)after curative surgery. Journal of Clinical Oncology 26(15_Suppl): 11029-11029
Xu, X.; Chen, W.; Miao, R.; Zhou, Y.; Wang, Z.; Zhang, L.; Wan, Y.; Dong, Y.; Qu, K.; Liu, C. 2015: MiR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway. Oncotarget 6(6): 3988-4004
Duan, K.; Ge, Y.-C.; Zhang, X.-P.; Wu, S.-Y.; Feng, J.-S.; Chen, S.-L.; Zhang, L.I.; Yuan, Z.-H.; Fu, C.-H. 2015: MiR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression. Oncology Letters 10(5): 3223-3227
Park, H.; Park, H.; Pak, H.-J.; Yang, D.-Y.; Kim, Y.-H.; Choi, W.-J.; Park, S.-J.; Cho, J.-A.; Lee, K.-W. 2015: MiR-34a inhibits differentiation of human adipose tissue-derived stem cells by regulating cell cycle and senescence induction. Differentiation; Research in Biological Diversity 90(4-5): 91-100
Sun, H.; Tian, J.; Xian, W.; Xie, T.; Yang, X. 2015: MiR-34a inhibits proliferation and invasion of bladder cancer cells by targeting orphan nuclear receptor HNF4G. Disease Markers 2015: 879254
Shi, H.; Zhou, S.; Liu, J.; Zhu, J.; Xue, J.; Gu, L.; Chen, Y. 2016: MiR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer. Pathology Research and Practice 212(5): 444-449
Nie, J.; Ge, X.; Geng, Y.; Cao, H.; Zhu, W.; Jiao, Y.; Wu, J.; Zhou, J.; Cao, J. 2015: MiR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1. Oncology Reports 34(1): 311-317
Zhan, J.; Qin, S.; Lu, L.; Hu, X.; Zhou, J.; Sun, Y.; Yang, J.; Liu, Y.; Wang, Z.; Tan, N.; Chen, J.; Zhang, C. 2016: MiR-34a is a common link in both HIV- and antiretroviral therapy-induced vascular aging. Aging 8(12): 3298-3310
Li, X.; Zhao, J.; Tang, J. 2014: MiR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1. Zhonghua Zhong Liu Za Zhi 36(12): 892-896
Song, C.; Lu, P.; Sun, G.; Yang, L.; Wang, Z.; Wang, Z. 2017: MiR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis. Biochemical and Biophysical Research Communications 482(1): 22-27
Lavery, C.A.; Kurowska-Stolarska, M.; Holmes, W.M.; Donnelly, I.; Caslake, M.; Collier, A.; Baker, A.H.; Miller, A.M. 2016: MiR-34a(-/-) mice are susceptible to diet-induced obesity. Obesity 24(8): 1741-1751
Wang, G.; Yao, J.; Li, Z.; Zu, G.; Feng, D.; Shan, W.; Li, Y.; Hu, Y.; Zhao, Y.; Tian, X. 2016: MiR-34a-5p Inhibition Alleviates Intestinal Ischemia/Reperfusion-Induced Reactive Oxygen Species Accumulation and Apoptosis via Activation of SIRT1 Signaling. Antioxidants and Redox Signaling 24(17): 961-973
Han, Y.; Meng, F.; Venter, J.; Wu, N.; Wan, Y.; Standeford, H.; Francis, H.; Meininger, C.; Greene, J.; Trzeciakowski, J.P.; Ehrlich, L.; Glaser, S.; Alpini, G. 2016: MiR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth. Journal of Hepatology 64(6): 1295-1304
Li, G.; Song, Y.; Zhang, Y.; Wang, H.; Xie, J. 2016: MiR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia. Oncology Research 24(2): 109-116
Xiao, J.; Li, Y.; Zhang, W.; Jiang, Y.; Du, B.; Tan, Y. 2016: MiR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22. Oncotargets and Therapy 9: 1525-1534
Wang, J.W.; Chen, P.; Qian, X.K.; Li, Y.H.; Cui, J.; Zhu, X.N.; Wang, Y.; Wang, S.M.; Wang, J.S. 2016: MiR-34b-3p regulates the angiogenesis of senescent endothelial cell. Zhonghua Yi Xue Za Zhi 96(16): 1293-1297
Li, F.; Chen, H.; Huang, Y.; Zhang, Q.; Xue, J.; Liu, Z.; Zheng, F. 2015: MiR-34c plays a role of tumor suppressor in HEC‑1-B cells by targeting E2F3 protein. Oncology Reports 33(6): 3069-3074
Liu, F.; Wang, X.; Li, J.; Gu, K.; Lv, L.; Zhang, S.; Che, D.; Cao, J.; Jin, S.; Yu, Y. 2015: MiR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer. Cell Proliferation 48(5): 582-592
Song, J.; Wang, Q.; Luo, Y.; Yuan, P.; Tang, C.; Hui, Y.; Wang, Z. 2015: MiR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS. International Journal of Clinical and Experimental Pathology 8(10): 12728-12737
Cui, W.; Li, Y.; Xu, K.; Chen, G.; Lu, X.; Duan, Q.; Kang, Z. 2016: MiR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA. Biochemical and Biophysical Research Communications 479(4): 901-906
Li, S.; Wang, C.; Yu, X.; Wu, H.; Hu, J.; Wang, S.; Ye, Z. 2017: MiR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression. Oncology Reports 37(1): 241-248
Zou, X.; Zhong, J.; Li, J.; Su, Z.; Chen, Y.; Deng, W.; Li, Y.; Lu, S.; Lin, Y.; Luo, L.; Li, Z.; Cai, Z.; Tang, A. 2016: MiR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells. Molecular Medicine Reports 13(1): 994-1002
Wu, K.; Yang, L.; Chen, J.; Zhao, H.; Wang, J.; Xu, S.; Huang, Z. 2015: MiR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2β. Febs Letters 589(15): 1911-1919
Morizane, R.; Fujii, S.; Monkawa, T.; Hiratsuka, K.; Yamaguchi, S.; Homma, K.; Itoh, H. 2016: MiR-363 induces transdifferentiation of human kidney tubular cells to mesenchymal phenotype. Clinical and Experimental Nephrology 20(3): 394-401
Zhang, P.-F.; Sheng, L.-L.; Wang, G.; Tian, M.; Zhu, L.-Y.; Zhang, R.; Zhang, J.; Zhu, J.-S. 2016: MiR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression. Oncotarget 7(23): 35284-35292
Tao, S.; Liu, Y.-B.; Zhou, Z.-W.; Lian, B.; Li, H.; Li, J.-P.; Zhou, S.-F. 2016: MiR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells. American Journal of Translational Research 8(4): 1659-1677
Gao, J.; Zhao, P.; Chen, X.; Wang, W.; Li, Y.; Xi, W.; Zhang, W.; Hu, P.; Wang, T.; Shan, L. 2016: MiR-365 inhibits proliferation and promotes apoptosis of SOSP9607 osteosarcoma cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32(1): 44-48
Meng, X.; Lu, P.; Fan, Q. 2016: MiR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN. Biochemical and Biophysical Research Communications 470(1): 187-191
Kaid, C.; Silva, P.íc.B.G.; Cortez, B.A.; Rodini, C.O.; Semedo-Kuriki, P.; Okamoto, O.K. 2015: MiR-367 promotes proliferation and stem-like traits in medulloblastoma cells. Cancer Science 106(9): 1188-1195
Song, J.; Kim, D.; Chun, C.-H.; Jin, E.-J. 2015: MiR-370 and miR-373 regulate the pathogenesis of osteoarthritis by modulating one-carbon metabolism via SHMT-2 and MECP-2, respectively. Aging Cell 14(5): 826-837
Li, W.; Cheng, P.; Nie, S.; Cui, W. 2016: MiR-370 mimic inhibits replication of Japanese encephalitis virus in glioblastoma cells. Neuropsychiatric Disease and Treatment 12: 2411-2417
Fan, H.; Lv, P.; Lv, J.; Zhao, X.; Liu, M.; Zhang, G.; Tang, H. 2017: MiR-370 suppresses HBV gene expression and replication by targeting nuclear factor IA. Journal of Medical Virology 89(5): 834-844
Yeh, L.-Y.; Liu, C.-J.; Wong, Y.-K.; Chang, C.; Lin, S.-C.; Chang, K.-W. 2015: MiR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo. Oncotarget 6(8): 6062-6075
Huang, X.; Huang, M.; Kong, L.; Li, Y. 2015: MiR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma. Cell Proliferation 48(5): 593-599
Wei, F.; Wang, Q.; Su, Q.; Huang, H.; Luan, J.; Xu, X.; Wang, J. 2016: MiR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2. Cellular and Molecular Neurobiology 36(8): 1389-1397
Lee, J.S.; Song, D.W.; Park, J.H.; Kim, J.O.; Cho, C.; Kim, D.H. 2017: MiR-374 promotes myocardial hypertrophy by negatively regulating vascular endothelial growth factor receptor-1 signaling. Bmb Reports 50(4): 208-213
Xu, X.; Wang, W.; Su, N.; Zhu, X.; Yao, J.; Gao, W.; Hu, Z.; Sun, Y. 2015: MiR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer. Febs Letters 589(3): 407-413
Yu, X.; Zhao, W.; Yang, X.; Wang, Z.; Hao, M. 2016: MiR-375 Affects the Proliferation, Invasion, and Apoptosis of HPV16-Positive Human Cervical Cancer Cells by Targeting IGF-1R. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society 26(5): 851-858
Song, L.; Liu, S.; Zeng, S.; Zhang, L.; Li, X. 2015: MiR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway. Medical science monitor: international medical journal of experimental and clinical research 21: 2210-2217
Hu, S.; Zhang, M.; Sun, F.; Ren, L.; He, X.; Hua, J.; Peng, S. 2016: MiR-375 controls porcine pancreatic stem cell fate by targeting 3-phosphoinositide-dependent protein kinase-1 (Pdk1). Cell Proliferation 49(3): 395-406
Guo, Y.; An, R.; Zhao, R.; Sun, Y.; Liu, M.; Tian, L. 2016: MiR-375 exhibits a more effective tumor-suppressor function in laryngeal squamous carcinoma cells by regulating KLF4 expression compared with simple co-transfection of miR-375 and miR-206. Oncology Reports 36(2): 952-960
Latreille, M.; Herrmanns, K.; Renwick, N.; Tuschl, T.; Malecki, M.T.; McCarthy, M.I.; Owen, K.R.; Rülicke, T.; Stoffel, M. 2015: MiR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development. Journal of Molecular Medicine 93(10): 1159-1169
Wang, Y.; Lieberman, R.; Pan, J.; Zhang, Q.; Du, M.; Zhang, P.; Nevalainen, M.; Kohli, M.; Shenoy, N.K.; Meng, H.; You, M.; Wang, L. 2016: MiR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1. Molecular Cancer 15(1): 70
Jia, L.; Huang, Y.; Zheng, Y.; Lyu, M.; Zhang, C.; Meng, Z.; Gan, Y.; Yu, G. 2015: MiR-375 inhibits cell growth and correlates with clinical outcomes in tongue squamous cell carcinoma. Oncology Reports 33(4): 2061-2071
Cui, F.; Wang, S.; Lao, I.; Zhou, C.; Kong, H.; Bayaxi, N.; Li, J.; Chen, Q.; Zhu, T.; Zhu, H. 2016: MiR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes. Oncology Reports 36(1): 487-493
Liu, S.; Sun, G.; Yuan, B.; Zhang, L.; Gao, Y.; Jiang, H.; Dai, L.; Zhang, J. 2016: MiR-375 negatively regulates porcine preadipocyte differentiation by targeting BMPR2. Febs Letters 590(10): 1417-1427
Miao, C.-g.; Shi, W.-j.; Xiong, Y.-y.; Yu, H.; Zhang, X.-l.; Qin, M.-s.; Du, C.-l.; Song, T.-w.; Li, J. 2015: MiR-375 regulates the canonical Wnt pathway through FZD8 silencing in arthritis synovial fibroblasts. Immunology Letters 164(1): 1-10
Deng, Y.; Xiong, Y.; Liu, Y. 2016: MiR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1. International Journal of Experimental Pathology 97(3): 257-265
Wang, R.; Ma, Y.; Yu, D.; Zhao, J.; Ma, P. 2015: MiR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1. Biomedicine and PharmacoTherapy 70: 64-71
Zhang, J.; Zhao, M.; Xue, Z.-Q.; Liu, Y.; Wang, Y.-X. 2016: MiR-377 inhibited tumorous behaviors of non-small cell lung cancer through directly targeting CDK6. European Review for Medical and Pharmacological Sciences 20(21): 4494-4499
Al-Harbi, S.; Choudhary, G.S.; Ebron, J.S.; Hill, B.T.; Vivekanathan, N.; Ting, A.H.; Radivoyevitch, T.; Smith, M.R.; Shukla, G.C.; Almasan, A. 2015: MiR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies. Molecular Cancer 14: 185
Zhang, Y.; Li, C.; Li, H.; Song, Y.; Zhao, Y.; Zhai, L.; Wang, H.; Zhong, R.; Tang, H.; Zhu, D. 2016: MiR-378 Activates the Pyruvate-PEP Futile Cycle and Enhances Lipolysis to Ameliorate Obesity in Mice. Ebiomedicine 5: 93-104
Zeng, P.; Han, W.; Li, C.; Li, H.; Zhu, D.; Zhang, Y.; Liu, X. 2016: MiR-378 attenuates muscle regeneration by delaying satellite cell activation and differentiation in mice. Acta Biochimica et Biophysica Sinica 48(9): 833-839
Kuang, X.; Wei, C.; Zhang, T.; Yang, Z.; Chi, J.; Wang, L. 2016: MiR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes. International Journal of Oncology 49(5): 1921-1930
Wei, X.; Li, H.; Zhang, B.; Li, C.; Dong, D.; Lan, X.; Huang, Y.; Bai, Y.; Lin, F.; Zhao, X.; Chen, H. 2016: MiR-378a-3p promotes differentiation and inhibits proliferation of myoblasts by targeting HDAC4 in skeletal muscle development. Rna Biology 13(12): 1300-1309
Li, K.; Wang, Y.; Zhang, A.; Liu, B.; Jia, L. 2017: MiR-379 Inhibits Cell Proliferation, Invasion, and Migration of Vascular Smooth Muscle Cells by Targeting Insulin-Like Factor-1. Yonsei Medical Journal 58(1): 234-240
Shi, X.; Yan, C.; Liu, B.; Yang, C.; Nie, X.; Wang, X.; Zheng, J.; Wang, Y.; Zhu, Y. 2015: MiR-381 Regulates Neural Stem Cell Proliferation and Differentiation via Regulating Hes1 Expression. Plos one 10(10): E0138973
Ming, J.; Zhou, Y.; Du, J.; Fan, S.; Pan, B.; Wang, Y.; Fan, L.; Jiang, J. 2015: MiR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells. Bioscience Reports 35(6)
Tan, H.; He, Q.; Gong, G.; Wang, Y.; Li, J.; Wang, J.; Zhu, D.; Wu, X. 2016: MiR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer. International Journal of Oncology 48(1): 181-190
Bei, Y.; Song, Y.; Wang, F.; Dimitrova-Shumkovska, J.; Xiang, Y.; Zhao, Y.; Liu, J.; Xiao, J.; Yang, C. 2016: MiR-382 targeting PTEN-Akt axis promotes liver regeneration. Oncotarget 7(2): 1584-1597
Zini, R.; Rossi, C.; Norfo, R.; Pennucci, V.; Barbieri, G.; Ruberti, S.; Rontauroli, S.; Salati, S.; Bianchi, E.; Manfredini, R. 2016: MiR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1. Stem Cells and Development 25(19): 1433-1443
Chen, L.; Guan, H.; Gu, C.; Cao, Y.; Shao, J.; Wang, F. 2016: MiR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(2): 2497-2507
Li, Y.; Hu, G.; Li, P.; Tang, S.; Zhang, J.; Jia, G. 2016: MiR-3940-5p enhances homologous recombination after DSB in Cr(VI) exposed 16HBE cell. Toxicology 344-346: 1-6
Tan, S.; Shi, H.; Ba, M.; Lin, S.; Tang, H.; Zeng, X.; Zhang, X. 2016: MiR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy. International Journal of Molecular Medicine 37(4): 1030-1038
Zhang, G.; Liu, Z.; Xu, H.; Yang, Q. 2016: MiR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1. Biochemical and Biophysical Research Communications 469(2): 189-195
Clark, A.L.; Maruyama, S.; Sano, S.; Accorsi, A.; Girgenrath, M.; Walsh, K.; Naya, F.J. 2016: MiR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and their Inhibition Attenuates Pathological Hypertrophy. Plos one 11(3): E0151515
Tsan, Y.-C.; Morell, M.H.; O'Shea, K.S. 2016: MiR-410 controls adult SVZ neurogenesis by targeting neurogenic genes. Stem Cell Research 17(2): 238-247
Mi, Y.; Guo, N.; He, T.; Ji, J.; Li, Z.; Huang, P. 2015: MiR-410 enhanced hESC-derived pancreatic endoderm transplant to alleviate gestational diabetes mellitus. Journal of molecular endocrinology 55(3): 219-229
Choi, S.W.; Kim, J.-J.; Seo, M.-S.; Park, S.-B.; Shin, T.-H.; Shin, J.-H.; Seo, Y.; Kim, H.-S.; Kang, K.-S. 2017: Inhibition by miR-410 facilitates direct retinal pigment epithelium differentiation of umbilical cord blood-derived mesenchymal stem cells. Journal of Veterinary Science 18(1): 59-65
Liu, D.; Zhang, N.; Zhang, J.; Zhao, H.; Wang, X. 2016: MiR-410 suppresses the expression of interleukin-6 as well as renal fibrosis in the pathogenesis of lupus nephritis. Clinical and Experimental Pharmacology and Physiology 43(6): 616-625
Zhang, Y.-F.; Yu, Y.; Song, W.-Z.; Zhang, R.-M.; Jin, S.; Bai, J.-W.; Kang, H.-B.; Wang, X.; Cao, X.-C. 2016: MiR-410-3p suppresses breast cancer progression by targeting Snail. Oncology Reports 36(1): 480-486
Zhao, Z.; Qin, L.; Li, S. 2016: MiR-411 contributes the cell proliferation of lung cancer by targeting FOXO1. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(4): 5551-5560
Xia, K.; Zhang, Y.; Cao, S.; Wu, Y.; Guo, W.; Yuan, W.; Zhang, S. 2015: MiR-411 regulated ITCH expression and promoted cell proliferation in human hepatocellular carcinoma cells. Biomedicine and PharmacoTherapy 70: 158-163
Zhang, Y.; Xu, G.; Liu, G.; Ye, Y.; Zhang, C.; Fan, C.; Wang, H.; Cai, H.; Xiao, R.; Huang, Z.; Luo, Q. 2016: MiR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. Biochemical and Biophysical Research Communications 476(4): 607-613
Zhou, S.; Wang, B.; Hu, J.; Zhou, Y.; Jiang, M.; Wu, M.; Qin, L.; Yang, X. 2016: MiR-421 is a diagnostic and prognostic marker in patients with osteosarcoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(7): 9001-9007
Zheng, G.-X.; Qu, A.-L.; Yang, Y.-M.; Zhang, X.; Zhang, S.-C.; Wang, C.-X. 2016: MiR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer. World Journal of Gastroenterology 22(24): 5589-5597
Li, S.; Zeng, A.; Hu, Q.; Yan, W.; Liu, Y.; You, Y. 2017: MiR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Neuro-Oncology 19(1): 55-65
Wang, X.; Li, Q.; Jin, H.; Zou, H.; Xia, W.; Dai, N.; Dai, X.-Y.; Wang, D.; Xu, C.-X.; Qing, Y. 2016: MiR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer. Oncotarget 7(47): 77508-77515
Wei, S.; Li, Q.; Li, Z.; Wang, L.; Zhang, L.; Xu, Z. 2016: MiR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway. Oncotarget 7(46): 75185-75196
Zhao, K.; Chen, Y.; Yang, R.; Bai, Y.; Li, C.; Li, H.; Xiong, C. 2015: MiR-424/322 is downregulated in the semen of patients with severe DNA damage and may regulate sperm DNA damage. Reproduction Fertility and Development 2015
Liu, P.; Hu, Y.; Ma, L.; Du, M.; Xia, L.; Hu, Z. 2015: MiR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1. Biomedicine and PharmacoTherapy 75: 51-57
Zhang, D.; Li, Z.; Zhang, Y.; Tu, C.; Huo, J.; Liu, Y. 2016: MiR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation. Oncology Reports 36(6): 3657-3663
Tamaddon, G.; Geramizadeh, B.; Karimi, M.H.; Mowla, S.J.; Abroun, S. 2016: MiR-4284 and miR-4484 as Putative Biomarkers for Diffuse Large B-Cell Lymphoma. Iranian Journal of Medical Sciences 41(4): 334-339
Peng, Y.; Chen, F.-F.; Ge, J.; Zhu, J.-Y.; Shi, X.-E.; Li, X.; Yu, T.-Y.; Chu, G.-Y.; Yang, G.-S. 2016: MiR-429 Inhibits Differentiation and Promotes Proliferation in Porcine Preadipocytes. International Journal of Molecular Sciences 17(12)
Song, B.; Zheng, K.; Ma, H.; Liu, A.; Jing, W.; Shao, C.; Li, G.; Jin, G. 2015: MiR-429 determines poor outcome and inhibits pancreatic ductal adenocarcinoma growth by targeting TBK1. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 35(5): 1846-1856
Zhang, M.; Dong, B.-B.; Lu, M.; Zheng, M.-J.; Chen, H.; Ding, J.-Z.; Xu, A.-M.; Xu, Y.-H. 2016: MiR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells. Oncotargets and Therapy 9: 1123-1133
Chen, W.; Zhang, B.; Guo, W.; Gao, L.; Shi, L.; Li, H.; Lu, S.; Liu, Y.; Li, X. 2015: MiR-429 inhibits glioma invasion through BMK1 suppression. Journal of Neuro-Oncology 125(1): 43-54
Fan, J.-Y.; Fan, Y.-J.; Wang, X.-L.; Xie, H.; Gao, H.-J.; Zhang, Y.; Liu, M.; Tang, H. 2017: MiR-429 is involved in regulation of NF-κBactivity by targeting IKKβ and suppresses oncogenic activity in cervical cancer cells. Febs Letters 591(1): 118-128
Wang, C.; Ju, H.; Shen, C.; Tong, Z. 2015: MiR-429 mediates δ-tocotrienol-induced apoptosis in triple-negative breast cancer cells by targeting XIAP. International Journal of Clinical and Experimental Medicine 8(9): 15648-15656
Xiao, P.; Liu, W.; Zhou, H. 2016: MiR-429 promotes the proliferation of non-small cell lung cancer cells via targeting DLC-1. Oncology Letters 12(3): 2163-2168
Xiao, J.; Tang, J.; Chen, Q.; Tang, D.; Liu, M.; Luo, M.; Wang, Y.; Wang, J.; Zhao, Z.; Tang, C.; Wang, D.; Mo, Z. 2015: MiR-429 regulates alveolar macrophage inflammatory cytokine production and is involved in LPS-induced acute lung injury. Biochemical Journal 471(2): 281-291
Shao, M.; Geng, Y.; Lu, P.; Xi, Y.; Wei, S.; Wang, L.; Fan, Q.; Ma, W. 2015: MiR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A. Biochemical and Biophysical Research Communications 464(4): 1309-1313
Miao, X.; Jia, L.; Zhou, H.; Song, X.; Zhou, M.; Xu, J.; Zhao, L.; Feng, X.; Zhao, Y. 2016: MiR-4299 mediates the invasive properties and tumorigenicity of human follicular thyroid carcinoma by targeting ST6GALNAC4. Iubmb Life 68(2): 136-144
Takacs, C.M.; Giraldez, A.J. 2016: MiR-430 regulates oriented cell division during neural tube development in zebrafish. Developmental Biology 409(2): 442-450
Fan, Y.; Zhang, Y.; Wu, R.; Chen, X.; Zhang, Y.; Chen, X.; Zhu, D. 2016: MiR-431 is involved in regulating cochlear function by targeting Eya4. Biochimica et Biophysica Acta 1862(11): 2119-2126
Lee, K.-P.; Shin, Y.J.; Panda, A.C.; Abdelmohsen, K.; Kim, J.Y.; Lee, S.-M.; Bahn, Y.J.; Choi, J.Y.; Kwon, E.-S.; Baek, S.-J.; Kim, S.-Y.; Gorospe, M.; Kwon, K.-S. 2015: MiR-431 promotes differentiation and regeneration of old skeletal muscle by targeting Smad4. Genes and Development 29(15): 1605-1617
Wang, X.-c.; Ma, Y.; Meng, P.-s.; Han, J.-l.; Yu, H.-y.; Bi, L.-j. 2015: MiR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6. Oral Oncology 51(7): 674-682
Chen, X.; Zhong, S.-L.; Lu, P.; Wang, D.-D.; Zhou, S.-Y.; Yang, S.-J.; Shen, H.-Y.; Zhang, L.; Zhang, X.-H.; Zhao, J.-H.; Tang, J.-H. 2016: MiR-4443 Participates in the Malignancy of Breast Cancer. Plos one 11(8): E0160780
Qin, Y.; Cheng, C.; Lu, H.; Wang, Y. 2016: MiR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells. Biochemical and Biophysical Research Communications 469(1): 37-43
Shen, L.; Liu, L.; Ge, L.; Xie, L.; Liu, S.; Sang, L.; Zhan, T.; Li, H. 2016: MiR-448 downregulates MPPED2 to promote cancer proliferation and inhibit apoptosis in oral squamous cell carcinoma. Experimental and Therapeutic Medicine 12(4): 2747-2752
Lv, Y.; Lei, Y.; Hu, Y.; Ding, W.; Zhang, C.; Fang, C. 2015: MiR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 17(11): 903-909
Wu, X.; Tang, H.; Liu, G.; Wang, H.; Shu, J.; Sun, F. 2016: MiR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(8): 10545-10551
Li, B.; Ge, L.; Li, M.; Wang, L.; Li, Z. 2016: MiR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells. American Journal of Translational Research 8(7): 3013-3022
Li, Z.; Huang, X.; Xu, J.; Su, Q.; Zhao, J.; Ma, J. 2016: MiR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-β-catenin signaling pathway. International Journal of Oncology 49(4): 1629-1637
Mao, A.; Liu, Y.; Wang, Y.; Zhao, Q.; Zhou, X.; Sun, C.; Di, C.; Si, J.; Gan, L.; Zhang, H. 2016: MiR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(4): 4831-4840
Sun, X.; Liu, S.; Chen, P.; Fu, D.; Hou, Y.; Hu, J.; Liu, Z.; Jiang, Y.; Cao, X.; Cheng, C.; Chen, X.; Tao, Y.; Li, C.; Hu, Y.; Liu, Z.; Zhan, Y.; Mao, J.; Wang, Q.; Ma, Y.; Cong, X.; Sun, R.; Shi, Y.; Wang, M.; Zhang, X. 2016: miR-449a inhibits colorectal cancer progression by targeting SATB2. Oncotarget (): -
Liu, S.; Liu, K.; Zhang, W.; Wang, Y.; Jin, Z.; Jia, B.; Liu, Y. 2016: MiR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma. American Journal of Translational Research 8(6): 2609-2619
Liu, Y.; Wang, Y.; Sun, X.; Mei, C.; Wang, L.; Li, Z.; Zha, X. 2016: MiR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1. Oncotarget 7(12): 13491-13501
Li, Q.; Peng, J.; Li, X.; Leng, A.; Liu, T. 2015: MiR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT. Diagnostic Pathology 10: 202
Zhang, P.; Wang, J.; Lu, T.; Wang, X.; Zheng, Y.; Guo, S.; Yang, Y.; Wang, M.; Kolluri, V.K.; Qiu, L.; Shen, F.; Fan, L.; Li, J.; Wang, Y.; Wei, Q.; Jin, L.; Wang, J.; Wang, M. 2015: MiR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(11): 8789-8795
Jin, Y.; Jiang, Z.; Guan, X.; Chen, Y.; Tang, Q.; Wang, G.; Wang, X. 2016: MiR-450b-5p Suppresses Stemness and the Development of Chemoresistance by Targeting SOX2 in Colorectal Cancer. Dna and Cell Biology 35(5): 249-256
Ye, Y.-P.; Wu, P.; Gu, C.-C.; Deng, D.-L.; Jiao, H.-L.; Li, T.-T.; Wang, S.-Y.; Wang, Y.-X.; Xiao, Z.-Y.; Wei, W.-T.; Chen, Y.-R.; Qiu, J.-F.; Yang, R.-W.; Lin, J.; Liang, L.; Liao, W.-T.; Ding, Y.-Q. 2016: MiR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression. Oncotarget 7(38): 61312-61324
Liu, X.; Zhang, A.; Xiang, J.; Lv, Y.; Zhang, X. 2016: MiR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Oncology Reports 36(3): 1385-1392
Liu, S.-Y.; Deng, S.-Y.; He, Y.-B.; Ni, G.-X. 2017: MiR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R. Biochemical and Biophysical Research Communications 482(4): 987-993
Zeng, T.; Peng, L.; Chao, C.; Fu, B.; Wang, G.; Wang, Y.; Zhu, X. 2014: MiR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. International Journal of Clinical and Experimental Pathology 7(11): 7653-7662
Li, Y.; Wang, J.; Dai, X.; Zhou, Z.; Liu, J.; Zhang, Y.; Li, Y.; Hou, Y.; Pang, L.; Wang, X.; Wang, C.; Hao, Z.; Zhang, Y.; Jiang, J.; Cheng, H.; Yu, D. 2015: MiR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer. American Journal of Translational Research 7(12): 2775-2785
Wang, J.; Zhao, X.; Shi, J.; Pan, Y.; Chen, Q.; Leng, P.; Wang, Y. 2016: MiR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc. Oncology Reports 36(4): 2049-2058
Sun, Y.; Peng, R.; Peng, H.; Liu, H.; Wen, L.; Wu, T.; Yi, H.; Li, A.; Zhang, Z. 2016: MiR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy. Molecular and Cellular Endocrinology 433: 75-86
Liu, Z.; Miao, T.; Feng, T.; Jiang, Z.; Li, M.; Zhou, L.; Li, H. 2015: MiR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor. Biomed Research International 2015: 207684
Minna, E.; Romeo, P.; Dugo, M.; De Cecco, L.; Todoerti, K.; Pilotti, S.; Perrone, F.; Seregni, E.; Agnelli, L.; Neri, A.; Greco, A.; Borrello, M.G. 2016: MiR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma. Oncotarget 7(11): 12731-12747
Yu, L.; Gong, X.; Sun, L.; Yao, H.; Lu, B.; Zhu, L. 2015: MiR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma. Oncotarget 6(36): 39225-39234
Niu, G.; Li, B.; Sun, J.; Sun, L. 2015: MiR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met. Cell Proliferation 48(3): 348-355
Lam, W.Y.; Cheung, A.C.Y.; Tung, C.K.C.; Yeung, A.C.M.; Ngai, K.L.K.; Lui, V.W.Y.; Chan, P.K.S.; Tsui, S.K.W. 2015: MiR-466 is putative negative regulator of Coxsackie virus and Adenovirus Receptor. Febs Letters 589(2): 246-254
Wang, B.; He, P.-P.; Zeng, G.-F.; Zhang, T.; Ou Yang, X.-P. 2017: MiR-467b regulates the cholesterol ester formation via targeting ACAT1 gene in RAW 264.7 macrophages. Biochimie 132: 38-44
Li, Y.; Chen, X. 2015: MiR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1. Biochemical and Biophysical Research Communications 468(4): 863-869
He, M.; Chen, Z.; Martin, M.; Zhang, J.; Sangwung, P.; Woo, B.; Tremoulet, A.H.; Shimizu, C.; Jain, M.K.; Burns, J.C.; Shyy, J.Y.-J. 2017: MiR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. Circulation Research 120(2): 354-365
Xiang, Y.; Song, Y.; Li, Y.; Zhao, D.; Ma, L.; Tan, L. 2016: MiR-483 is Down-Regulated in Polycystic Ovarian Syndrome and Inhibits KGN Cell Proliferation via Targeting Insulin-Like Growth Factor 1 (IGF1). Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 22: 3383-3393
Emmerling, V.V.; Fischer, S.; Kleemann, M.; Handrick, R.é; Kochanek, S.; Otte, K. 2016: MiR-483 is a self-regulating microRNA and can activate its own expression via USF1 in Hela cells. International Journal of Biochemistry and Cell Biology 80: 81-86
Ma, J.; Hong, L.; Xu, G.; Hao, J.; Wang, R.; Guo, H.; Liu, J.; Zhang, Y.; Nie, Y.; Fan, D. 2016: MiR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24. Cell Biology International 40(4): 448-455
Qiao, Y.; Zhao, Y.; Liu, Y.; Ma, N.; Wang, C.; Zou, J.; Liu, Z.; Zhou, Z.; Han, D.; He, J.; Sun, Q.; Liu, Y.; Xu, C.; Du, Z.; Huang, H. 2016: MiR-483-3p regulates hyperglycaemia-induced cardiomyocyte apoptosis in transgenic mice. Biochemical and Biophysical Research Communications 477(4): 541-547
Shi, L.; Liu, S.; Zhao, W.; Shi, J. 2015: MiR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase Ii oocytes from women with polycystic ovary syndrome. Reproductive Biomedicine Online 31(4): 565-572
Fan, S.; Chen, W.-X.; Lv, X.-B.; Tang, Q.-L.; Sun, L.-J.; Liu, B.-D.; Zhong, J.-L.; Lin, Z.-Y.; Wang, Y.-Y.; Li, Q.-X.; Yu, X.; Zhang, H.-Q.; Li, Y.-L.; Wen, B.; Zhang, Z.; Chen, W.-L.; Li, J.-S. 2015: MiR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1. Cancer Letters 362(2): 183-191
Kang, M.; Ren, M.-P.; Zhao, L.; Li, C.-P.; Deng, M.-M. 2015: MiR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1. American Journal of Translational Research 7(11): 2212-2222
Sun, H.; Cui, C.; Xiao, F.; Wang, H.; Xu, J.; Shi, X.; Yang, Y.; Zhang, Q.; Zheng, X.; Yang, X.; Wu, C.; Wang, L. 2015: MiR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON. Hepatology Research: the Official Journal of the Japan Society of Hepatology 45(13): 1312-1322
Liu, C.; Li, M.; Hu, Y.; Shi, N.; Yu, H.; Liu, H.; Lian, H. 2016: MiR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma. Oncotargets and Therapy 9: 2865-2871
Ren, C.; Chen, H.; Han, C.; Fu, D.; Zhou, L.; Jin, G.; Wang, F.; Wang, D.; Chen, Y.; Ma, L.; Zheng, X.; Han, D. 2016: MiR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value. Oncotarget 7(13): 15840-15853
Ma, X.; Wei, J.; Zhang, L.; Deng, D.; Liu, L.; Mei, X.; He, X.; Tian, J. 2016: MiR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. Biomedicine and PharmacoTherapy 80: 220-226
Zhang, X.; Zhang, T.; Yang, K.; Zhang, M.; Wang, K. 2016: MiR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition. Oncotargets and Therapy 9: 6909-6914
Feng, N.; Wang, Z.; Zhang, Z.; He, X.; Wang, C.; Zhang, L. 2015: MiR-487b promotes human umbilical vein endothelial cell proliferation, migration, invasion and tube formation through regulating THBS1. Neuroscience Letters 591: 1-7
Katase, N.; Terada, K.; Suzuki, T.; Nishimatsu, S.-i.; Nohno, T. 2015: MiR-487b, miR-3963 and miR-6412 delay myogenic differentiation in mouse myoblast-derived C2C12 cells. Bmc Cell Biology 16: 13
Bao, L.; Lv, L.; Feng, J.; Chen, Y.; Wang, X.; Han, S.; Zhao, H. 2016: MiR-487b-5p Regulates Temozolomide Resistance of Lung Cancer Cells Through LAMP2-Medicated Autophagy. Dna and Cell Biology 35(8): 385-392
Zhao, Y.; Lu, G.; Ke, X.; Lu, X.; Wang, X.; Li, H.; Ren, M.; He, S. 2016: MiR-488 acts as a tumor suppressor gene in gastric cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(7): 8691-8698
Zhang, B.; Ji, S.; Ma, F.; Ma, Q.; Lu, X.; Chen, X. 2016: MiR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1. American Journal of Cancer Research 6(9): 2021-2030
Jia, Z.; Liu, Y.; Gao, Q.; Han, Y.; Zhang, G.; Xu, S.; Cheng, K.; Zou, W. 2016: MiR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2. Gene 593(1): 41-47
Chen, K.; Zeng, J.; Tang, K.; Xiao, H.; Hu, J.; Huang, C.; Yao, W.; Yu, G.; Xiao, W.; Guan, W.; Guo, X.; Xu, H.; Ye, Z. 2016: MiR-490-5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA. Biology of the Cell 108(2): 41-50
Wang, J.; Liu, Z.; Dou, C.; Han, S.; Li, C.; Tu, K.; Yang, W. 2016: MiR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32(4): 512-517
Qi, Z.; Cai, S.; Cai, J.; Chen, L.; Yao, Y.; Chen, L.; Mao, Y. 2016: MiR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro. Bmc Neurology 16(1): 248
Hui, Z.; Yiling, C.; Wenting, Y.; XuQun, H.; ChuanYi, Z.; Hui, L. 2015: MiR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer. Febs Letters 589(7): 812-821
Zhang, Q.; Li, Q.; Xu, T.; Jiang, H.; Xu, L.-G. 2016: MiR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma. Oncology Reports 35(6): 3541-3547
Yu, G.; Xiao, Q.; Ma, X.-P.; Chen, X.; Shi, Z.; Zhang, L.-Y.; Chen, H.; Zhang, P.; Ding, D.-L.; Huang, H.-X.; Saiyin, H.; Chen, T.-Y.; Lu, P.-X.; Wang, N.-J.; Yu, H.; Sun, J.; Conran, C.; Zheng, S.L.; Xu, J.; Yu, L.; Jiang, D.-K. 2016: MiR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(7): 8961-8972
Jia, X.; Li, N.; Peng, C.; Deng, Y.; Wang, J.; Deng, M.; Lu, M.; Yin, J.; Zheng, G.; Liu, H.; He, Z. 2016: MiR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells. Oncotarget 7(6): 7044-7054
Zhao, L.; Feng, X.; Song, X.; Zhou, H.; Zhao, Y.; Cheng, L.; Jia, L. 2016: MiR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4. Oncology Reports 36(2): 1007-1015
Zhao, X.-Q.; Liang, T.-J.; Fu, J.-W. 2016: MiR-494 inhibits invasion and proliferation of gastric cancer by targeting IGF-1R. European Review for Medical and Pharmacological Sciences 20(18): 3818-3824
Zhao, X.; Zhou, Y.; Chen, Y.U.; Yu, F. 2016: MiR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2. Oncology Letters 11(6): 4245-4251
Liu, K.; Liu, S.; Zhang, W.; Jia, B.; Tan, L.; Jin, Z.; Liu, Y. 2015: MiR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN. Oncology Reports 34(2): 1003-1010
Libório-Kimura, T.N.; Jung, H.M.; Chan, E.K.L. 2015: MiR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer. Oral Oncology 51(2): 151-157
Song, L.; Liu, D.; Wang, B.; He, J.; Zhang, S.; Dai, Z.; Ma, X.; Wang, X. 2015: MiR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway. Oncology Reports 34(1): 525-531
Li, N.; Zhao, X.; Wang, L.; Zhang, S.; Cui, M.; He, J. 2016: MiR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(6): 7767-7776
Weng, J.-H.; Yu, C.-C.; Lee, Y.-C.; Lin, C.-W.; Chang, W.-W.; Kuo, Y.-L. 2016: MiR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells. International Journal of Molecular Sciences 17(7)
Li, X.-T.; Wang, H.-Z.; Wu, Z.-W.; Yang, T.-Q.; Zhao, Z.-H.; Chen, G.-L.; Xie, X.-S.; Li, B.; Wei, Y.-X.; Huang, Y.-L.; Zhou, Y.-X.; Du, Z.-W. 2015: MiR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Cellular and Molecular Neurobiology 35(5): 679-687
Nie, S.; Li, K.; Huang, Y.; Hu, Q.; Gao, X.; Jie, S. 2015: MiR-495 mediates metabolic shift in glioma cells via targeting Glut1. Journal of Craniofacial Surgery 26(2): E155-E158
Han, Z.; Zhang, Y.; Yang, Q.; Liu, B.; Wu, J.; Zhang, Y.; Yang, C.; Jiang, Y. 2015: MiR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget 6(15): 13149-13163
Pang, P.-C.; Shi, X.-Y.; Huang, W.-L.; Sun, K. 2016: MiR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma. European Review for Medical and Pharmacological Sciences 20(18): 3765-3769
Yang, G.; Xiong, G.; Cao, Z.; Zheng, S.; You, L.; Zhang, T.; Zhao, Y. 2016: MiR-497 expression, function and clinical application in cancer. Oncotarget 7(34): 55900-55911
Wu, Z.; Li, X.; Cai, X.; Huang, C.; Zheng, M. 2016: MiR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(6): 7939-7950
Wu, Z.; Cai, X.; Huang, C.; Xu, J.; Liu, A. 2016: MiR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α. Oncology Reports 35(3): 1696-1702
Zhang, N.; Shen, Q.; Zhang, P. 2016: MiR-497 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1. Oncotargets and Therapy 9: 6597-6604
Chen, Y.; Kuang, D.; Zhao, X.; Chen, D.; Wang, X.; Yang, Q.; Wan, J.; Zhu, Y.; Wang, Y.; Zhang, S.; Wang, Y.; Tang, Q.; Masuzawa, M.; Wang, G.; Duan, Y. 2016: MiR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma. Oncotarget 7(36): 58148-58161
Kwak, S.-Y.; Yoo, J.-O.; An, H.-J.; Bae, I.-H.; Park, M.-J.; Kim, J.; Han, Y.-H. 2016: MiR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin. Journal of Molecular Cell Biology 8(5): 372-383
Hu, Z.; Zhao, J.; Hu, T.; Luo, Y.; Zhu, J.; Li, Z. 2015: MiR-501-3p mediates the activity-dependent regulation of the expression of AMPA receptor subunit GluA1. Journal of Cell Biology 208(7): 949-959
Chen, S.; Li, F.; Chai, H.; Tao, X.; Wang, H.; Ji, A. 2015: MiR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma. Biochemical and Biophysical Research Communications 464(2): 500-505
Chang, S.-W.; Yue, J.; Wang, B.-C.; Zhang, X.-L. 2015: MiR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3. International Journal of Clinical and Experimental Pathology 8(10): 12853-12860
Liu, H.; Song, Z.; Liao, D.; Zhang, T.; Liu, F.; Zheng, W.; Luo, K.; Yang, L. 2015: MiR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM. International Journal of Clinical and Experimental Medicine 8(10): 18441-18447
Bi, R.; Ding, F.; He, Y.; Jiang, L.; Jiang, Z.; Mei, J.; Liu, H. 2016: MiR-503 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting the insulin receptor. Biomedicine and PharmacoTherapy 84: 1711-1716
Yang, X.; Zang, J.; Pan, X.; Yin, J.; Xiang, Q.; Yu, J.; Gan, R.; Lei, X. 2017: MiR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5‑fluorouracil by targeting EIF4E. Oncology Reports 37(1): 563-570
Polioudakis, D.; Abell, N.S.; Iyer, V.R. 2015: MiR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing. Bmc Genomics 16: 40
Li, B.; Liu, L.; Li, X.; Wu, L. 2015: MiR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1. Biochemical and Biophysical Research Communications 464(4): 982-987
Guo, J.; Liu, X.; Wang, M. 2015: MiR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer. Biochemical and Biophysical Research Communications 464(4): 1302-1308
Hirakawa, T.; Nasu, K.; Abe, W.; Aoyagi, Y.; Okamoto, M.; Kai, K.; Takebayashi, K.; Narahara, H. 2016: MiR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells. Human Reproduction 31(11): 2587-2597
Zhao, L.; Tang, M.; Hu, Z.; Yan, B.; Pi, W.; Li, Z.; Zhang, J.; Zhang, L.; Jiang, W.; Li, G.; Qiu, Y.; Hu, F.; Liu, F.; Lu, J.; Chen, X.; Xiao, L.; Xu, Z.; Tao, Y.; Yang, L.; Bode, A.M.; Dong, Z.; Zhou, J.; Fan, J.; Sun, L.; Cao, Y. 2015: MiR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma. Oncotarget 6(18): 15995-16018
Li, Z.; Liu, Z.; Dong, S.; Zhang, J.; Tan, J.; Wang, Y.; Ge, C.; Li, R.; Xue, Y.; Li, M.; Wang, W.; Xiang, X.; Yang, J.; Ding, H.; Geng, T.; Yao, K.; Song, X. 2015: MiR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer. American Journal of Pathology 185(9): 2412-2420
Wu, M.; Zhang, Y.; Tang, A.; Tian, L. 2016: MiR-506 inhibits cell proliferation and invasion by targeting TET family in colorectal cancer. Iranian Journal of Basic Medical Sciences 19(3): 316-322
Luo, Y.; Sun, R.; Zhang, J.; Sun, T.; Liu, X.; Yang, B. 2015: MiR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma. American Journal of Translational Research 7(10): 2007-2014
Sun, G.; Liu, Y.; Wang, K.; Xu, Z. 2015: MiR-506 regulates breast cancer cell metastasis by targeting IQGAP1. International Journal of Oncology 47(5): 1963-1970
Liu, G.; Xue, F.; Zhang, W. 2015: MiR-506: a regulator of chemo-sensitivity through suppression of the RAD51-homologous recombination axis. Chinese Journal of Cancer 34(11): 485-487
Huang, T.; Kang, W.; Zhang, B.; Wu, F.; Dong, Y.; Tong, J.H.M.; Yang, W.; Zhou, Y.; Zhang, L.; Cheng, A.S.L.; Yu, J.; To, K.F. 2016: MiR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis. Molecular Cancer 15: 9
Wu, S.G.; Huang, Y.J.; Bao, B.; Wu, L.M.; Dong, J.; Liu, X.H.; Li, Z.H.; Wang, X.Y.; Wang, L.; Chen, B.J.; Chen, W. 2017: MiR-508-5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma. Neoplasma 64(1): 40-47
Pan, Y.; Robertson, G.; Pedersen, L.; Lim, E.; Hernandez-Herrera, A.; Rowat, A.C.; Patil, S.L.; Chan, C.K.; Wen, Y.; Zhang, X.; Basu-Roy, U.; Mansukhani, A.; Chu, A.; Sipahimalani, P.; Bowlby, R.; Brooks, D.; Thiessen, N.; Coarfa, C.; Ma, Y.; Moore, R.A.; Schein, J.E.; Mungall, A.J.; Liu, J.; Pecot, C.V.; Sood, A.K.; Jones, S.J.M.; Marra, M.A.; Gunaratne, P.H. 2016: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer. Oncotarget 7(18): 25930-25948
Huang, H.; Jiang, Y.; Wang, Y.; Chen, T.; Yang, L.; He, H.; Lin, Z.; Liu, T.; Yang, T.; Kamp, D.W.; Wu, B.; Liu, G. 2015: MiR-5100 promotes tumor growth in lung cancer by targeting Rab6. Cancer Letters 362(1): 15-24
Li, J.; Lei, H.; Xu, Y.; Tao, Z.-Z. 2015: MiR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo. Plos one 10(8): E0135265
Dai, N.; Qing, Y.; Cun, Y.; Zhong, Z.; Li, C.; Zhang, S.; Shan, J.; Yang, X.; Dai, X.; Cheng, Y.; Xiao, H.; Xu, C.; Li, M.; Wang, D. 2016: miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease. Oncotarget (): -
Stark, M.S.; Bonazzi, V.F.; Boyle, G.M.; Palmer, J.M.; Symmons, J.; Lanagan, C.M.; Schmidt, C.W.; Herington, A.C.; Ballotti, R.; Pollock, P.M.; Hayward, N.K. 2015: MiR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma. Oncotarget 6(19): 17753-17763
Pardo, O.E.; Castellano, L.; Munro, C.E.; Hu, Y.; Mauri, F.; Krell, J.; Lara, R.; Pinho, F.G.; Choudhury, T.; Frampton, A.E.; Pellegrino, L.; Pshezhetskiy, D.; Wang, Y.; Waxman, J.; Seckl, M.J.; Stebbing, J. 2016: MiR-515-5p controls cancer cell migration through MARK4 regulation. Embo Reports 17(4): 570-584
Ma, W.; Yu, Q.; Jiang, J.; Du, X.; Huang, L.; Zhao, L.; Zhou, Q.I. 2016: MiR-517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer. Oncology Letters 11(4): 2583-2589
Deng, X.; Zhao, Y.; Wang, B. 2015: MiR-519d-mediated downregulation of STAT3 suppresses breast cancer progression. Oncology Reports 34(4): 2188-2194
Yi, M.; Li, M.; Long, X.; Ye, J.; Cui, J.; Wei, W.; Wan, H.; Yin, M.; Gao, S.; Su, Z.; Zhang, F. 2016: MiR-520e regulates cell proliferation, apoptosis and migration in breast cancer. Oncology Letters 12(5): 3543-3548
Zhang, H.; Yu, C.; Chen, M.; Li, Z.; Tian, S.; Jiang, J.; Sun, C. 2016: MiR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(8): 11321-11329
Zhao, L.; Hua, C.; Li, Y.; Sun, Q.; Wu, W. 2015: MiR-525-5p inhibits ADAMTS13 and is correlated with Ischemia/reperfusion injury-induced neuronal cell death. International Journal of Clinical and Experimental Medicine 8(10): 18115-18122
Yang, X.; Wang, C.; Xu, C.; Yan, Z.; Wei, C.; Guan, K.; Ma, S.; Cao, Y.; Liu, L.; Zou, D.; He, X.; Zhang, B.; Ma, Q.; Zheng, Z. 2015: MiR-526a regulates apoptotic cell growth in human carcinoma cells. Molecular and Cellular Biochemistry 407(1-2): 69-76
Zhang, R.; Zhao, J.; Xu, J.; Wang, J.; Jia, J. 2016: MiR-526b-3p functions as a tumor suppressor in colon cancer by regulating HIF-1α. American Journal of Translational Research 8(6): 2783-2789
Lv, L.-y.; Wang, Y.-z.; Zhang, Q.; Zang, H.-r.; Wang, X.-j. 2015: MiR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4. Cell Biochemistry and Function 33(8): 534-540
Zhang, H.; Li, S.; Yang, X.; Qiao, B.; Zhang, Z.; Xu, Y. 2016: MiR-539 inhibits prostate cancer progression by directly targeting SPAG5. Journal of Experimental and Clinical Cancer Research: Cr 35: 60
Meng, X.; Zhang, L.; Chen, X.; Xiang, Z.; Li, D.; Han, X. 2016: MiR-541 Contributes to Microcystin-LR-Induced Reproductive Toxicity through Regulating the Expression of p15 in Mice. Toxins 8(9)
Long, H.-C.; Gao, X.; Lei, C.-J.; Zhu, B.; Li, L.; Zeng, C.; Huang, J.-B.; Feng, J.-R. 2016: MiR-542-3p inhibits the growth and invasion of colorectal cancer cells through targeted regulation of cortactin. International Journal of Molecular Medicine 37(4): 1112-1118
Rang, Z.; Yang, G.; Wang, Y.-W.; Cui, F. 2016: MiR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma. Biochemical and Biophysical Research Communications 474(2): 315-320
Lee, S.; Yu, K.-R.; Ryu, Y.-S.; Oh, Y.S.; Hong, I.-S.; Kim, H.-S.; Lee, J.Y.; Kim, S.; Seo, K.-W.; Kang, K.-S. 2014: MiR-543 and miR-590-3p regulate human mesenchymal stem cell aging via direct targeting of AIMP3/p18. Age 36(6): 9724
Bi, M.; Chen, W.; Yu, H.; Wang, J.; Ding, F.; Tang, D.J.; Tang, C. 2016: MiR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog. Biochemical and Biophysical Research Communications 480(3): 369-374
Li, J.; Dong, G.; Wang, B.; Gao, W.; Yang, Q. 2016: MiR-543 promotes gastric cancer cell proliferation by targeting SIRT1. Biochemical and Biophysical Research Communications 469(1): 15-21
Song, W.; Mu, H.; Wu, J.; Liao, M.; Zhu, H.; Zheng, L.; He, X.; Niu, B.; Zhai, Y.; Bai, C.; Lei, A.; Li, G.; Hua, J. 2015: MiR-544 Regulates Dairy Goat Male Germline Stem Cell Self-Renewal via Targeting PLZF. Journal of Cellular Biochemistry 116(10): 2155-2165
Lu, P.; Gu, Y.; Li, L.; Wang, F.; Qiu, X. 2016: MiR-544a Promotes Breast Cancer Cell Migration and Invasion Reducing Cadherin 1 Expression. Oncology Research 23(4): 165-170
Yanaka, Y.; Muramatsu, T.; Uetake, H.; Kozaki, K.-i.; Inazawa, J. 2015: MiR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer. Carcinogenesis 36(11): 1363-1371
Pan, Y.; Liang, W.; Zhao, X.; Liu, L.; Qing, Y.; Li, Y. 2016: MiR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2. Neuroreport 27(17): 1266-1273
Song, Q.; Song, J.; Wang, Q.; Ma, Y.; Sun, N.; Ma, J.; Chen, Q.; Xia, G.; Huo, Y.; Yang, L.; Li, B. 2016: MiR-548d-3p/TP53BP2 axis regulates the proliferation and apoptosis of breast cancer cells. Cancer Medicine 5(2): 315-324
Dahiya, N.; Sarachana, T.; Kulkarni, S.; Wood, W.H.; Zhang, Y.; Becker, K.G.; Wang, B-Dar.; Atreya, C.D. 2017: MiR-570 interacts with mitochondrial ATPase subunit g (ATP5L) encoding mRNA in stored platelets. Platelets 28(1): 74-81
Zhang, W.; Shen, C.; Li, C.; Yang, G.; Liu, H.; Chen, X.; Zhu, D.; Zou, H.; Zhen, Y.; Zhang, D.; Zhao, S. 2016: MiR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway. Molecular Carcinogenesis 55(5): 575-585
Fattore, L.; Mancini, R.; Acunzo, M.; Romano, G.; Laganà, A.; Pisanu, M.E.; Malpicci, D.; Madonna, G.; Mallardo, D.; Capone, M.; Fulciniti, F.; Mazzucchelli, L.; Botti, G.; Croce, C.M.; Ascierto, P.A.; Ciliberto, G. 2016: MiR-579-3p controls melanoma progression and resistance to target therapy. Proceedings of the National Academy of Sciences of the United States of America 113(34): E5005-E5013
De Lucas, M.ía.P.; Sáez, A.G.; Lozano, E.ón. 2015: MiR-58 family and TGF-β pathways regulate each other in Caenorhabditis elegans. Nucleic Acids Research 43(20): 9978-9993
Shu, Z.; Chen, L.; Ding, D. 2016: MiR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli. World Journal of Surgical Oncology 14(1): 239
Zhang, Y.; Huang, W.; Ran, Y.; Xiong, Y.; Zhong, Z.; Fan, X.; Wang, Z.; Ye, Q. 2015: MiR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(11): 8309-8316
Xiang, J.; Wu, Y.; Li, D-Shu.; Wang, Z-Ying.; Shen, Q.; Sun, T-Qi.; Guan, Q.; Wang, Y-Jun. 2015: MiR-584 Suppresses Invasion and Cell Migration of Thyroid Carcinoma by Regulating the Target Oncogene ROCK1. Oncology Research and Treatment 38(9): 436-440
Zhang, X.; Jiang, P.; Shuai, L.; Chen, K.; Li, Z.; Zhang, Y.; Jiang, Y.; Li, X. 2016: MiR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma. Journal of Experimental and Clinical Cancer Research: Cr 35(1): 176
Miao, M.-H.; Ji, X.-Q.; Zhang, H.; Xu, J.; Zhu, H.; Shao, X.-J. 2016: MiR-590 promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia by inhibiting RB1. Oncotarget 7(26): 39527-39534
Zhao, S.; Yang, G.; Liu, P-Ning.; Deng, Y-Yang.; Zhao, Z.; Sun, T.; Zhuo, X-Zhen.; Liu, J-Hui.; Tian, Y.; Zhou, J.; Yuan, Z.; Wu, Y. 2015: MiR-590-3p Is a Novel MicroRNA in Myocarditis by Targeting Nuclear Factor Kappa-B in vivo. Cardiology 132(3): 182-188
Pang, H.; Zheng, Y.; Zhao, Y.; Xiu, X.; Wang, J. 2015: MiR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2. Biochemical and Biophysical Research Communications 468(4): 739-745
Shen, B.; Yu, S.; Zhang, Y.; Yuan, Y.; Li, X.; Zhong, J.; Feng, J. 2016: MiR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway. Oncotargets and Therapy 9: 6009-6019
Jia, Y.-Y.; Zhao, J.-Y.; Li, B.-L.; Gao, K.; Song, Y.; Liu, M.-Y.; Yang, X.-J.; Xue, Y.; Wen, A.-D.; Shi, L. 2016: MiR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth. Oncotarget 7(23): 35257-35269
Xie, B.; Zhang, C.; Kang, K.; Jiang, S. 2015: MiR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2. Plos one 10(11): E0141512
Hu, J.-Y.; Yi, W.; Wei, X.; Zhang, M.-Y.; Xu, R.; Zeng, L.-S.; Huang, Z.-J.; Chen, J.-S. 2016: MiR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer. Biomedicine and PharmacoTherapy 79: 247-253
Guo, M.; Zhang, X.; Wang, G.; Sun, J.; Jiang, Z.; Khadarian, K.; Yu, S.; Zhao, Y.; Xie, C.; Zhang, K.; Zhu, M.; Shen, H.; Lin, Z.; Jiang, C.; Shen, J.; Zheng, Y. 2015: MiR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1. Cancer Letters 360(1): 76-86
Hashemi, M.; Sanaei, S.; Rezaei, M.; Bahari, G.; Hashemi, S.M.; Mashhadi, M.A.; Taheri, M.; Ghavami, S. 2016: MiR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation. Experimental Oncology 38(1): 57-59
Wu, J.; Yuan, P.; Mao, Q.; Lu, P.; Xie, T.; Yang, H.; Wang, C. 2016: MiR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA. Biochemical and Biophysical Research Communications 478(1): 274-278
Wang, W.; Zhang, H.; Wang, L.; Zhang, S.; Tang, M. 2016: MiR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1. Biochemical and Biophysical Research Communications 473(4): 987-992
Wu, Z.; Qi, Y.; Guo, Z.; Li, P.; Zhou, D. 2016: MiR-613 suppresses ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting the programmed cell death 10 gene. Bioscience Trends 10(4): 251-257
Wu, X.; Deng, L.; Tang, D.; Ying, G.; Yao, X.; Liu, F.; Liang, G. 2016: MiR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(5): 6813-6821
Huang, X.; Taeb, S.; Jahangiri, S.; Korpela, E.; Cadonic, I.; Yu, N.; Krylov, S.N.; Fokas, E.; Boutros, P.C.; Liu, S.K. 2015: MiR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD). Oncotarget 6(26): 22439-22451
Zhou, W.-b.; Zhong, C.-n.; Luo, X.-p.; Zhang, Y.-y.; Zhang, G.-y.; Zhou, D.-x.; Liu, L.-p. 2016: MiR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer. Biochemical and Biophysical Research Communications 470(4): 838-844
Yu, Y.; Li, X.; Liu, L.; Chai, J.; Haijun, Z.; Chu, W.; Yin, H.; Ma, L.; Duan, H.; Xiao, M. 2016: MiR-628 Promotes Burn-Induced Skeletal Muscle Atrophy via Targeting IRS1. International Journal of Biological Sciences 12(10): 1213-1224
Zhao, J.-J.; Chen, P.-J.; Duan, R.-Q.; Li, K.-J.; Wang, Y.-Z.; Li, Y. 2016: MiR-630 functions as a tumor oncogene in renal cell carcinoma. Archives of Medical Science: Ams 12(3): 473-478
Zhang, J.-w.; Li, Y.; Zeng, X.-C.; Zhang, T.; Fu, B.-S.; Yi, H.-M.; Zhang, Q.; Jiang, N. 2015: MiR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 21: 667-673
Song, Y.-F.; Hong, J.-F.; Liu, D.-L.; Lin, Q.-A.; Lan, X.-P.; Lai, G.-X. 2015: MiR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer. American Journal of Translational Research 7(7): 1271-1279
Fujiwara, N.; Inoue, J.; Kawano, T.; Tanimoto, K.; Kozaki, K.-I.; Inazawa, J. 2015: MiR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity. Cancer Research 75(18): 3890-3901
Zhang, C.Z.; Cao, Y.; Fu, J.; Yun, J.-P.; Zhang, M.-F. 2016: MiR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33. Molecular Oncology 10(10): 1532-1541
Van Jaarsveld, M.T.M.; van Kuijk, P.F.; Boersma, A.W.M.; Helleman, J.; van IJcken, W.F.; Mathijssen, R.H.J.; Pothof, J.; Berns, E.M.J.J.; Verweij, J.; Wiemer, E.A.C. 2015: MiR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Molecular Cancer 14: 196
Bhattacharya, A.; Schmitz, U.; Raatz, Y.; Schönherr, M.; Kottek, T.; Schauer, M.; Franz, S.; Saalbach, A.; Anderegg, U.; Wolkenhauer, O.; Schadendorf, D.; Simon, J.C.; Magin, T.; Vera, J.; Kunz, M. 2015: MiR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy. Oncotarget 6(5): 2966-2980
Lin, Y.; Li, D.; Liang, Q.; Liu, S.; Zuo, X.; Li, L.; Sun, X.; Li, W.; Guo, M.; Huang, Z. 2015: MiR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2. Journal of Biological Chemistry 290(3): 1818-1828
He, M.; Lin, Y.; Tang, Y.; Liu, Y.; Zhou, W.; Li, C.; Sun, G.; Guo, M. 2016: MiR-638 suppresses DNA damage repair by targeting SMC1A expression in terminally differentiated cells. Aging 8(7): 1442-1456
Pan, Y.; Chen, Y.; Ma, D.; Ji, Z.; Cao, F.; Chen, Z.; Ning, Y.; Bai, C. 2016: MiR-646 is a key negative regulator of EGFR pathway in lung cancer. Experimental Lung Research 42(6): 286-295
Lv, Z.-D.; Kong, B.; Liu, X.-P.; Jin, L.-Y.; Dong, Q.; Li, F.-N.; Wang, H.-B. 2016: MiR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer. Journal of Cellular and Molecular Medicine 20(5): 864-873
Li, S.; Fang, Y.; Qin, H.; Fu, W.; Zhang, X. 2016: MiR-659-3p is involved in the regulation of the chemotherapy response of colorectal cancer via modulating the expression of SPHK1. American Journal of Cancer Research 6(9): 1976-1985
Shi, Y.; Chen, C.; Yu, S.-Z.; Liu, Q.; Rao, J.; Zhang, H.-R.; Xiao, H.-L.; Fu, T.-W.; Long, H.; He, Z.-C.; Zhou, K.; Yao, X.-H.; Cui, Y.-H.; Zhang, X.; Ping, Y.-F.; Bian, X.-W. 2015: MiR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 21(17): 4004-4013
Zang, W.; Wang, Y.; Wang, T.; Du, Y.; Chen, X.; Li, M.; Zhao, G. 2015: MiR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Molecular Cancer 14: 37
Huang, Y.; Liu, J.; Fan, L.; Wang, F.; Yu, H.; Wei, W.; Sun, G. 2016: MiR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1. Oncotargets and Therapy 9: 1623-1633
Huang, W.; Li, J.; Guo, X.; Zhao, Y.; Yuan, X. 2016: MiR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2. Biomedicine and PharmacoTherapy 81: 431-438
Zhu, H.; Miao, M.-H.; Ji, X.-Q.; Xue, J.; Shao, X.-J. 2015: MiR-664 negatively regulates PLP2 and promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia. Biochemical and Biophysical Research Communications 459(2): 340-345
Tan, X.; Fu, Y.; Chen, L.; Lee, W.; Lai, Y.; Rezaei, K.; Tabbara, S.; Latham, P.; Teal, C.B.; Man, Y.-G.; Siegel, R.S.; Brem, R.F.; Fu, S.W. 2016: MiR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget 7(1): 293-307
Kang, M.R.; Park, K.H.; Yang, J.-O.; Lee, C.W.; Oh, S.J.; Yun, J.; Lee, M.Y.; Han, S.-B.; Kang, J.S. 2016: MiR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells. Plos one 11(8): E0160961
Zhou, Y.-W.; Zhang, H.; Duan, C.-J.; Gao, Y.; Cheng, Y.-D.; He, D.; Li, R.; Zhang, C.-F. 2016: MiR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2. Oncotarget 7(21): 30730-30747
Fang, Z.; Li, P.; Jia, W.; Jiang, T.; Wang, Z.; Xiang, Y. 2016: MiR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α. International Journal of Molecular Medicine 38(3): 845-852
Swiercz, A.; Chechlinska, M.; Kupryjanczyk, J.; Dansonka-Mieszkowska, A.; Rembiszewska, A.; Goryca, K.; Kulinczak, M.; Zajdel, M.; Sromek, M.; Siwicki, J.K. 2015: MiR-7 expression in serous ovarian carcinomas. Anticancer Research 35(4): 2423-2429
Liu, H.; Wu, X.; Huang, J.; Peng, J.; Guo, L. 2015: MiR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1. International Journal of Experimental Pathology 96(4): 240-247
Sun, X.; Li, J.; Sun, Y.; Zhang, Y.; Dong, L.; Shen, C.; Yang, L.; Yang, M.; Li, Y.; Shen, G.; Tu, Y.; Tao, J. 2016: MiR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways. Oncotarget 7(33): 53558-53570
Shi, Y.; Luo, X.; Li, P.; Tan, J.; Wang, X.; Xiang, T.; Ren, G. 2015: MiR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ. Cancer Letters 358(1): 27-36
Ma, L.; Ma, S.; Zhao, G.; Yang, L.; Zhang, P.; Yi, Q.; Cheng, S. 2016: MiR-708/LSD1 axis regulates the proliferation and invasion of breast cancer cells. Cancer Medicine 5(4): 684-692
Li, M.; Chen, H.; Chen, L.; Chen, Y.; Liu, X.; Mo, D. 2016: MiR-709 modulates LPS-induced inflammatory response through targeting GSK-3β. International Immunopharmacology 36: 333-338
Liu, T.; Zhang, X.; Sha, K.; Liu, X.; Zhang, L.; Wang, B. 2015: MiR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5. Cell Proliferation 48(3): 330-337
Yang, M.; Wang, Y.; Jiang, F.; Song, T.; Wang, H.; Liu, Q.; Zhang, J.; Zhang, J.; Kang, L. 2016: MiR-71 and miR-263 Jointly Regulate Target Genes Chitin synthase and Chitinase to Control Locust Molting. Plos Genetics 12(8): E1006257
Wu, Y.Y.; Zhao, J.M.; Liu, Q.; Guo, Q.; Liu, Z.; Wang, X.X.; Wang, C.Y.; Li, R.Y.; Zhang, Y.Z.; Zhang, S.T. 2015: MiR-71b regulation of insulin/IGF-1 signaling during starvation in planarians. Genetics and Molecular Research: Gmr 14(4): 11905-11914
Das, S.G.; Romagnoli, M.; Mineva, N.D.; Barillé-Nion, S.; Jézéquel, P.; Campone, M.; Sonenshein, G.E. 2016: MiR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells. Breast Cancer Research: Bcr 18(1): 40
Choy, F.C.; Klarić, T.S.; Koblar, S.A.; Lewis, M.D. 2017: MiR-744 and miR-224 Downregulate Npas4 and Affect Lineage Differentiation Potential and Neurite Development During Neural Differentiation of Mouse Embryonic Stem Cells. Molecular Neurobiology 54(5): 3528-3541
Tan, Y.-L.; Bai, Z.-G.; Zou, W.-L.; Ma, X.-M.; Wang, T.-T.; Guo, W.; Liu, J.; Li, J.-S.; Jie-Yin; Zang, Y.-J.; Zhang, Z.-T. 2015: MiR-744 is a potential prognostic marker in patients with hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 39(3): 359-365
Shi, C.; Zhang, Z. 2016: MiR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(4): 5437-5443
Bolin, K.; Rachmaninoff, N.; Moncada, K.; Pula, K.; Kennell, J.; Buttitta, L. 2016: MiR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings. Developmental Biology 412(1): 83-98
Gao, Y.; Xue, Q.; Wang, D.; Du, M.; Zhang, Y.; Gao, S. 2015: MiR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1. American Journal of Translational Research 7(11): 2519-2526
Zhang, X.; Tang, J.; Zhi, X.; Xie, K.; Wang, W.; Li, Z.; Zhu, Y.; Yang, L.; Xu, H.; Xu, Z. 2015: MiR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer. Oncotarget 6(3): 1605-1617
Dong, D.; Gong, Y.; Zhang, D.; Bao, H.; Gu, G. 2016: MiR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(5): 6447-6455
Zhang, Z.; Yin, J.; Yang, J.; Shen, W.; Zhang, C.; Mou, W.; Luo, J.; Yan, H.; Sun, P.; Luo, Y.; Tian, Y.; Xiang, R. 2016: MiR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway. Oncotarget 7(46): 75038-75051
Hovey, A.M.; Devor, E.J.; Breheny, P.J.; Mott, S.L.; Dai, D.; Thiel, K.W.; Leslie, K.K. 2015: MiR-888: a Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer. Translational Oncology 8(2): 85-96
Xu, Y.; He, J.; Wang, Y.; Zhu, X.; Pan, Q.; Xie, Q.; Sun, F. 2015: MiR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP. Febs Letters 589(10): 1127-1135
Liang, W-long.; Cao, J.; Xu, B.; Yang, P.; Shen, F.; Sun, Z.; Li, W-lin.; Wang, Q.; Liu, F. 2015: MiR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells. Biomedicine and PharmacoTherapy 72: 119-124
Jiang, L.; Yu, L.; Zhang, X.; Lei, F.; Wang, L.; Liu, X.; Wu, S.; Zhu, J.; Wu, G.; Cao, L.; Liu, A.; Song, L.; Li, J. 2016: MiR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer. Cancer Research 76(5): 1101-1111
Seashols-Williams, S.J.; Budd, W.; Clark, G.C.; Wu, Q.; Daniel, R.; Dragoescu, E.; Zehner, Z.E. 2016: MiR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways that Drive Tumour Progression and Metastasis. Plos one 11(7): E0159601
Liu, W.; Ao, Q.; Guo, Q.; He, W.; Peng, L.; Jiang, J.; Hu, X. 2017: MiR-9 Mediates CALHM1-Activated ATP-P2X7R Signal in Painful Diabetic Neuropathy Rats. Molecular Neurobiology 54(2): 922-929
Zhu, S-Wen.; Li, J-Peng.; Ma, X-Long.; Ma, J-Xiong.; Yang, Y.; Chen, Y.; Liu, W. 2015: MiR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor. Asian Pacific journal of cancer prevention: APJCP 16(11): 4509-4513
D'Ippolito, E.; Plantamura, I.; Bongiovanni, L.; Casalini, P.; Baroni, S.; Piovan, C.; Orlandi, R.; Gualeni, A.V.; Gloghini, A.; Rossini, A.; Cresta, S.; Tessari, A.; De Braud, F.; Di Leva, G.; Tripodo, C.; Iorio, M.V. 2016: MiR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. Cancer Research 76(18): 5562-5572
Zeng, Y.; Wang, Y.; Wu, Z.; Kang, K.; Peng, X.; Peng, W.; Qu, J.; Liu, L.; Raj, J.U.; Gou, D. 2015: MiR-9 enhances the transactivation of nuclear factor of activated T cells by targeting KPNB1 and DYRK1B. American Journal of Physiology. Cell Physiology 308(9): C720-C728
Wang, H.; Zhang, W.; Zuo, Y.; Ding, M.; Ke, C.; Yan, R.; Zhan, H.; Liu, J.; Wang, J. 2015: MiR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(12): 9631-9640
Fierro-Fernández, M.; Busnadiego, Óscar.; Sandoval, P.; Espinosa-Díez, C.; Blanco-Ruiz, E.; Rodríguez, M.; Pian, Héctor.; Ramos, R.; López-Cabrera, M.; García-Bermejo, M.Laura.; Lamas, S. 2015: MiR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2. Embo Reports 16(10): 1358-1377
Bhatwadekar, A.D.; Yan, Y.; Stepps, V.; Hazra, S.; Korah, M.; Bartelmez, S.; Chaqour, B.; Grant, M.B. 2015: MiR-92a Corrects CD34+ Cell Dysfunction in Diabetes by Modulating Core Circadian Genes Involved in Progenitor Differentiation. Diabetes 64(12): 4226-4237
Zhou, C.; Shen, L.; Mao, L.; Wang, B.; Li, Y.; Yu, H. 2015: MiR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Biochemical and Biophysical Research Communications 458(1): 63-69
Kalinina, N.; Klink, G.; Glukhanyuk, E.; Lopatina, T.; Efimenko, A.; Akopyan, Z.; Tkachuk, V. 2015: MiR-92a regulates angiogenic activity of adipose-derived mesenchymal stromal cells. Experimental Cell Research 339(1): 61-66
Song, H.; Zhang, Y.; Liu, N.; Zhao, S.; Kong, Y.; Yuan, L. 2016: MiR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways. International Journal of Molecular Sciences 17(11)
Venza, M.; Visalli, M.; Beninati, C.; Benfatto, S.; Teti, D.; Venza, I. 2016: MiR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells. International Immunopharmacology 40: 235-243
Song, H.; Zhang, Y.; Liu, N.; Wan, C.; Zhang, D.; Zhao, S.; Kong, Y.; Yuan, L. 2016: MiR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway. Journal of Physiology and Biochemistry 72(2): 201-211
Huang, J.; Wang, B.; Hui, K.; Zeng, J.; Fan, J.; Wang, X.; Hsieh, J.-T.; He, D.; Wu, K. 2016: MiR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion. Oncology Reports 36(3): 1693-1701
Shyamasundar, S.; Lim, J.P.; Bay, B.H. 2016: MiR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1. International Journal of Oncology 49(6): 2629-2636
Qu, M.-H.; Han, C.; Srivastava, A.K.; Cui, T.; Zou, N.; Gao, Z.-Q.; Wang, Q.-E. 2016: MiR-93 promotes TGF-β-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(4): 5645-5651
Jiang, L.; Wang, C.; Lei, F.; Zhang, L.; Zhang, X.; Liu, A.; Wu, G.; Zhu, J.; Song, L. 2015: MiR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway. Oncotarget 6(10): 8286-8299
Xu, L.; Li, X.; Liu, Y.; Kong, Q.; Long, D.; Li, S. 2015: Mir-93-5p Suppresses Osteogenic Differentiation of Mouse C3h10t1/2 cells by Targeting Smad5. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 29(10): 1288-1294
Choi, N.; Park, J.; Lee, J.-S.; Yoe, J.; Park, G.Y.; Kim, E.; Jeon, H.; Cho, Y.M.; Roh, T.-Y.; Lee, Y. 2015: MiR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression. Oncotarget 6(27): 23533-23547
Yang, M.; Cui, G.; Ding, M.; Yang, W.; Liu, Y.; Dai, D.; Chen, L. 2016: MiR-935 promotes gastric cancer cell proliferation by targeting SOX7. Biomedicine and PharmacoTherapy 79: 153-158
Yan, C.; Yu, J.; Kang, W.; Liu, Y.; Ma, Z.; Zhou, L. 2016: MiR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression. Biochemical and Biophysical Research Communications 470(1): 68-74
Zhang, L.; Zeng, D.; Chen, Y.; Li, N.; Lv, Y.; Li, Y.; Xu, X.; Xu, G. 2016: MiR-937 contributes to the lung cancer cell proliferation by targeting INPP4B. Life Sciences 155: 110-115
Ding, D.; Zhang, Y.; Yang, R.; Wang, X.; Ji, G.; Huo, L.; Shao, Z.; Li, X. 2016: MiR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma. Biomed Research International 2016: 7618342
Ge, C.; Wu, S.; Wang, W.; Liu, Z.; Zhang, J.; Wang, Z.; Li, R.; Zhang, Z.; Li, Z.; Dong, S.; Wang, Y.; Xue, Y.; Yang, J.; Tan, Q.; Wang, Z.; Song, X. 2015: MiR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Oncotarget 6(13): 10964-10977
Wu, L.; Pu, X.; Wang, Q.; Cao, J.; Xu, F.; Xu, L.I.; Li, K. 2016: MiR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9. Oncology Letters 11(2): 945-952
Xia, Y.; Sheng, J.; Liang, G.Y.; Liu, D.X.; Tang, Q.; Cheng, A.P. 2015: MiR-96 inhibits cardiac hypertrophy by targeting growth factor receptor-bound 2. Genetics and Molecular Research: Gmr 14(4): 18958-18964
Yang, M.; Pan, Y.; Zhou, Y. 2014: MiR-96 promotes osteogenic differentiation by suppressing HBEGF-EGFR signaling in osteoblastic cells. Febs Letters 588(24): 4761-4768
Xu, L.; Zhong, J.; Guo, B.; Zhu, Q.; Liang, H.; Wen, N.; Yun, W.; Zhang, L. 2016: MiR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(9): 12023-12032
Yu, N.; Fu, S.; Liu, Y.; Xu, Z.; Liu, Y.; Hao, J.; Wang, B.; Zhang, A. 2015: MiR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression. Journal of Experimental and Clinical Cancer Research: Cr 34: 107
Budzinska, M.; Owczarz, M.; Pawlik-Pachucka, E.; Roszkowska-Gancarz, M.; Slusarczyk, P.; Puzianowska-Kuznicka, M. 2016: MiR-96, miR-145 and miR-9 expression increases, and IGF-1R and FOXO1 expression decreases in peripheral blood mononuclear cells of aging humans. Bmc Geriatrics 16(1): 200
Verma, P.; Cohen, S.M. 2015: MiR-965 controls cell proliferation and migration during tissue morphogenesis in the Drosophila abdomen. Elife 4
Liu, X.; Zhang, W.; Guo, H.; Yue, J.; Zhuo, S. 2016: MiR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomas. Oncotargets and Therapy 9: 1777-1786
Zhang, J.-J.; Chen, J.-T.; Hua, L.; Yao, K.-H.; Wang, C.-Y. 2017: MiR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway. Biomedicine and PharmacoTherapy 85: 472-478
Li, H.-w.; Meng, Y.; Xie, Q.; Yi, W.-j.; Lai, X.-l.; Bian, Q.; Wang, J.; Wang, J.-f.; Yu, G. 2015: MiR-98 protects endothelial cells against hypoxia/reoxygenation induced-apoptosis by targeting caspase-3. Biochemical and Biophysical Research Communications 467(3): 595-601
Du, Y.; Li, Y.; Lv, H.; Zhou, S.; Sun, Z.; Wang, M. 2015: MiR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma. International Journal of Clinical and Experimental Pathology 8(10): 12252-12259
Ni, R.; Huang, Y.; Wang, J. 2015: MiR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer. Oncotargets and Therapy 8: 2689-2697
Li, Q.; Li, X.; Wang, L.; Zhang, Y.; Chen, L. 2016: MiR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression. Journal of molecular neuroscience: MN 60(4): 413-420
Yang, J.; Liu, X.; Yuan, X.; Wang, Z. 2015: MiR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker. Oncology Reports 34(3): 1415-1423
Li, J.; Fang, R.; Gong, Q.; Wang, J. 2015: MiR-99b suppresses IGF-1R expression and contributes to inhibition of cell proliferation in human epidermal keratinocytes. Biomedicine and PharmacoTherapy 75: 159-164
Han, Z.; Liu, X.; Chen, X.; Zhou, X.; Du, T.; Roizman, B.; Zhou, G. 2016: MiR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells. Proceedings of the National Academy of Sciences of the United States of America 113(7): E894-E901
Song, J.; Oh, Y.; Lee, J.E. 2015: MiR-Let7A Modulates Autophagy Induction in LPS-Activated Microglia. Experimental Neurobiology 24(2): 117-125
Wang, C.; Fang, J. 2015: MiR-RACE: an effective approach to accurately determine the sequence of computationally identified miRNAs. Methods in Molecular Biology 1296: 109-118
Montani, F.; Marzi, M.J.; Dezi, F.; Dama, E.; Carletti, R.M.; Bonizzi, G.; Bertolotti, R.; Bellomi, M.; Rampinelli, C.; Maisonneuve, P.; Spaggiari, L.; Veronesi, G.; Nicassio, F.; Di Fiore, P.P.; Bianchi, F. 2015: MiR-Test: a blood test for lung cancer early detection. Journal of the National Cancer Institute 107(6): Djv063
Yi, S.; Wang, S.; Zhao, Q.; Yao, C.; Gu, Y.; Liu, J.; Gu, X.; Li, S. 2016: MiR-sc3, a Novel MicroRNA, Promotes Schwann Cell Proliferation and Migration by Targeting Astn1. Cell Transplantation 25(5): 973-982
Gu, Y.; Chen, C.; Yi, S.; Wang, S.; Gong, L.; Liu, J.; Gu, X.; Zhao, Q.; Li, S. 2015: MiR-sc8 Inhibits Schwann Cell Proliferation and Migration by Targeting Egfr. Plos one 10(12): E0145185
Shan, Z.-N.; Tian, R.; Zhang, M.; Gui, Z.-H.; Wu, J.; Ding, M.; Zhou, X.-F.; He, J. 2016: MiR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Oncotarget 7(48): 78813-78826
Tan, H.; Zhu, Y.; Zhang, J.; Peng, L.; Ji, T. 2016: MiR141 expression is downregulated and negatively correlated with STAT5 expression in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine 11(5): 1803-1808
Sundaravinayagam, D.; Kim, H.R.; Wu, T.; Kim, H.H.; Lee, H.-S.; Jun, S.; Cha, J.-H.; Kee, Y.; You, H.J.; Lee, J.-H. 2016: MiR146a-mediated targeting of FANCM during inflammation compromises genome integrity. Oncotarget 7(29): 45976-45994
Lei, K.J.; Lin, Y.M.; An, G.Y. 2016: MiR156 modulates rhizosphere acidification in response to phosphate limitation in Arabidopsis. Journal of Plant Research 129(2): 275-284
Tian, Y.; Cai, L.; Tian, Y.; Tu, Y.; Qiu, H.; Xie, G.; Huang, D.; Zheng, R.; Zhang, W. 2016: MiR156a Mimic Represses the Epithelial-Mesenchymal Transition of Human Nasopharyngeal Cancer Cells by Targeting Junctional Adhesion Molecule A. Plos one 11(6): E0157686
Zhao, X.; Wang, Y.; Deng, R.; Zhang, H.; Dou, J.; Yuan, H.; Hou, G.; Du, Y.; Chen, Q.; Yu, J. 2016: MiR186 suppresses prostate cancer progression by targeting Twist1. Oncotarget 7(22): 33136-33151
Hu, T.; Zhou, F.-J.; Chang, Y.-F.; Li, Y.-S.; Liu, G.-C.; Hong, Y.; Chen, H.-L.; Xiyang, Y.-B.; Bao, T.-h. 2015: MiR21 is Associated with the Cognitive Improvement Following Voluntary Running Wheel Exercise in TBi Mice. Journal of Molecular Neuroscience: Mn 57(1): 114-122
Li, C.; Zhao, M.; Zhang, C.; Zhang, W.; Zhao, X.; Duan, X.; Xu, W. 2016: MiR210 modulates respiratory burst in Apostichopus japonicus coelomocytes via targeting Toll-like receptor. Developmental and Comparative Immunology 65: 377-381
Ta, K.N.; Sabot, F.; Adam, H.; Vigouroux, Y.; De Mita, S.; Ghesquière, A.; Do, N.V.; Gantet, P.; Jouannic, S. 2016: MiR2118-triggered phased si RNAs are differentially expressed during the panicle development of wild and domesticated African rice species. Rice 9(1): 10
Ma, W.; Li, J.; Hu, J.; Cheng, Y.; Wang, J.; Zhang, X.; Xu, M. 2016: MiR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells. Chemico-Biological Interactions 245: 72-81
Shi, Y.; Chen, G.-B.; Huang, Q.-W.; Chen, X.; Liu, J.-J.; Xu, W.; Huang, X.-X.; Liu, Y.-P.; Xiao, C.-X.; Wu, D.-C.; Guleng, B.; Ren, J.-L. 2015: MiR218-5p regulates the proliferation of gastric cancer cells by targeting TFF1 in an Erk1/2-dependent manner. Biochimica et Biophysica Acta 1852(5): 970-979
Bhattacharya, A.; Cui, Y. 2015: MiR2GO: comparative functional analysis for microRNAs. Bioinformatics 31(14): 2403-2405
Boufraqech, M.; Nilubol, N.; Zhang, L.; Gara, S.K.; Sadowski, S.M.; Mehta, A.; He, M.; Davis, S.; Dreiling, J.; Copland, J.A.; Smallridge, R.C.; Quezado, M.M.; Kebebew, E. 2015: MiR30a inhibits LOX expression and anaplastic thyroid cancer progression. Cancer Research 75(2): 367-377
Sjöholm, P.; Pahkala, K.; Davison, B.; Juonala, M.; Singh, G.R. 2018: Early life determinants of cardiovascular health in adulthood. the Australian Aboriginal Birth Cohort study. International Journal of Cardiology 269: 304-309
Yamashita, D.; Kondo, T.; Ohue, S.; Takahashi, H.; Ishikawa, M.; Matoba, R.; Suehiro, S.; Kohno, S.; Harada, H.; Tanaka, J.; Ohnishi, T. 2015: MiR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator. Cancer Research 75(6): 1123-1133
Wójcik, A.M.; Gaj, Młgorzata.D. 2016: MiR393 contributes to the embryogenic transition induced in vitro in Arabidopsis via the modification of the tissue sensitivity to auxin treatment. Planta 244(1): 231-243
Ma, C.; Burd, S.; Lers, A. 2015: MiR408 is involved in abiotic stress responses in Arabidopsis. Plant Journal: for Cell and Molecular Biology 84(1): 169-187
Hajyzadeh, M.; Turktas, M.; Khawar, K.M.; Unver, T. 2015: MiR408 overexpression causes increased drought tolerance in chickpea. Gene 555(2): 186-193
Li, H.; Li, J.; Jia, S.; Wu, M.; An, J.; Zheng, Q.; Zhang, W.; Lu, D. 2015: MiR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer. Oncotarget 6(31): 31958-31984
Evers, M.; Huttner, M.; Dueck, A.; Meister, G.; Engelmann, J.C. 2015: MiRA: adaptable novel miRNA identification in plants using small RNA sequencing data. Bmc Bioinformatics 16: 370
Tran, V.D.T.; Tempel, S.; Zerath, B.; Zehraoui, F.; Tahi, F. 2015: MiRBoost: boosting support vector machines for microRNA precursor classification. Rna 21(5): 775-785
Ulfenborg, B.; Jurcevic, S.; Lindlöf, A.; Klinga-Levan, K.; Olsson, B.ör. 2015: MiREC: a database of mi RNAs involved in the development of endometrial cancer. Bmc Research Notes 8: 104
Chen, X. 2016: MiREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method. Molecular Biosystems 12(2): 624-633
Andrés-León, E.; González Peña, D.; Gómez-López, G.; Pisano, D.G. 2015: MiRGate: a curated database of human, mouse and rat miRNA-mRNA targets. Database: the Journal of Biological Databases and Curation 2015: Bav035
Kuzuoğlu-Öztürk, D.; Bhandari, D.; Huntzinger, E.; Fauser, M.; Helms, S.; Izaurralde, E. 2016: MiRISC and the CCR4-NOT complex silence mRNA targets independently of 43S ribosomal scanning. EMBO Journal 35(11): 1186-1203
Le, T.D.; Zhang, J.; Liu, L.; Liu, H.; Li, J. 2015: MiRLAB: An R Based Dry Lab for Exploring miRNA-mRNA Regulatory Relationships. Plos one 10(12): E0145386
Cui, H.; Zhai, J.; Ma, C. 2015: MiRLocator: Machine Learning-Based Prediction of Mature MicroRNAs within Plant Pre-miRNA Sequences. Plos one 10(11): E0142753
Kaushik, A.; Saraf, S.; Mukherjee, S.K.; Gupta, D. 2015: MiRMOD: a tool for identification and analysis of 5' and 3' miRNA modifications in Next Generation Sequencing small RNA data. Peerj 3: E1332
Zaleska, K. 2015: MiRNA - Therapeutic tool in breast cancer? Where are we now?. Reports of Practical Oncology and Radiotherapy: Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 20(2): 79-86
Zhou, J.; Shao, G.; Chen, X.; Yang, X.; Huang, X.; Peng, P.; Ba, Y.; Zhang, L.; Jehangir, T.; Bu, S.; Liu, N.; Lian, J. 2015: MiRNA 206 and miRNA 574-5p are highly expression in coronary artery disease. Bioscience Reports 36(1): E00295
Shah, S.; Jadhav, K.; Shah, V.; Gupta, N.; Dagrus, K. 2016: MiRNA 21: Diagnostic Prognostic and Therapeutic Marker for Oral Cancer. Microrna 5(3): 175-179
Achkar, N.P.; Cambiagno, D.án.A.; Manavella, P.A. 2016: MiRNA Biogenesis: a Dynamic Pathway. Trends in Plant Science 21(12): 1034-1044
Rupaimoole, R.; Calin, G.A.; Lopez-Berestein, G.; Sood, A.K. 2016: MiRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discovery 6(3): 235-246
Bucay, N.; Shahryari, V.; Majid, S.; Yamamura, S.; Mitsui, Y.; Tabatabai, Z.L.; Greene, K.; Deng, G.; Dahiya, R.; Tanaka, Y.; Saini, S. 2015: MiRNA Expression Analyses in Prostate Cancer Clinical Tissues. Journal of Visualized Experiments: Jove 2015(103)
Gao, D.; Zhang, Y.; Zhu, M.; Liu, S.; Wang, X. 2016: MiRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China. Plos one 11(10): E0164701
Ayers, D.; Baron, B.; Hunter, T. 2015: MiRNA Influences in NRF2 Pathway Interactions within Cancer Models. Journal of Nucleic Acids 2015: 143636
Nagy, Z.óf.B.; Wichmann, B.ás.; Kalmár, A.; Barták, B.K.; Tulassay, Z.; Molnár, B.él. 2016: MiRNA Isolation from FFPET Specimen: a Technical Comparison of miRNA and Total RNA Isolation Methods. Pathology Oncology Research: Por 22(3): 505-513
Rolle, K. 2015: MiRNA Multiplayers in glioma. from bench to bedside. Acta Biochimica Polonica 62(3): 353-365
Desvignes, T.; Batzel, P.; Berezikov, E.; Eilbeck, K.; Eppig, J.T.; McAndrews, M.S.; Singer, A.; Postlethwait, J.H. 2015: MiRNA Nomenclature: a View Incorporating Genetic Origins, Biosynthetic Pathways, and Sequence Variants. Trends in Genetics: Tig 31(11): 613-626
Drewry, M.; Helwa, I.; Allingham, R.R.; Hauser, M.A.; Liu, Y. 2016: MiRNA Profile in Three Different Normal Human Ocular Tissues by miRNA-Seq. Investigative Ophthalmology and Visual Science 57(8): 3731-3739
Kito, N.; Endo, K.; Ikesue, M.; Weng, H.; Iwai, N. 2015: MiRNA Profiles of Tubular Cells: Diagnosis of Kidney Injury. Biomed Research International 2015: 465479
Li, S.; Wang, S.; Guo, Z.; Wu, H.; Jin, X.; Wang, Y.; Li, X.; Liang, S. 2016: MiRNA Profiling Reveals Dysregulation of RET and RET-Regulating Pathways in Hirschsprung's Disease. Plos one 11(3): E0150222
Liu, L.; Wan, Y.; Shen, A.; Zhao, J.; Lin, J.; Zhong, X.; Zhang, Y.; Hong, Z. 2015: MiRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia. Evidence-Based Complementary and Alternative Medicine: Ecam 2015: 365484
Schjenken, J.E.; Zhang, B.; Chan, H.Y.; Sharkey, D.J.; Fullston, T.; Robertson, S.A. 2016: MiRNA Regulation of Immune Tolerance in Early Pregnancy. American Journal of Reproductive Immunology 75(3): 272-280
Liew, Y.J.; Ryu, T.; Aranda, M.; Ravasi, T. 2016: MiRNA Repertoires of Demosponges Stylissa carteri and Xestospongia testudinaria. Plos one 11(2): E0149080
Balzano, F.; Deiana, M.; Dei Giudici, S.; Oggiano, A.; Baralla, A.; Pasella, S.; Mannu, A.; Pescatori, M.; Porcu, B.; Fanciulli, G.; Zinellu, A.; Carru, C.; Deiana, L. 2015: MiRNA Stability in Frozen Plasma Samples. Molecules 20(10): 19030-19040
He, M. 2012: MiRNA Tagging and Affinity-purification (miRAP). Bio-Protocol 2(19)
Schmidt, M.F. 2017: MiRNA Targeting Drugs: the Next Blockbusters?. Methods in Molecular Biology 1517: 3-22
Ouimet, M.; Hennessy, E.J.; van Solingen, C.; Koelwyn, G.J.; Hussein, M.A.; Ramkhelawon, B.; Rayner, K.J.; Temel, R.E.; Perisic, L.; Hedin, U.; Maegdefessel, L.; Garabedian, M.J.; Holdt, L.M.; Teupser, D.; Moore, K.J. 2016: MiRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux. Arteriosclerosis Thrombosis and Vascular Biology 36(5): 942-951
Li, Z.; Zhang, X.; Liu, X.; Zhao, Y.; Wang, B.; Zhang, J. 2016: MiRNA alterations are important mechanism in maize adaptations to low-phosphate environments. Plant Science: An International Journal of Experimental Plant Biology 252: 103-117
Jeon, T.-I.; Osborne, T.F. 2016: MiRNA and cholesterol homeostasis. Biochimica et Biophysica Acta 1861(12 Part B): 2041-2046
Chhabra, R. 2015: MiRNA and methylation: a multifaceted liaison. Chembiochem: a European Journal of Chemical Biology 16(2): 195-203
Wu, S.R.; Guo, W.; Li, Y.L.; Ren, X.C.; Lei, X.Y.; Li, X.Y.; Yao, J.H.; Yang, X.J. 2017: MiRNA and piRNA expression profiles of breeder cock testes detected by next-generation sequencing. Reproduction in Domestic Animals 52(2): 203-213
Lv, Y.; Gao, S.; Zhang, Y.; Wang, L.; Chen, X.; Wang, Y. 2016: MiRNA and target gene expression in menstrual endometria and early pregnancy decidua. European Journal of Obstetrics Gynecology and Reproductive Biology 197: 27-30
Khalil, S.; Fabbri, E.; Santangelo, A.; Bezzerri, V.; Cantù, C.; Di Gennaro, G.; Finotti, A.; Ghimenton, C.; Eccher, A.; Dechecchi, M.; Scarpa, A.; Hirshman, B.; Chen, C.; Ferracin, M.; Negrini, M.; Gambari, R.; Cabrini, G. 2016: MiRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma. Oncotarget 7(19): 28195-28206
Škrha, P.; Hajer, J.; Anděl, M.; Hořínek, A.š; Korabečná, M. 2015: MiRNA as a new marker of diabetes mellitus and pancreatic carcinoma progression. Casopis Lekaru Ceskych 154(3): 122-126
Romero-Cordoba, S.L.; Salido-Guadarrama, I.; Rodriguez-Dorantes, M.; Hidalgo-Miranda, A. 2014: MiRNA biogenesis: biological impact in the development of cancer. Cancer Biology and Therapy 15(11): 1444-1455
Di Leva, G.; Cheung, D.G.; Croce, C.M. 2015: MiRNA clusters as therapeutic targets for hormone-resistant breast cancer. Expert Review of Endocrinology and Metabolism 10(6): 607-617
Akers, J.C.; Ramakrishnan, V.; Kim, R.; Phillips, S.; Kaimal, V.; Mao, Y.; Hua, W.; Yang, I.; Fu, C.-C.; Nolan, J.; Nakano, I.; Yang, Y.; Beaulieu, M.; Carter, B.S.; Chen, C.C. 2015: MiRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients. Journal of Neuro-Oncology 123(2): 205-216
Sen, C.K.; Ghatak, S. 2015: MiRNA control of tissue repair and regeneration. American Journal of Pathology 185(10): 2629-2640
Usó, M.; Jantus-Lewintre, E.; Sirera, R.; Bremnes, R.M.; Camps, C. 2014: MiRNA detection methods and clinical implications in lung cancer. Future Oncology 10(14): 2279-2292
Mühlberg, L.; Kühnemuth, B.; Costello, E.; Shaw, V.; Sipos, B.; Huber, M.; Griesmann, H.; Krug, S.; Schober, M.; Gress, T.M.; Michl, P. 2016: MiRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. Oncoimmunology 5(6): E1160181
Saiselet, M.; Pita, J.M.; Augenlicht, A.; Dom, G.èv.; Tarabichi, M.; Fimereli, D.; Dumont, J.E.; Detours, V.; Maenhaut, C. 2016: MiRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers. Oncotarget 7(32): 52475-52492
Portilho, D.éb.M.; Alves, M.R.; Kratassiouk, G.; Roche, S.ép.; Magdinier, F.éd.ér.; de Santana, E.C.êa.; Polesskaya, A.; Harel-Bellan, A.; Mouly, V.; Savino, W.; Butler-Browne, G.; Dumonceaux, J. 2015: MiRNA expression in control and FSHD fetal human muscle biopsies. Plos one 10(2): E0116853
Köpke, S.; Buhrke, T.; Lampen, A. 2015: MiRNA expression in human intestinal Caco-2 cells is comparably regulated by cis- and trans-fatty acids. Lipids 50(3): 227-239
Alieva, A.K.; Filatova, E.V.; Karabanov, A.V.; Illarioshkin, S.N.; Limborska, S.A.; Shadrina, M.I.; Slominsky, P.A. 2015: MiRNA expression is highly sensitive to a drug therapy in Parkinson's disease. Parkinsonism and Related Disorders 21(1): 72-74
Lv, J.; Xia, K.; Xu, P.; Sun, E.; Ma, J.; Gao, S.; Zhou, Q.; Zhang, M.; Wang, F.; Chen, F.; Zhou, P.; Fu, Z.; Xie, H. 2014: MiRNA expression patterns in chemoresistant breast cancer tissues. Biomedicine and PharmacoTherapy 68(8): 935-942
Vos, S.; Vesuna, F.; Raman, V.; van Diest, P.J.; van der Groep, P. 2015: MiRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers. Oncotarget 6(31): 32115-32137
Luo, T.; Yin, S.; Shi, R.; Xu, C.; Wang, Y.; Cai, J.; Yue, Y.; Wu, A. 2015: MiRNA expression profile and involvement of Let-7d-APP in aged rats with isoflurane-induced learning and memory impairment. Plos one 10(3): E0119336
Yang, X.; Wu, X. 2016: MiRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p. Oncology Reports 35(1): 398-408
Louwies, T.; Vuegen, C.; Panis, L.I.; Cox, B.; Vrijens, K.; Nawrot, T.S.; De Boever, P. 2016: MiRNA expression profiles and retinal blood vessel calibers are associated with short-term particulate matter air pollution exposure. Environmental Research 147: 24-31
Sørensen, S.S.øl.; Nygaard, A.-B.; Christensen, T. 2016: MiRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study. Translational Neurodegeneration 5: 6
Hartmann, S.; Döring, C.; Agostinelli, C.; Portscher-Kim, S.-J.; Lonardi, S.; Lorenzi, L.; Fuligni, F.; Martinez, D.; Mehta, J.; Borges, A.; Hackstein, H.; Kippenberger, S.; Piccaluga, P.P.; Simonitsch-Klupp, I.; Cabeçadas, J.é; Campo, E.; Facchetti, F.; Pileri, S.A.; Hansmann, M.-L. 2016: MiRNA expression profiling divides follicular dendritic cell sarcomas into two groups, related to fibroblasts and myopericytomas or Castleman's disease. European Journal of Cancer 64: 159-166
Alles, J.; Menegatti, J.; Motsch, N.; Hart, M.; Eichner, N.; Reinhardt, R.; Meister, G.; Grässer, F.A. 2016: MiRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing. Febs Open Bio 6(4): 251-263
Stylli, S.S.; Adamides, A.A.; Koldej, R.M.; Luwor, R.B.; Ritchie, D.S.; Ziogas, J.; Kaye, A.H. 2017: MiRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 126(4): 1131-1139
Tanić, M.; Yanowski, K.; Andrés, E.; Gómez-López, G.; Socorro, M.ía.R.íg.-P.; Pisano, D.G.; Martinez-Delgado, B.; Benítez, J. 2015: MiRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors. Genomics Data 3: 75-79
Wang, Y.; Tian, Y. 2016: MiRNA for diagnosis and clinical implications of human hepatocellular carcinoma. Hepatology Research: the Official Journal of the Japan Society of Hepatology 46(1): 89-99
Roy, S. 2016: MiRNA in Macrophage Development and Function. Antioxidants and Redox Signaling 25(15): 795-804
Mekhail, S.M.; Yousef, P.G.; Jackinsky, S.W.; Pasic, M.; Yousef, G.M. 2014: MiRNA in Prostate Cancer: New Prospects for Old Challenges. Ejifcc 25(1): 79-98
Gandhi, R. 2015: MiRNA in multiple sclerosis: search for novel biomarkers. Multiple Sclerosis 21(9): 1095-1103
Chen, L.; Kang, C. 2015: MiRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks. Oncotarget 6(36): 38628-38642
Wang, L.; Lee, A.Y.W.; Wigg, J.P.; Peshavariya, H.; Liu, P.; Zhang, H. 2016: MiRNA involvement in angiogenesis in age-related macular degeneration. Journal of Physiology and Biochemistry 72(4): 583-592
Katayama, M.; Sjögren, R.J.O.; Egan, B.; Krook, A. 2015: MiRNA let-7 expression is regulated by glucose and TNF-α by a remote upstream promoter. Biochemical Journal 472(2): 147-156
Wu, D.; Bi, X.; Qu, L.; Han, L.; Yin, C.; Deng, J.; Dong, Z.; Mi, Q.-S.; Zhou, L. 2017: MiRNA miR-17-92 cluster is differentially regulated in the imiqumod-treated skin but is not required for imiqumod-induced psoriasis-like dermatitis in mice. Experimental Dermatology 26(1): 82-84
Ganju, A.; Khan, S.; Hafeez, B.B.; Behrman, S.W.; Yallapu, M.M.; Chauhan, S.C.; Jaggi, M. 2017: MiRNA nanotherapeutics for cancer. Drug Discovery Today 22(2): 424-432
Gao, S.; Tian, H.; Guo, Y.; Li, Y.; Guo, Z.; Zhu, X.; Chen, X. 2015: MiRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy. Acta Biomaterialia 25: 184-193
Pandey, C.; Raghuram, B.; Sinha, A.K.; Gupta, M. 2015: MiRNA plays a role in the antagonistic effect of selenium on arsenic stress in rice seedlings. Metallomics: Integrated Biometal Science 7(5): 857-866
Sung, J.-H.; Kim, S.-H.; Yang, W.-I.; Kim, W.-J.; Moon, J.-Y.; Kim, I.J.; Cha, D.-H.; Cho, S.-Y.; Kim, J.O.; Kim, K.A.; Kim, O.-J.; Lim, S.-W.; Kim, N.-K. 2016: MiRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease. Molecular Medicine Reports 14(3): 2328-2342
Resnick, K.E.; Cohn, D.E.; Ivanov, I.; Liu, C.; Taccioli, C.; Croce, C.M. 2016: miRNA profile and advanced stage endometrial cancer. Journal of Clinical Oncology 26(15_Suppl): 5561-5561
Huang, F.; Zhou, T.; Yao, X.; Yi, J.; Zhou, F.; Long, Z.; Hou, X.; Wang, C.; Chen, Z.; Jiang, H. 2015: MiRNA profiling in autism spectrum disorder in China. Genomics Data 6: 108-109
Nannini, M.; Ravegnini, G.; Angelini, S.; Astolfi, A.; Biasco, G.; Pantaleo, M.A. 2015: MiRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers. Epigenomics 7(6): 1033-1049
Petriella, D.; De Summa, S.; Lacalamita, R.; Galetta, D.; Catino, A.; Logroscino, A.F.; Palumbo, O.; Carella, M.; Zito, F.A.; Simone, G.; Tommasi, S. 2016: MiRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(4): 5503-5513
Jin, X.; Guo, X.; Zhu, D.; Ayaz, M.; Zheng, Y. 2017: MiRNA profiling in the mice in response to Echinococcus multilocularis infection. Acta Tropica 166: 39-44
Ragusa, M.; Barbagallo, C.; Statello, L.; Caltabiano, R.; Russo, A.; Puzzo, L.; Avitabile, T.; Longo, A.; Toro, M.D.; Barbagallo, D.; Valadi, H.; Di Pietro, C.; Purrello, M.; Reibaldi, M. 2015: MiRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications. Cancer Biology and Therapy 16(9): 1387-1396
Ostenfeld, M.S.; Jensen, S.G.; Jeppesen, D.K.øl.; Christensen, L.-L.; Thorsen, S.B.; Stenvang, J.; Hvam, M.L.; Thomsen, A.; Mouritzen, P.; Rasmussen, M.H.; Nielsen, H.J.ør.; Ørntoft, T.F.; Andersen, C.L. 2016: MiRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer. Journal of Extracellular Vesicles 5: 31488
Stiefel, F.; Fischer, S.; Sczyrba, A.; Otte, K.; Hesse, F. 2016: MiRNA profiling of high, low and non-producing CHO cells during biphasic fed-batch cultivation reveals process relevant targets for host cell engineering. Journal of Biotechnology 225: 31-43
Titov, S.E.; Ivanov, M.K.; Karpinskaya, E.V.; Tsivlikova, E.V.; Shevchenko, S.P.; Veryaskina, Y.A.; Akhmerova, L.G.; Poloz, T.L.; Klimova, O.A.; Gulyaeva, L.F.; Zhimulev, I.F.; Kolesnikov, N.N. 2016: MiRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumors. Bmc Cancer 16: 201
Kurcon, T.; Liu, Z.; Paradkar, A.V.; Vaiana, C.A.; Koppolu, S.; Agrawal, P.; Mahal, L.K. 2015: MiRNA proxy approach reveals hidden functions of glycosylation. Proceedings of the National Academy of Sciences of the United States of America 112(23): 7327-7332
Chaitra, K.L.; Ulaganathan, K.; James, A.; Ananthapur, V.; Nallari, P. 2013: MiRNA regulation during cardiac development and remodeling in cardiomyopathy. Excli Journal 12: 980-992
Goedeke, L.; Wagschal, A.; Fernández-Hernando, C.; Näär, A.M. 2016: MiRNA regulation of LDL-cholesterol metabolism. Biochimica et Biophysica Acta 1861(12 Part B): 2047-2052
Romeo, S.G.; Conti, A.; Polito, F.; Tomasello, C.; Barresi, V.; La Torre, D.L.; Cucinotta, M.; Angileri, F.F.; Bartolotta, M.; Di Giorgio, R.M.; Aguennouz, M.'H. 2016: MiRNA regulation of Sirtuin-1 expression in human astrocytoma. Oncology Letters 12(4): 2992-2998
Paul, S.; Datta, S.K.; Datta, K. 2015: MiRNA regulation of nutrient homeostasis in plants. Frontiers in Plant Science 6: 232
Price, N.L.; Fernández-Hernando, C. 2016: MiRNA regulation of white and brown adipose tissue differentiation and function. Biochimica et Biophysica Acta 1861(12 Part B): 2104-2110
Iwasaki, Y.W.; Siomi, H. 2014: MiRNA regulatory ecosystem in early development. Molecular Cell 56(5): 615-616
Yang, Y.; Mei, Q. 2015: MiRNA signature identification of retinoblastoma and the correlations between differentially expressed mi RNAs during retinoblastoma progression. Molecular Vision 21: 1307-1317
Mansuri, M.S.; Singh, M.; Begum, R. 2016: MiRNA signatures and transcriptional regulation of their target genes in vitiligo. Journal of Dermatological Science 84(1): 50-58
Katanforoush, A.; Mahdavi, E. 2015: MiRNA target recognition using features of suboptimal alignments. International Journal of Data Mining and Bioinformatics 13(2): 171-180
Li, G.; Li, Q.-S.; Li, W.-B.; Wei, J.; Chang, W.-K.; Chen, Z.; Qiao, H.-Y.; Jia, Y.-W.; Tian, J.-H.; Liang, B.-S. 2016: MiRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy. Neural Regeneration Research 11(8): 1293-1303
Nouraee, N.; Mowla, S.J. 2015: MiRNA therapeutics in cardiovascular diseases: promises and problems. Frontiers in Genetics 6: 232
Bernardo, B.C.; Ooi, J.Y.Y.; Lin, R.C.Y.; McMullen, J.R. 2015: MiRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Medicinal Chemistry 7(13): 1771-1792
Osaki, M.; Okada, F.; Ochiya, T. 2015: MiRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence. Therapeutic Delivery 6(3): 323-337
Izarra, A.; Moscoso, I.; Cañón, S.; Carreiro, C.; Fondevila, D.; Martín-Caballero, J.; Blanca, V.; Valiente, I.ñi.; Díez-Juan, A.; Bernad, A. 2017: MiRNA-1 and miRNA-133a are involved in early commitment of pluripotent stem cells and demonstrate antagonistic roles in the regulation of cardiac differentiation. Journal of Tissue Engineering and Regenerative Medicine 11(3): 787-799
Jiang, W.; Gu, W.; Qiu, R.; He, S.; Shen, C.; Wu, Y.; Zhang, J.; Zhou, J.; Guo, Y.; Wan, D.; Li, Z.; Deng, J.; Zeng, L.; Tang, J.; Zhou, J.; Zhi, Q.; Deng, X. 2016: MiRNA-101 Suppresses Epithelial-to-Mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry 16(4): 432-439
Hui, Y.; Li, Y.; Jing, Y.; Feng, J.-Q.; Ding, Y. 2016: MiRNA-101 acts as a tumor suppressor in oral squamous cell carcinoma by targeting CX chemokine receptor 7. American Journal of Translational Research 8(11): 4902-4911
Zheng, H.-B.; Zheng, X.-G.; Liu, B.-P. 2015: MiRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2. International Journal of Clinical and Experimental Medicine 8(11): 20263-20270
Liu, J.-x.; Zhang, Q.-f.; Tian, C.-h.; Zhang, Y.; Han, X.-z.; Guo, H. 2015: MiRNA-101 inhibits the expression of the enhancer of zeste homolog 2 in androgen-independent prostate cancer LNCaP cell line. Zhonghua Nan Ke Xue 21(6): 500-503
Klingelhöffer, C.; Codrin, C.; Ettl, T.; Reichert, T.; Morsczeck, C. 2016: MiRNA-101 supports the osteogenic differentiation in human dental follicle cells. Archives of Oral Biology 72: 47-50
Xu, Q.; Li, Y.; Shang, Y.-F.; Wang, H.-L.; Yao, M.-X. 2015: MiRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease. World Journal of Gastroenterology 21(2): 511-516
Shen, C.-T.; Qiu, Z.-L.; Song, H.-J.; Wei, W.-J.; Luo, Q.-Y. 2016: MiRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway. Journal of Experimental and Clinical Cancer Research: Cr 35(1): 101
Yang, X.; Zang, W.; Xuan, X.; Wang, Z.; Liu, Z.; Wang, J.; Cui, J.; Zhao, G. 2015: MiRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma. International Journal of Oncology 46(5): 2163-2171
Qin, Z.; Wang, P.-Y.; Su, D.-F.; Liu, X. 2016: MiRNA-124 in Immune System and Immune Disorders. Frontiers in Immunology 7: 406
Li, Z.; Wang, X.; Li, W.; Wu, L.; Chang, L.; Chen, H. 2016: MiRNA-124 modulates lung carcinoma cell migration and invasion. International Journal of Clinical Pharmacology and Therapeutics 54(8): 603-612
Nucera, S.; Giustacchini, A.; Boccalatte, F.; Calabria, A.; Fanciullo, C.; Plati, T.; Ranghetti, A.; Garcia-Manteiga, J.; Cittaro, D.; Benedicenti, F.; Lechman, E.R.; Dick, J.E.; Ponzoni, M.; Ciceri, F.; Montini, E.; Gentner, B.; Naldini, L. 2016: MiRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia. Cancer Cell 29(6): 905-921
He, L.; Yuan, J.; Xu, Q.; Chen, R.; Chen, L.; Fang, M. 2016: MiRNA-1283 Regulates the PERK/ATF4 Pathway in Vascular Injury by Targeting ATF4. Plos one 11(8): E0159171
Peng, X.-P.; Huang, L.; Liu, Z.-H. 2016: MiRNA-133a attenuates lipid accumulation via TR4-CD36 pathway in macrophages. Biochimie 127: 79-85
Zhou, W.; Bi, X.; Gao, G.; Sun, L. 2016: MiRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells. Biomedicine and PharmacoTherapy 84: 722-729
Zeng, Y.-B.; Liang, X.-H.; Zhang, G.-X.; Jiang, N.; Zhang, T.; Huang, J.-Y.; Zhang, L.; Zeng, X.-C. 2016: MiRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1. Cancer Cell International 16: 63
Rothman, A.M.; Rowlands, D.J.; Lawrie, A. 2016: MiRNA-140-5p: new avenue for pulmonary arterial hypertension drug development?. Epigenomics 8(10): 1311-1313
Xiao, R.; Li, C.; Chai, B. 2015: MiRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1. Biomedicine and PharmacoTherapy 74: 138-144
Xie, Y.-F.; Shu, R.; Jiang, S.-Y.; Song, Z.-C.; Guo, Q.-M.; Dong, J.-C.; Lin, Z.-K. 2014: MiRNA-146 negatively regulates the production of pro-inflammatory cytokines via NF-κB signalling in human gingival fibroblasts. Journal of Inflammation 11(1): 38
Wu, Z.W.; Liu, Y.F.; Wang, S.; Li, B. 2015: MiRNA-146a induces vascular smooth muscle cell apoptosis in a rat model of coronary heart disease via NF-κB pathway. Genetics and Molecular Research: Gmr 14(4): 18703-18712
Zhai, G.; Li, G.; Xu, B.; Jia, T.; Sun, Y.; Zheng, J.; Li, J. 2016: MiRNA-148b regulates radioresistance in non-small lung cancer cells via regulation of MutL homologue 1. Bioscience Reports 36(3)
Liu, Q.; Xu, Y.; Wei, S.; Gao, W.; Chen, L.; Zhou, T.; Wang, Z.; Ying, M.; Zheng, Q. 2015: MiRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1. Bioscience Reports 35(4)
Fan, S.-J.; Li, H.-B.; Cui, G.; Kong, X.-L.; Sun, L.-L.; Zhao, Y.-Q.; Li, Y.-H.; Zhou, J. 2016: MiRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia. Leukemia Research 41: 62-70
Wuerkenbieke, D.; Wang, J.; Li, Y.; Ma, C. 2015: MiRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation. Archives of Gynecology and Obstetrics 292(5): 1109-1116
Zheng, Y.; Zhu, C.; Ma, L.; Shao, P.; Qin, C.; Li, P.; Cao, Q.; Ju, X.; Cheng, G.; Zhu, Q.; Gu, X.; Hua, L. 2017: MiRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines. Urologia Internationalis 98(1): 102-110
Ji, W.-G.; Zhang, X.-D.; Sun, X.-D.; Wang, X.-Q.; Chang, B.-P.; Zhang, M.-Z. 2014: MiRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene. Journal of Huazhong University of Science and Technology. Medical Sciences 34(6): 882-888
Liu, X-J.; Bai, X-G.; Teng, Y-L.; Song, L.; Lu, N.; Yang, R-Q. 2016: MiRNA-15a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. European Review for Medical and Pharmacological Sciences 20(16): 3319-3326
Huang, E.; Liu, R.; Chu, Y. 2015: MiRNA-15a/16: as tumor suppressors and more. Future Oncology 11(16): 2351-2363
Chu, B.; Zhong, L.; Dou, S.; Wang, J.; Li, J.; Wang, M.; Shi, Q.; Mei, Y.; Wu, M. 2015: MiRNA-181 regulates embryo implantation in mice through targeting leukemia inhibitory factor. Journal of Molecular Cell Biology 7(1): 12-22
Dong, N.; Tang, X.; Xu, B. 2015: MiRNA-181a inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells. Investigative Ophthalmology and Visual Science 56(2): 993-1001
Wei, X.; Hou, X.; Li, J.; Liu, Y. 2017: MiRNA-181a/b Regulates Phenotypes of Vessel Smooth Muscle Cells Through Serum Response Factor. Dna and Cell Biology 36(2): 127-135
Kouri, F.M.; Ritner, C.; Stegh, A.H. 2015: MiRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics. Cell Cycle 14(24): 3794-3800
Yang, M.; Liu, R.; Li, X.; Liao, J.; Pu, Y.; Pan, E.; Yin, L.; Wang, Y. 2014: MiRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. Molecules and Cells 37(12): 873-880
Haenisch, S.; von Rüden, E.-L.; Wahmkow, H.; Rettenbeck, M.L.; Michler, C.; Russmann, V.; Bruckmueller, H.; Waetzig, V.; Cascorbi, I.; Potschka, H. 2016: MiRNA-187-3p-Mediated Regulation of the KCNK10/TREK-2 Potassium Channel in a Rat Epilepsy Model. Acs Chemical Neuroscience 7(11): 1585-1594
Škrha, P.; Hořínek, A.š; Anděl, M.; Škrha, J. 2015: MiRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?. Vnitrni Lekarstvi 61(4): 351-354
Jacques, C.; Calleja, L.R.; Baud'huin, M.; Quillard, T.; Heymann, D.; Lamoureux, F.ço.; Ory, B. 2016: MiRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors. Oncotarget 7(34): 54503-54514
Rebucci, M.; Sermeus, A.; Leonard, E.; Delaive, E.; Dieu, M.; Fransolet, M.; Arnould, T.; Michiels, C. 2015: MiRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1. Molecular Cancer 14: 79
Remon, J.; Alvarez-Berdugo, D.; Majem, M.; Moran, T.; Reguart, N.; Lianes, P. 2016: MiRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 18(2): 153-159
Schulte, C.; Molz, S.; Appelbaum, S.; Karakas, M.; Ojeda, F.; Lau, D.M.; Hartmann, T.; Lackner, K.J.; Westermann, D.; Schnabel, R.B.; Blankenberg, S.; Zeller, T. 2015: MiRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease. Plos one 10(12): E0145930
Orenes-Piñero, E.; Marín, F.; Lip, G.Y.H. 2016: MiRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients. Annals of Translational Medicine 4(10): 200
Teng, Y.; Su, X.; Zhang, X.; Zhang, Y.; Li, C.; Niu, W.; Liu, C.; Qu, K. 2016: MiRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Oncotarget 7(49): 81621-81633
Lu, H.; Zhang, C.; Hu, Y.; Qin, H.; Gu, A.; Li, Y.; Zhang, L.; Li, Z.; Wang, Y. 2016: MiRNA-200c mediates mono-butyl phthalate-disrupted steroidogenesis by targeting vimentin in Leydig tumor cells and murine adrenocortical tumor cells. Toxicology Letters 241: 95-102
Shen, X.; Guo, Y.; Yu, J.; Qi, J.; Shi, W.; Wu, X.; Ni, H.; Ju, S. 2016: MiRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor. Clinical and Experimental Medicine 16(3): 307-316
Liang, D.; Li, J.; Wu, Y.; Zhen, L.; Li, C.; Qi, M.; Wang, L.; Deng, F.; Huang, J.; Lv, F.; Liu, Y.; Ma, X.; Yu, Z.; Zhang, Y.; Chen, Y.-H. 2015: MiRNA-204 drives cardiomyocyte proliferation via targeting Jarid2. International Journal of Cardiology 201: 38-48
Zhang, S.; Gao, L.; Thakur, A.; Shi, P.; Liu, F.; Feng, J.; Wang, T.; Liang, Y.; Liu, J.J.; Chen, M.; Ren, H. 2016: MiRNA-204 suppresses human non-small cell lung cancer by targeting ATF2. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(8): 11177-11186
Chen, Z.; Tang, Z.-Y.; He, Y.; Liu, L.-F.; Li, D.-J.; Chen, X. 2014: MiRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma. Oncology Research and Treatment 37(11): 658-664
Alemar, B.ár.; Izetti, P.íc.; Gregório, C.; Macedo, G.S.; Castro, M.A.A.; Osvaldt, A.B.; Matte, U.; Ashton-Prolla, P. 2016: MiRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Pancreas 45(1): 84-92
Cao, C.-L.; Niu, H.-J.; Kang, S.-P.; Cong, C.-L.; Kang, S.-R. 2016: MiRNA-21 sensitizes gastrointestinal stromal tumors (GISTs) cells to Imatinib via targeting B-cell lymphoma 2 (Bcl-2). European Review for Medical and Pharmacological Sciences 20(17): 3574-3581
He, H.; Zhang, H.; Li, Z.; Wang, R.; Li, N.; Zhu, L. 2015: MiRNA-214: expression, therapeutic and diagnostic potential in cancer. Tumori 101(4): 375-383
Zhou, Y.; Huang, H.; Zhang, K.; Ding, X.; Jia, L.; Yu, L.; Zhu, G.; Guo, J. 2016: MiRNA-216 and miRNA-499 target cyb561d2 in zebrafish in response to fipronil exposure. Environmental Toxicology and Pharmacology 45: 98-107
Ihle, M.A.; Trautmann, M.; Kuenstlinger, H.; Huss, S.; Heydt, C.; Fassunke, J.; Wardelmann, E.; Bauer, S.; Schildhaus, H.-U.; Buettner, R.; Merkelbach-Bruse, S. 2015: MiRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours. Molecular Oncology 9(7): 1421-1433
Oglesby, I.K.; Agrawal, R.; Mall, M.A.; McElvaney, N.G.; Greene, C.M. 2015: MiRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6. Molecular and Cellular Pediatrics 2(1): 1
Lu, G.-J.; Dong, Y.-Q.; Zhang, Q.-M.; Di, W.-Y.; Jiao, L.-Y.; Gao, Q.-Z.; Zhang, C.-G. 2015: MiRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma. International Journal of Clinical and Experimental Pathology 8(5): 5224-5229
Zhou, Y.; Yang, Q.; Xu, H.; Zhang, J.; Deng, H.; Gao, H.; Yang, J.; Zhao, D.; Liu, F. 2016: MiRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway. Plos one 11(2): E0148821
Hu, J.; Shan, Z.; Hu, K.; Ren, F.; Zhang, W.; Han, M.; Li, Y.; Feng, K.; Lei, L.; Feng, Y. 2016: MiRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1. International Journal of Oncology 49(1): 325-335
Dong, J.; Liu, Y.; Liao, W.; Liu, R.; Shi, P.; Wang, L. 2016: MiRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma. Journal of Bone Oncology 5(2): 74-79
Lu, K.; Wang, J.; Song, Y.; Zhao, S.; Liu, H.; Tang, D.; Pan, B.; Zhao, H.; Zhang, Q. 2015: MiRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. Oncology Reports 34(2): 995-1002
Sun, X.; Xiao, D.; Xu, T.; Yuan, Y. 2016: MiRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5. Future Oncology 12(23): 2701-2712
Benderska, N.; Dittrich, A.-L.; Knaup, S.; Rau, T.T.; Neufert, C.; Wach, S.; Fahlbusch, F.B.; Rauh, M.; Wirtz, R.M.; Agaimy, A.; Srinivasan, S.; Mahadevan, V.; Rümmele, P.; Rapti, E.; Gazouli, M.; Hartmann, A.; Schneider-Stock, R. 2015: MiRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflammatory Bowel Diseases 21(9): 2039-2051
Ekström, L.; Skilving, I.; Ovesjö, M.-L.; Aklillu, E.; Nylén, H.; Rane, A.; Diczfalusy, U.; Björkhem-Bergman, L. 2015: MiRNA-27b levels are associated with CYP3A activity in vitro and in vivo. Pharmacology Research and Perspectives 3(6): E00192
Qun, L.; Wenda, X.; Weihong, S.; Jianyang, M.; Wei, C.; Fangzhou, L.; Zhenyao, X.; Pingjin, G. 2016: MiRNA-27b modulates endothelial cell angiogenesis by directly targeting Naa15 in atherogenesis. Atherosclerosis 254: 184-192
Luo, W.; Lin, Y.; Meng, S.; Guo, Y.; Zhang, J.; Zhang, W. 2016: MiRNA-296-3p modulates chemosensitivity of lung cancer cells by targeting CX3CR1. American Journal of Translational Research 8(4): 1848-1856
O'Reilly, S. 2015: MiRNA-29a in systemic sclerosis: a valid target. Autoimmunity 48(8): 511-512
Chuan-Hao, L.; Wei, C.; Jia-Qing, H.; Yan-Dong, W.; Shou-Dong, W.; Yong-Qing, Z.; Hui, W. 2016: MiRNA-29a targets COL3A1 to regulate the level of type IIi collagen in pig. Gene 592(1): 140-147
Lee, W.Y.; Li, N.; Lin, S.; Wang, B.; Lan, H.Y.; Li, G. 2016: MiRNA-29b improves bone healing in mouse fracture model. Molecular and Cellular Endocrinology 430: 97-107
Zhang, L.; Zhang, X.-W.; Liu, C.-H.; Lu, K.; Huang, Y.-Q.; Wang, Y.-D.; Xing, L.; Zhang, L.-J.; Liu, N.; Jiang, H.; Sun, C.; Yang, Y.; Chen, S.-Q.; Chen, M.; Xu, B. 2016: MiRNA-30a functions as a tumor suppressor by downregulating cyclin E2 expression in castration-resistant prostate cancer. Molecular Medicine Reports 14(3): 2077-2084
Shan, T-Dong.; Ouyang, H.; Yu, T.; Li, J-Yao.; Huang, C-Ze.; Yang, H-Sheng.; Zhong, W.; Xia, Z-Sheng.; Chen, Q-Kui. 2016: MiRNA-30e regulates abnormal differentiation of small intestinal epithelial cells in diabetic mice by downregulating Dll4 expression. Cell Proliferation 49(1): 102-114
Wu, H.M.; Kim, S.G. 2016: MiRNA-324, a potential therapeutic target for paracetamol-induced liver injury. Stem Cell Investigation 3: 67
Ou, D.; Wu, Y.; Liu, J.; Lao, X.; Zhang, S.; Liao, G. 2016: MiRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin. Oncology Letters 12(4): 2531-2537
Zheng, L.; Jiao, W.; Mei, H.; Song, H.; Li, D.; Xiang, X.; Chen, Y.; Yang, F.; Li, H.; Huang, K.; Tong, Q. 2016: MiRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14. Oncotarget 7(26): 40314-40328
Xiang, X.; Mei, H.; Zhao, X.; Pu, J.; Li, D.; Qu, H.; Jiao, W.; Zhao, J.; Huang, K.; Zheng, L.; Tong, Q. 2015: MiRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14. Oncotarget 6(26): 22452-22466
Weng, C.; Nguyen, T.; Shively, J.E. 2016: MiRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis. Journal of Biological Chemistry 291(32): 16777-16786
Wang, P.; Xu, J.; Hou, Z.; Wang, F.; Song, Y.; Wang, J.; Zhu, H.; Jin, H. 2016: MiRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA. Cell Proliferation 49(4): 484-493
Chen, Q.; Yang, F.; Guo, M.; Wen, G.; Zhang, C.; Luong, L.A.; Zhu, J.; Xiao, Q.; Zhang, L. 2015: MiRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration. Journal of Molecular and Cellular Cardiology 89(Part A): 75-86
Veija, T.; Sahi, H.; Koljonen, V.; Bohling, T.; Knuutila, S.; Mosakhani, N. 2015: MiRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma. Virchows Archiv: An International Journal of Pathology 466(3): 289-295
Liang, W.; Gao, S.; Liang, L.; Huang, X.; Hu, N.; Lu, X.; Zhao, Y. 2017: MiRNA-34b is directly involved in the aging of macrophages. Aging Clinical and Experimental Research 29(4): 599-607
Marchand, L.; Jalabert, A.; Meugnier, E.; Van den Hende, K.; Fabien, N.; Nicolino, M.; Madec, A.-M.; Thivolet, C.; Rome, S. 2016: MiRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes. Journal of Diabetes Research 2016: 1869082
Guo, L.; Yuan, J.; Xie, N.; Wu, H.; Chen, W.; Song, S.; Wang, X. 2016: MiRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer. Molecular Medicine Reports 14(4): 2975-2982
Peng, G.; Liao, Y.; Shen, C. 2017: MiRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1. Pathology oncology research: POR 23(2): 369-376
Chen, J.; Zhou, J.; Chen, X.; Yang, B.; Wang, D.; Yang, P.; He, X.; Li, H. 2015: MiRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(10): 8221-8229
Guo, H.; Nan, Y.; Zhen, Y.; Zhang, Y.; Guo, L.; Yu, K.; Huang, Q.; Zhong, Y. 2016: MiRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(10): 13751-13761
Chang, R.-M.; Xiao, S.; Lei, X.; Yang, H.; Fang, F.; Yang, L.-Y. 2017: MiRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 23(10): 2593-2604
Liu, L.; Zheng, W.; Song, Y.; Du, X.; Tang, Y.; Nie, J.; Han, W. 2015: MiRNA-497 Enhances the Sensitivity of Colorectal Cancer Cells to Neoadjuvant Chemotherapeutic Drug. Current Protein and Peptide Science 16(4): 310-315
Lu, Y.; Li, F.; Xu, T.; Sun, J. 2016: MiRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A. Oncology Research 23(4): 155-163
Noguchi, T.; Toiyama, Y.; Kitajima, T.; Imaoka, H.; Hiro, J.; Saigusa, S.; Tanaka, K.; Inoue, Y.; Mohri, Y.; Toden, S.; Kusunoki, M. 2016: MiRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer. Oncology 90(4): 221-231
Xu, X.; Zhang, Y.; Liu, Z.; Zhang, X.; Jia, J. 2016: MiRNA-532-5p functions as an oncogenic microRNA in human gastric cancer by directly targeting RUNX3. Journal of Cellular and Molecular Medicine 20(1): 95-103
Hu, X.-M.; Yan, X.-H.; Hu, Y.-W.; Huang, J.-L.; Cao, S.-W.; Ren, T.-Y.; Tang, Y.-T.; Lin, L.; Zheng, L.; Wang, Q. 2016: MiRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein hepatitis B x-interacting protein. Hepatology Research: the Official Journal of the Japan Society of Hepatology 46(8): 804-815
Qu, H.; Zheng, L.; Pu, J.; Mei, H.; Xiang, X.; Zhao, X.; Li, D.; Li, S.; Mao, L.; Huang, K.; Tong, Q. 2015: MiRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase. Human Molecular Genetics 24(9): 2539-2551
Xiang, X.; Mei, H.; Qu, H.; Zhao, X.; Li, D.; Song, H.; Jiao, W.; Pu, J.; Huang, K.; Zheng, L.; Tong, Q. 2015: MiRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14. Biochimica et Biophysica Acta 1852(9): 1743-1754
Song, J.; Luo, S.; Li, S-Wei. 2015: MiRNA-592 is downregulated and may target LHCGR in polycystic ovary syndrome patients. Reproductive Biology 15(4): 229-237
Chen, W-Shu.; Yen, C-Jui.; Chen, Y-Ju.; Chen, J-Yu.; Wang, L-Yun.; Chiu, S-Jun.; Shih, W-Ling.; Ho, C-Yi.; Wei, T-Tang.; Pan, H-Lin.; Chien, P-Hsuan.; Hung, M-Chie.; Chen, C-Chow.; Huang, W-Chien. 2015: MiRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget 6(28): 25962-25974
O Sullivan, J.F.; Neylon, A.; McGorrian, C.; Blake, G.J. 2016: MiRNA-93-5p and other mi RNAs as predictors of coronary artery disease and STEMi. International Journal of Cardiology 224: 310-316
He, K.; Tong, D.; Zhang, S.; Cai, D.; Wang, L.; Yang, Y.; Gao, L.; Chang, S.'e.; Guo, B.; Song, T.; Li, A.; Huang, C. 2015: MiRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells. International Journal of Oncology 47(4): 1528-1536
Li, W.; Chang, J.; Wang, S.; Liu, X.; Peng, J.; Huang, D.; Sun, M.; Chen, Z.; Zhang, W.; Guo, W.; Li, J. 2015: MiRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget 6(27): 24448-24462
Van Zonneveld, A.J.; Rabelink, T.J.; Bijkerk, R. 2017: MiRNA-Coordinated Networks as Promising Therapeutic Targets for Acute Kidney Injury. American Journal of Pathology 187(1): 20-24
Puppo, M.; Bucci, G.; Rossi, M.; Giovarelli, M.; Bordo, D.; Moshiri, A.; Gorlero, F.; Gherzi, R.; Briata, P. 2016: MiRNA-Mediated KHSRP Silencing Rewires Distinct Post-transcriptional Programs during TGF-β-Induced Epithelial-to-Mesenchymal Transition. Cell Reports 16(4): 967-978
Sharma, A.R.; Sharma, G.; Lee, S.-S.; Chakraborty, C. 2016: MiRNA-Regulated Key Components of Cytokine Signaling Pathways and Inflammation in Rheumatoid Arthritis. Medicinal Research Reviews 36(3): 425-439
Akdogan, G.; Tufekci, E.D.; Uranbey, S.; Unver, T. 2016: MiRNA-based drought regulation in wheat. Functional and Integrative Genomics 16(3): 221-233
Baumann, V.; Winkler, J. 2014: MiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Medicinal Chemistry 6(17): 1967-1984
Ni, W-Juan.; Leng, X-Min. 2016: MiRNA-Dependent Activation of mRNA Translation. Microrna 5(2): 83-86
Delay, C.; Grenier-Boley, B.; Amouyel, P.; Dumont, J.; Lambert, J-Charles. 2016: MiRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease. Alzheimer's Research and Therapy 8(1): 20
Zhao, Y.; Zhu, C.-D.; Yan, B.; Zhao, J.-L.; Wang, Z.-H. 2014: MiRNA-directed regulation of VEGF in tilapia under hypoxia condition. Biochemical and Biophysical Research Communications 454(1): 183-188
Liu, B.; Fang, L.; Chen, J.; Liu, F.; Wang, X. 2015: MiRNA-dis: microRNA precursor identification based on distance structure status pairs. Molecular Biosystems 11(4): 1194-1204
Couzigou, J-Malo.; Lauressergues, D.; Bécard, G.; Combier, J-Philippe. 2015: MiRNA-encoded peptides (miPEPs): A new tool to analyze the roles of mi RNAs in plant biology. Rna Biology 12(11): 1178-1180
Sharma, P.; Sharma, R. 2015: MiRNA-mRNA crosstalk in esophageal cancer: from diagnosis to therapy. Critical Reviews in Oncology/Hematology 96(3): 449-462
Ma, R.; Wang, C.; Wang, J.; Wang, D.; Xu, J. 2015: MiRNA-mRNA interaction network in non-small-cell lung cancer. Interdisciplinary Sciences Computational Life Sciences 2015
Sattar, S.; Addo-Quaye, C.; Thompson, G.A. 2016: MiRNA-mediated auxin signalling repression during Vat-mediated aphid resistance in Cucumis melo. Plant Cell and Environment 39(6): 1216-1227
Tan, J.Y.; Marques, A.C. 2016: MiRNA-mediated crosstalk between transcripts: the missing "linc"?. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 38(3): 295-301
Tang, W.; Liu, D.-F.; Kai, H.; Zhao, L.-M.; Mao, J.-M.; Zhuang, X.-J.; Ma, L.-L.; Hui, J. 2015: MiRNA-mediated regulation of heat shock proteins in human ejaculated spermatozoa. Turkish Journal of Medical Sciences 45(6): 1285-1291
Xu, J.; Shao, T.; Ding, N.; Li, Y.; Li, X. 2017: MiRNA-miRNA crosstalk: from genomics to phenomics. Briefings in Bioinformatics 18(6): 1002-1011
Chakraborty, C.; Chin, K.-Y.; Das, S. 2016: MiRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(10): 13039-13048
Wang, J.; Lei, Z.-j.; Guo, Y.; Wang, T.; Qin, Z.-y.; Xiao, H.-l.; Fan, L.-l.; Chen, D.-f.; Bian, X.-w.; Liu, J.; Wang, B. 2015: MiRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells. Oncotarget 6(35): 37852-37870
Buoli Comani, G.; Panceri, R.; Dinelli, M.; Biondi, A.; Mancuso, C.; Meneveri, R.; Barisani, D. 2015: MiRNA-regulated gene expression differs in celiac disease patients according to the age of presentation. Genes and Nutrition 10(5): 482
Chekouo, T.; Stingo, F.C.; Doecke, J.D.; Do, K-Anh. 2015: MiRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer. Biometrics 71(2): 428-438
Butz, H.; Szabó, P.M.; Khella, H.W.Z.; Nofech-Mozes, R.; Patocs, A.; Yousef, G.M. 2015: MiRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1. Oncotarget 6(14): 12543-12557
Liang, B.; Song, Y.; Zheng, W.; Ma, W. 2016: MiRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 22: 2761-2767
Tang, H.; Fernandez, R.A.; Yuan, J.X.-J. 2015: MiRNA208/Mef2 and TNF-α in right ventricular dysfunction: the transition from hypertrophy to failure. Circulation Research 116(1): 6-8
Zhou, M.; Li, C.; Lu, C.; Zhang, X.; Pan, Y.; Liu, X.; Liu, G.; Zhao, Z.; Sun, B. 2016: MiRNA29 Promotes Viral Replication During Early Stage of PRRSV Infection in Vitro. Dna and Cell Biology 35(10): 636-642
Wang, L.; ZengJ, H.Q.; Song, J.; Feng, S.J.; Yang, Z.M. 2015: MiRNA778 and SUVH6 are involved in phosphate homeostasis in Arabidopsis. Plant Science: An International Journal of Experimental Plant Biology 238: 273-285
Serr, I.; Fürst, R.W.; Ott, V.B.; Scherm, M.G.; Nikolaev, A.; Gökmen, F.üs.; Kälin, S.; Zillmer, S.; Bunk, M.; Weigmann, B.; Kunschke, N.; Loretz, B.; Lehr, C.-M.; Kirchner, B.; Haase, B.; Pfaffl, M.; Waisman, A.; Willis, R.A.; Ziegler, A.-G.; Daniel, C. 2016: MiRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proceedings of the National Academy of Sciences of the United States of America 113(43): E6659-E6668
Zhang, Y.; Chen, X.; Yang, F.; Zhang, L.; Liu, W. 2016: MiRNA: a Novel Link Between Rice Ragged Stunt Virus and Oryza sativa. Indian Journal of Microbiology 56(2): 219-224
Tav, C.; Tempel, S.éb.; Poligny, L.; Tahi, F. 2016: MiRNAFold: a web server for fast miRNA precursor prediction in genomes. Nucleic Acids Research 44(W1): W181-W184
Yones, C.A.; Stegmayer, G.; Kamenetzky, L.; Milone, D.H. 2015: MiRNAfe: a comprehensive tool for feature extraction in microRNA prediction. Bio Systems 138: 1-5
Haunsberger, S.J.; Connolly, N.M.C.; Prehn, J.H.M. 2017: MiRNAmeConverter: an R/bioconductor package for translating mature miRNA names to different mi RBase versions. Bioinformatics 33(4): 592-593
Yang, C.; Liu, T.; Bai, F.; Wang, N.; Pan, Z.; Yan, X.; Peng, S. 2015: MiRNAome analysis associated with anatomic and transcriptomic investigations reveal the polar exhibition of corky split vein in boron deficient Citrus sinensis. Molecular Genetics and Genomics: Mgg 290(5): 1639-1657
Coffre, M.; Benhamou, D.; Rieß, D.; Blumenberg, L.; Snetkova, V.; Hines, M.J.; Chakraborty, T.; Bajwa, S.; Jensen, K.; Chong, M.M.W.; Getu, L.; Silverman, G.J.; Blelloch, R.; Littman, D.R.; Calado, D.; Melamed, D.; Skok, J.A.; Rajewsky, K.; Koralov, S.B. 2016: MiRNAs Are Essential for the Regulation of the PI3K/AKT/FOXO Pathway and Receptor Editing during B Cell Maturation. Cell Reports 17(9): 2271-2285
Dong, B.; Wang, H.; Song, A.; Liu, T.; Chen, Y.; Fang, W.; Chen, S.; Chen, F.; Guan, Z.; Jiang, J. 2016: MiRNAs Are Involved in Determining the Improved Vigor of Autotetrapoid Chrysanthemum nankingense. Frontiers in Plant Science 7: 1412
Alemar, B.ár.; Gregório, C.; Ashton-Prolla, P. 2015: MiRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and its Precursor Lesions: a Review. Biomarker Insights 10: 113-124
Galloway, D.A.; Moore, C.S. 2016: MiRNAs as Emerging Regulators of Oligodendrocyte Development and Differentiation. Frontiers in Cell and Developmental Biology 4: 59
Ntambi, J.M. 2016: MiRNAs Caught up in Metabolic Organ Crosstalk to Combat Obesity. Ebiomedicine 5: 10-11
Wu, T.; Chen, G. 2016: MiRNAs Participate in MS Pathological Processes and Its Therapeutic Response. Mediators of Inflammation 2016: 4578230
Ragusa, M.; Bosco, P.; Tamburello, L.; Barbagallo, C.; Condorelli, A.G.; Tornitore, M.; Spada, R.S.; Barbagallo, D.; Scalia, M.; Elia, M.; Di Pietro, C.; Purrello, M. 2016: MiRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications. Frontiers in Cellular Neuroscience 10: 51
Lian, J.; Guo, J.; Huang, X.; Yang, X.I.; Huang, G.; Mao, H.; Sun, H.Huan.; Ba, Y.; Zhou, J. 2016: MiRNAs Regulate hERG. Journal of Cardiovascular Electrophysiology 27(12): 1472-1482
Marí-Alexandre, J.; Sánchez-Izquierdo, D.; Gilabert-Estellés, J.; Barceló-Molina, M.és.; Braza-Boïls, A.; Sandoval, J. 2016: MiRNAs Regulation and its Role as Biomarkers in Endometriosis. International Journal of Molecular Sciences 17(1)
Seeliger, C.; Balmayor, E.R.; van Griensven, M. 2016: MiRNAs Related to Skeletal Diseases. Stem Cells and Development 25(17): 1261-1281
Irani, S. 2016: MiRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review. Journal of Dentistry 17(2): 71-83
Baldán, Án.; de Aguiar Vallim, T.Q. 2016: MiRNAs and High-Density Lipoprotein metabolism. Biochimica et Biophysica Acta 1861(12 Part B): 2053-2061
Witwer, K.W.; Buchanan, E.L.; Myers, S.L.; McAlexander, M.A. 2015: MiRNAs and SAMHD1 regulation in vitro and in a model of HIV CNS disease. Journal of Neuroinflammation 12: 159
Li, Z.-F.; Zhang, Y.-C.; Chen, Y.-Q. 2015: MiRNAs and lnc RNAs in reproductive development. Plant Science: An International Journal of Experimental Plant Biology 238: 46-52
Schmidt, U.; Keck, M.E.; Buell, D.R. 2015: MiRNAs and other non-coding RNAs in posttraumatic stress disorder: a systematic review of clinical and animal studies. Journal of Psychiatric Research 65: 1-8
Samuel, P.; Pink, R.C.; Brooks, S.A.; Carter, D.R. 2016: MiRNAs and ovarian cancer: a mi Riad of mechanisms to induce cisplatin drug resistance. Expert Review of Anticancer Therapy 16(1): 57-70
Ricciuti, B.; Mecca, C.; Cenci, M.; Leonardi, G.C.; Perrone, L.; Mencaroni, C.; Crinò, L.; Grignani, F.; Baglivo, S.; Chiari, R.; Sidoni, A.; Paglialunga, L.; Currà, M.F.; Murano, E.; Minotti, V.; Metro, G. 2015: MiRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistance. Ecancermedicalscience 9: 569
Hecksteden, A.; Leidinger, P.; Backes, C.; Rheinheimer, S.; Pfeiffer, M.; Ferrauti, A.; Kellmann, M.; Sedaghat-Hamedani, F.; Meder, B.; Meese, E.; Meyer, T.; Keller, A. 2016: MiRNAs and sports: tracking training status and potentially confounding diagnoses. Journal of Translational Medicine 14(1): 219
Rizos, E.; Siafakas, N.; Skourti, E.; Papageorgiou, C.; Tsoporis, J.; Parker, T.H.; Christodoulou, D.I.; Spandidos, D.A.; Katsantoni, E.; Zoumpourlis, V. 2016: MiRNAs and their role in the correlation between schizophrenia and cancer (Review). Molecular Medicine Reports 14(6): 4942-4946
Li, X.; Chen, Y.; Chi, Q.; Hu, X.; Xu, X.; Zhang, Z.; Qiu, M.; Zheng, K. 2016: MiRNAs are required for the terminal differentiation of white matter astrocytes in the developing CNS. Neuroscience 312: 99-107
Kotagama, K.; Chang, Y.; Mangone, M. 2015: MiRNAs as Biomarkers in Chronic Myelogenous Leukemia. Drug Development Research 76(6): 278-285
Mushtaq, G.; Greig, N.H.; Anwar, F.; Zamzami, M.A.; Choudhry, H.; Shaik, M.M.; Tamargo, I.A.; Kamal, M.A. 2016: MiRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease. Medicinal Chemistry 12(3): 217-225
Goretti, E.; Wagner, D.R.; Devaux, Y. 2014: MiRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?. Trends in Molecular Medicine 20(12): 716-725
Brooks, S.A.; Martin, E.; Smeester, L.; Grace, M.R.; Boggess, K.; Fry, R.C. 2016: MiRNAs as common regulators of the transforming growth factor (TGF)-β pathway in the preeclamptic placenta and cadmium-treated trophoblasts: Links between the environment, the epigenome and preeclampsia. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 98(Part A): 50-57
Yates, C.; Long, M.D.; Campbell, M.J.; Sucheston-Campbell, L. 2017: MiRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men. Frontiers in Bioscience 22: 212-229
Xu, X.-M.; Zhang, H.-J. 2016: MiRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World Journal of Gastroenterology 22(7): 2206-2218
Filella, X.; Foj, L. 2017: MiRNAs as novel biomarkers in the management of prostate cancer. Clinical Chemistry and Laboratory Medicine 55(5): 715-736
Fu, S.W.; Lee, W.; Coffey, C.; Lean, A.; Wu, X.; Tan, X.; Man, Y.-G.; Brem, R.F. 2016: MiRNAs as potential biomarkers in early breast cancer detection following mammography. Cell and Bioscience 6: 6
Nagaraj, A.B.; Joseph, P.; DiFeo, A. 2015: MiRNAs as prognostic and therapeutic tools in epithelial ovarian cancer. Biomarkers in Medicine 9(3): 241-257
Haapanen, M.J.; Perälä, M.M.; Salonen, M.K.; Kajantie, E.; Simonen, M.; Pohjolainen, P.; Eriksson, J.G.; von Bonsdorff, M.B. 2018: Early life determinants of frailty in old age: the Helsinki Birth Cohort Study. Age and Ageing 47(4): 569-575
Wang, D.; Zhang, Q.; Jin, Y. 2016: MiRNAs associated with the malignant transformation of non-small cell lung cancer. Acta Biochimica et Biophysica Sinica 48(4): 395-398
Keller, A.; Leidinger, P.; Vogel, B.; Backes, C.; ElSharawy, A.; Galata, V.; Mueller, S.C.; Marquart, S.; Schrauder, M.G.; Strick, R.; Bauer, A.; Wischhusen, J.ör.; Beier, M.; Kohlhaas, J.; Katus, H.A.; Hoheisel, J.ör.; Franke, A.; Meder, B.; Meese, E. 2014: MiRNAs can be generally associated with human pathologies as exemplified for miR-144. Bmc Medicine 12: 224
Lizarraga, D.; Huen, K.; Combs, M.; Escudero-Fung, M.; Eskenazi, B.; Holland, N. 2016: MiRNAs differentially expressed by next-generation sequencing in cord blood buffy coat samples of boys and girls. Epigenomics 8(12): 1619-1635
Lichner, Z.; Ding, Q.; Samaan, S.; Saleh, C.; Nasser, A.; Al-Haddad, S.; Samuel, J.N.; Fleshner, N.E.; Stephan, C.; Jung, K.; Yousef, G.M. 2015: MiRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways. Journal of Pathology 237(2): 226-237
Ristori, E.; Nicoli, S. 2015: MiRNAs expression profile in zebrafish developing vessels. Methods in Molecular Biology 1214: 129-150
Papaioannou, G. 2015: MiRNAs in Bone Development. Current Genomics 16(6): 427-434
Wozniak, M.; Mielczarek, A.; Czyz, M. 2016: MiRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential. Current Medicinal Chemistry 23(28): 3136-3153
Shen, H.; Li, Z. 2016: MiRNAs in NMDA receptor-dependent synaptic plasticity and psychiatric disorders. Clinical Science 130(14): 1137-1146
Hamdi, K.; Goerlitz, D.; Stambouli, N.; Islam, M.; Baroudi, O.; Neili, B.; Benayed, F.; Chivi, S.; Loffredo, C.; Jillson, I.A.; Benammar Elgaaied, A.; Blancato, J.K.; Marrakchi, R. 2014: MiRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer. Springerplus 3: 636
Jia, Y.; Guan, M.; Zheng, Z.; Zhang, Q.; Tang, C.; Xu, W.; Xiao, Z.; Wang, L.; Xue, Y. 2016: MiRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy. Journal of Diabetes Research 2016: 7932765
Liao, Q.; Wang, B.; Li, X.; Jiang, G. 2017: MiRNAs in acute myeloid leukemia. Oncotarget 8(2): 3666-3682
Andreou, I.; Sun, X.; Stone, P.H.; Edelman, E.R.; Feinberg, M.W. 2015: MiRNAs in atherosclerotic plaque initiation, progression, and rupture. Trends in Molecular Medicine 21(5): 307-318
Litwińska, Z.; Machaliński, Bław. 2017: MiRNAs in chronic myeloid leukemia: small molecules, essential function. Leukemia and Lymphoma 58(6): 1297-1305
Granata, M.; Malatino, L.; Zanoli, L.; Fatuzzo, P.; Granata, A. 2016: MiRNAs in main renal diseases: a new frontier for the nephrologist. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 33(4)
Seckinger, A.; Meißner, T.; Moreaux, J.ér.ôm.; Benes, V.; Hillengass, J.; Castoldi, M.; Zimmermann, J.ür.; Ho, A.D.; Jauch, A.; Goldschmidt, H.; Klein, B.; Hose, D. 2015: MiRNAs in multiple myeloma--a survival relevant complex regulator of gene expression. Oncotarget 6(36): 39165-39183
He, Z.; Hu, C.; Jia, W. 2016: MiRNAs in non-alcoholic fatty liver disease. Frontiers of Medicine 10(4): 389-396
Lycoudi, A.; Mavreli, D.; Mavrou, A.; Papantoniou, N.; Kolialexi, A. 2015: MiRNAs in pregnancy-related complications. Expert Review of Molecular Diagnostics 15(8): 999-1010
Qu, B.; Shen, N. 2015: MiRNAs in the Pathogenesis of Systemic Lupus Erythematosus. International Journal of Molecular Sciences 16(5): 9557-9572
Papadopoulos, T.; Belliere, J.; Bascands, J.-L.; Neau, E.; Klein, J.; Schanstra, J.P. 2015: MiRNAs in urine: a mirror image of kidney disease?. Expert Review of Molecular Diagnostics 15(3): 361-374
Kim, Y.Sol.; Park, S.Jeong.; Lee, Y.Seon.; Kong, H.Kyung.; Park, J.Hoon. 2016: MiRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer. Oncotarget 7(27): 42261-42273
Daimiel, L.; Ordovás, J.M.; Dávalos, A. 2015: MiRNAs modified by dietary lipids in Caco-2 cells. a microarray screening. Genomics Data 5: 171-172
Klinge, C.M. 2015: MiRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Molecular and Cellular Endocrinology 418 Pt 3: 273-297
Karnati, H.K.; Panigrahi, M.K.; Gutti, R.K.; Greig, N.H.; Tamargo, I.A. 2015: MiRNAs: Key Players in Neurodegenerative Disorders and Epilepsy. Journal of Alzheimer's Disease: Jad 48(3): 563-580
Alsharafi, W.A.; Xiao, B.; Abuhamed, M.M.; Luo, Z. 2015: MiRNAs: biological and clinical determinants in epilepsy. Frontiers in Molecular Neuroscience 8: 59
Bhatia, P.; Raina, S.; Chugh, J.; Sharma, S. 2015: MiRNAs: early prognostic biomarkers for Type 2 diabetes mellitus?. Biomarkers in Medicine 9(10): 1025-1040
Adem, B.ár.F.; Bastos, N.R.A.; Dias, F.; Teixeira, A.L.ís.; Medeiros, R. 2016: MiRNAs: mediators of ErbB family targeted therapy resistance. Pharmacogenomics 17(10): 1175-1187
Fan, Y.; Siklenka, K.; Arora, S.K.; Ribeiro, P.; Kimmins, S.; Xia, J. 2016: MiRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic acids research 44(W1): W135-W141
Yang, Y.; Ding, N.; Dong, X.; Fang, X. 2016: MiRNome Analysis of CML Cells. Methods in Molecular Biology 1465: 207-217
Maltseva, D.V.; Galatenko, V.V.; Samatov, T.R.; Zhikrivetskaya, S.O.; Khaustova, N.A.; Nechaev, I.N.; Shkurnikov, M.U.; Lebedev, A.E.; Mityakina, I.A.; Kaprin, A.D.; Schumacher, U.; Tonevitsky, A.G. 2014: MiRNome of inflammatory breast cancer. Bmc Research Notes 7: 871
Backes, C.; Kehl, T.; Stöckel, D.; Fehlmann, T.; Schneider, L.; Meese, E.; Lenhof, H.-P.; Keller, A. 2017: MiRPathDB: a new dictionary on micro RNAs and target pathways. Nucleic Acids Research 45(D1): D90-D96
Aguiar, R.R.; Ambrosio, L.A.; Sepúlveda-Hermosilla, G.; Maracaja-Coutinho, V.; Paschoal, A.R. 2016: MiRQuest: integration of tools on a Web server for microRNA research. Genetics and Molecular Research: Gmr 15(1)
Yousef, G.M. 2015: MiRSNP-Based Approach Identifies a miRNA that Regulates Prostate-Specific Antigen in an Allele-Specific Manner. Cancer Discovery 5(4): 351-352
Ozbayer, C.; Degirmenci, I.; Ustuner, D.; Ak, G.; Saydam, F.; Colak, E.; Gunes, H.V.; Metintas, M. 2016: MiRSNPs of miR1274 and miR3202 Genes that Target MeCP2 and DNMT3b Are Associated with Lung Cancer Risk: a Study Conducted on MassARRAY Genotyping. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 35(3): 223-236
Wang, P.; Zhi, H.; Zhang, Y.; Liu, Y.; Zhang, J.; Gao, Y.; Guo, M.; Ning, S.; Li, X. 2015: MiRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs. Database: the Journal of Biological Databases and Curation 2015
Ahadi, A.; Sablok, G.; Hutvagner, G. 2017: MiRTar2GO: a novel rule-based model learning method for cell line specific microRNA target prediction that integrates Ago2 CLIP-Seq and validated microRNA-target interaction data. Nucleic Acids Research 45(6): E42
Chou, C-Hung.; Chang, N-Wen.; Shrestha, S.; Hsu, S-Da.; Lin, Y-Ling.; Lee, W-Hsiang.; Yang, C-Dung.; Hong, H-Chin.; Wei, T-Yen.; Tu, S-Jyun.; Tsai, T-Ren.; Ho, S-Yi.; Jian, T-Yan.; Wu, H-Yi.; Chen, P-Rong.; Lin, N-Chieh.; Huang, H-Tzu.; Yang, T-Ling.; Pai, C-Yuan.; Tai, C-San.; Chen, W-Liang.; Huang, C-Yen.; Liu, C-Chi.; Weng, S-Long.; Liao, K-Wen.; Hsu, W-Lian.; Huang, H-Da. 2016: MiRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Research 44(D1): D239-D247
Jung, D.; Kim, B.; Freishtat, R.J.; Giri, M.; Hoffman, E.; Seo, J. 2015: MiRTarVis: an interactive visual analysis tool for microRNA-mRNA expression profile data. Bmc Proceedings 9(Suppl 6 Proceedings of the 5th Symposium on Biological Data): S2
Li, G.; Ross, K.E.; Arighi, C.N.; Peng, Y.; Wu, C.H.; Vijay-Shanker, K. 2015: MiRTex: a Text Mining System for miRNA-Gene Relation Extraction. Plos Computational Biology 11(9): E1004391
Cammaerts, S.; Strazisar, M.; Dierckx, J.; Del Favero, J.; De Rijk, P. 2016: MiRVaS: a tool to predict the impact of genetic variants on miRNAs. Nucleic Acids Research 44(3): E23
Belli Kullan, J.; Lopes Paim Pinto, D.; Bertolini, E.; Fasoli, M.; Zenoni, S.; Tornielli, G.B.; Pezzotti, M.; Meyers, B.C.; Farina, L.; Pè, M.E.; Mica, E. 2015: MiRVine: a microRNA expression atlas of grapevine based on small RNA sequencing. Bmc Genomics 16: 393
Baras, A.S.; Mitchell, C.J.; Myers, J.R.; Gupta, S.; Weng, L.-C.; Ashton, J.M.; Cornish, T.C.; Pandey, A.; Halushka, M.K. 2015: MiRge - a Multiplexed Method of Processing Small RNA-Seq Data to Determine MicroRNA Entropy. Plos one 10(11): E0143066
Gupta, S.; Ross, K.E.; Tudor, C.O.; Wu, C.H.; Schmidt, C.J.; Vijay-Shanker, K. 2016: MiRiaD: A Text Mining Tool for Detecting Associations of micro RNAs with Diseases. Journal of Biomedical Semantics 7(1): 9
Bonnal, R.J.P.; Rossi, R.L.; Carpi, D.; Ranzani, V.; Abrignani, S.; Pagani, M. 2015: MiRiadne: a web tool for consistent integration of miRNA nomenclature. Nucleic Acids Research 43(W1): W487-W492
Lánczky, A.ás.; Nagy, Ád.ám.; Bottai, G.; Munkácsy, G.ön.; Szabó, A.ás.; Santarpia, L.; Győrffy, B.áz. 2016: MiRpower: a web-tool to validate survival-associated mi RNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Research and Treatment 160(3): 439-446
Giordano, S. 2016: MiRs*: Innocent bystanders only?. Hepatology 64(5): 1424-1426
Sheppard, M.; Rateri, D.L.; Daugherty, A. 2016: MiRs, mi Rs in the Wall, who Is the Most Causative of them All?. Journal of the American College of Cardiology 67(25): 2978-2980
Berg, V.; Rusch, M.; Vartak, N.; Jüngst, C.; Schauss, A.; Waldmann, H.; Hedberg, C.; Pallasch, C.P.; Bastiaens, P.I.H.; Hallek, M.; Wendtner, C.-M.; Frenzel, L.P. 2015: MiRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL. Blood 125(19): 2948-2957
Machida, T.; Tomofuji, T.; Maruyama, T.; Yoneda, T.; Ekuni, D.; Azuma, T.; Miyai, H.; Mizuno, H.; Kato, H.; Tsutsumi, K.; Uchida, D.; Takaki, A.; Okada, H.; Morita, M. 2016: MiR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. Oncology Reports 36(4): 2375-2381
Sun, J.; Tao, S.; Liu, L.; Guo, D.; Xia, Z.; Huang, M. 2016: MiR‑140‑5p regulates angiogenesis following ischemic stroke by targeting VEGFA. Molecular Medicine Reports 13(5): 4499-4505
Feng, S.; Zhu, X.; Fan, B.; Xie, D.; Li, T.; Zhang, X. 2016: MiR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion. Molecular Medicine Reports 13(5): 4030-4038
Wang, H.; Chen, B.; Duan, B.; Zheng, J.; Wu, X. 2016: MiR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma. Molecular Medicine Reports 14(4): 3343-3349
Wang, Y.-C.; Liu, J.-S.; Tang, H.-K.; Nie, J.; Zhu, J.-X.; Wen, L.-L.; Guo, Q.-L. 2016: MiR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT. International Journal of Molecular Medicine 38(4): 1208-1216
Li, W.-Q.; Yu, H.-Y.; Zhong, N.-Z.; Hou, L.-J.; Li, Y.-M.; He, J.; Liu, H.-M.; Xia, C.-Y.; Lu, Y.-C. 2015: MiR‑27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2. International Journal of Oncology 46(4): 1601-1608
Li, Y.; Li, Y.; Chen, D.; Jin, L.; Su, Z.; Liu, J.; Duan, H.; Li, X.; Qi, Z.; Shi, M.; Ni, L.; Yang, S.; Gui, Y.; Mao, X.; Chen, Y.; Lai, Y. 2016: MiR‑30a‑5p in the tumorigenesis of renal cell carcinoma: a tumor suppressive microRNA. Molecular Medicine Reports 13(5): 4085-4094
Wen, C.; Liu, X.; Ma, H.; Zhang, W.; Li, H. 2015: MiR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2. International Journal of Oncology 46(5): 2277-2285
Xiang, W.; Lin, H.; Wang, Q.; Chen, W.; Liu, Z.; Chen, H.; Zhang, H.; Chen, W. 2016: MiR‑34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3. Molecular Medicine Reports 14(6): 5049-5056
Li, M.; Liu, L.; Zang, W.; Wang, Y.; Du, Y.; Chen, X.; Li, P.; Li, J.; Zhao, G. 2015: MiR‑365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in breast cancer. International Journal of Oncology 47(1): 296-302
Liu, C.; Zhang, A.; Cheng, L.; Gao, Y. 2016: MiR‑410 regulates apoptosis by targeting Bak1 in human colorectal cancer cells. Molecular Medicine Reports 14(1): 467-473
Wu, K.; Ma, L.; Zhu, J. 2016: MiR‑483‑5p promotes growth, invasion and self‑renewal of gastric cancer stem cells by Wnt/β‑catenin signaling. Molecular Medicine Reports 14(4): 3421-3428
Chen, Z.; Li, Q.; Wang, S.; Zhang, J. 2015: MiR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2. International Journal of Molecular Medicine 36(4): 1136-1142
Çorapçıoğlu, M.E.; Oğul, H. 2015: MiSEA: microRNA set enrichment analysis. Bio Systems 134: 37-42
Preusse, M.; Theis, F.J.; Mueller, N.S. 2016: MiTALOS v2: Analyzing Tissue Specific microRNA Function. Plos one 11(3): E0151771
Patel, P.; Ramachandruni, S.D.; Kakrana, A.; Nakano, M.; Meyers, B.C. 2016: MiTRATA: a web-based tool for microRNA Truncation and Tailing Analysis. Bioinformatics 32(3): 450-452
Yang, X.; Dai, H.; Yi, X.; Wang, Y.; Yang, S.; Zhang, B.; Wang, Z.; Zhou, Y.; Peng, X. 2016: MicROS: a morphable, intelligent and collective robot operating system. Robotics and Biomimetics 3(1): 21
Holt, D.B.; Gupta, V.; Meyer, D.ör.; Abel, N.B.; Andersen, S.U.; Stougaard, J.; Markmann, K. 2015: Micro RNA 172 (miR172) signals epidermal infection and is expressed in cells primed for bacterial invasion in Lotus japonicus roots and nodules. New Phytologist 208(1): 241-256
Massart, J.; Katayama, M.; Krook, A. 2016: MicroManaging glucose and lipid metabolism in skeletal muscle: Role of microRNAs. Biochimica et Biophysica Acta 1861(12 Part B): 2130-2138
de Klein, N.; Magnani, E.; Banf, M.; Rhee, S.Yon. 2015: MicroProtein Prediction Program (miP3): A Software for Predicting micro Proteins and Their Target Transcription Factors. International Journal of Genomics 2015: 734147
Kojima, S.; Seki, N. 2016: MicroRNA. Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl. 3: 201-204
Yu, L.; Lu, Y.; Han, X.; Zhao, W.; Li, J.; Mao, J.; Wang, B.; Shen, J.; Fan, S.; Wang, L.; Wang, M.; Li, L.; Tang, J.; Song, B. 2016: MicroRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5. Stem Cell Research and Therapy 7(1): 180
Bakkar, A.; Alshalalfa, M.; Petersen, L.F.; Abou-Ouf, H.; Al-Mami, A.; Hegazy, S.A.; Feng, F.; Alhajj, R.; Bijian, K.; Alaoui-Jamali, M.A.; Bismar, T.A. 2016: MicroRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. Molecular Biology Reports 43(4): 229-240
Lai, X.J.; Cheng, X.Y.; Hu, L.D. 2016: MicroRNA 421 induces apoptosis of c-33a cervical cancer cells via down-regulation of Bcl-xL. Genetics and Molecular Research: Gmr 15(4)
Rounge, T.B.; Lauritzen, M.; Langseth, H.; Enerly, E.; Lyle, R.; Gislefoss, R.E. 2015: MicroRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 24(9): 1381-1387
Sun, W.; Pei, L. 2015: MicroRNA Expression Profiling of Propofol-Treated Developing Rat Hippocampal Astrocytes. Dna and Cell Biology 34(8): 511-523
Roden, C.; Mastriano, S.; Wang, N.; Lu, J. 2015: MicroRNA Expression Profiling: Technologies, Insights, and Prospects. Advances in Experimental Medicine and Biology 888: 409-421
Chang, C.-W.; Wu, H.-C.; Terry, M.B.; Santella, R.M. 2015: MicroRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR. Anticancer Research 35(7): 3969-3977
Gao, B.; Zheng, L. 2013: MicroRNA Expression in Rat Apical Periodontitis Bone Lesion. Bone Research 1(2): 170-185
Aguado, L.C.; Schmid, S.; Sachs, D.; Shim, J.V.; Lim, J.K.; tenOever, B.R. 2015: MicroRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection. Cell Host and Microbe 18(6): 714-722
Hoss, A.G.; Labadorf, A.; Beach, T.G.; Latourelle, J.C.; Myers, R.H. 2016: MicroRNA Profiles in Parkinson's Disease Prefrontal Cortex. Frontiers in Aging Neuroscience 8: 36
Smirnova, L.; Seiler, A.E.M.; Luch, A. 2015: MicroRNA Profiling as Tool for Developmental Neurotoxicity Testing (DNT). Current Protocols in Toxicology 64: 20.9.1-20.9.22
Sun, T.; Li, W.; Li, T.; Ling, S. 2016: MicroRNA Profiling of Amniotic Fluid: Evidence of Synergy of micro RNAs in Fetal Development. Plos one 11(5): E0153950
Ritchie, W. 2017: MicroRNA Target Prediction. Methods in Molecular Biology 1513: 193-200
Shah, M.Y.; Ferrajoli, A.; Sood, A.K.; Lopez-Berestein, G.; Calin, G.A. 2016: MicroRNA Therapeutics in Cancer - An Emerging Concept. Ebiomedicine 12: 34-42
Bibi, F.; Naseer, M.I.; Alvi, S.A.; Yasir, M.; Jiman-Fatani, A.A.; Sawan, A.; Abuzenadah, A.M.; Al-Qahtani, M.H.; Azhar, E.I. 2016: MicroRNA analysis of gastric cancer patients from Saudi Arabian population. Bmc Genomics 17(Suppl 9): 751
Rebane, A. 2015: MicroRNA and Allergy. Advances in Experimental Medicine and Biology 888: 331-352
Anitha, A.; Thanseem, I. 2015: MicroRNA and Autism. Advances in Experimental Medicine and Biology 888: 71-83
Nugent, M. 2015: MicroRNA and Bone Cancer. Advances in Experimental Medicine and Biology 889: 201-230
Gnecchi, M.; Pisano, F.; Bariani, R. 2015: MicroRNA and Cardiac Regeneration. Advances in Experimental Medicine and Biology 887: 119-141
Giza, D.E.; Calin, G.A. 2015: MicroRNA and Chronic Lymphocytic Leukemia. Advances in Experimental Medicine and Biology 889: 23-40
Reschke, C.R.; Henshall, D.C. 2015: MicroRNA and Epilepsy. Advances in Experimental Medicine and Biology 888: 41-70
Jelencsics, K.ír.; Oberbauer, R. 2015: MicroRNA and Kidney Transplantation. Advances in Experimental Medicine and Biology 888: 271-290
Del Vescovo, V.; Denti, M.A. 2015: MicroRNA and Lung Cancer. Advances in Experimental Medicine and Biology 889: 153-177
Yuan, Y.; Tong, L.; Wu, S. 2015: MicroRNA and NF-kappa B. Advances in Experimental Medicine and Biology 887: 157-170
Langhe, R. 2015: MicroRNA and Ovarian Cancer. Advances in Experimental Medicine and Biology 889: 119-151
Sakai, A.; Suzuki, H. 2015: MicroRNA and Pain. Advances in Experimental Medicine and Biology 888: 17-39
Boucherat, O.; Potus, F.ço.; Bonnet, S.éb. 2015: MicroRNA and Pulmonary Hypertension. Advances in Experimental Medicine and Biology 888: 237-252
Banerjee, J.; Sen, C.K. 2015: MicroRNA and Wound Healing. Advances in Experimental Medicine and Biology 888: 291-305
Zhang, F.; Xu, Z.; Wang, K.; Sun, L.; Liu, G.; Han, B. 2015: MicroRNA and gene networks in human laryngeal cancer. Experimental and Therapeutic Medicine 10(6): 2245-2252
Vinding, M.S.; Brenner, D.; Tse, D.H.Y.; Vellmer, S.; Vosegaard, T.; Suter, D.; Stöcker, T.; Maximov, I.I. 2017: Application of the limited-memory quasi-Newton algorithm for multi-dimensional, large flip-angle RF pulses at 7T. Magma 30(1): 29-39
Van Keuren-Jensen, K.R.; Malenica, I.; Courtright, A.L.; Ghaffari, L.T.; Starr, A.P.; Metpally, R.P.; Beecroft, T.A.; Carlson, E.W.J.; Kiefer, J.A.; Pockros, P.J.; Rakela, J. 2016: MicroRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C. Liver International: Official Journal of the International Association for the Study of the Liver 36(3): 334-343
Gasparini, P.; Cascione, L.; Landi, L.; Carasi, S.; Lovat, F.; Tibaldi, C.; Alì, G.; D'Incecco, A.; Minuti, G.; Chella, A.; Fontanini, G.; Fassan, M.; Cappuzzo, F.; Croce, C.M. 2015: MicroRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proceedings of the National Academy of Sciences of the United States of America 112(48): 14924-14929
Yu, X.; Li, Z.; Chan, M.T.V.; Wu, W.K.K. 2015: MicroRNA deregulation in keloids: an opportunity for clinical intervention?. Cell Proliferation 48(6): 626-630
Nigita, G.; Acunzo, M.; Romano, G.; Veneziano, D.; Laganà, A.; Vitiello, M.; Wernicke, D.; Ferro, A.; Croce, C.M. 2016: MicroRNA editing in seed region aligns with cellular changes in hypoxic conditions. Nucleic Acids Research 44(13): 6298-6308
Xie, F.; Zhang, B. 2015: MicroRNA evolution and expression analysis in polyploidized cotton genome. Plant Biotechnology Journal 13(3): 421-434
Sardu, C.; Santamaria, M.; Paolisso, G.; Marfella, R. 2015: MicroRNA expression changes after atrial fibrillation catheter ablation. Pharmacogenomics 16(16): 1863-1877
Floor, S.éb.L.; Trésallet, C.; Hébrant, A.; Desbuleux, A.; Libert, F.éd.ér.; Hoang, C.; Capello, M.; Andry, G.; van Staveren, W.C.G.; Maenhaut, C. 2015: MicroRNA expression in autonomous thyroid adenomas: Correlation with mRNA regulation. Molecular and Cellular Endocrinology 411: 1-10
Tambyah, P.A.; Ching, C.S.; Sepramaniam, S.; Ali, J.M.; Armugam, A.; Jeyaseelan, K. 2016: MicroRNA expression in blood of dengue patients. Annals of Clinical Biochemistry 53(Part 4): 466-476
Sanders, A.P.; Burris, H.H.; Just, A.C.; Motta, V.; Svensson, K.; Mercado-Garcia, A.; Pantic, I.; Schwartz, J.; Tellez-Rojo, M.M.; Wright, R.O.; Baccarelli, A.A. 2015: MicroRNA expression in the cervix during pregnancy is associated with length of gestation. Epigenetics 10(3): 221-228
de Gonzalo-Calvo, D.; Cenarro, A.; Civeira, F.; Llorente-Cortes, V. 2016: MicroRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers. Clinica e Investigacion en Arteriosclerosis: Publicacion Oficial de la Sociedad Espanola de Arteriosclerosis 28(4): 167-177
Amir, S.; Mabjeesh, N.J. 2017: MicroRNA expression profiles as decision-making biomarkers in the management of bladder cancer. Histology and Histopathology 32(2): 107-119
Dong, D.; Zhang, Y.; Reece, E.Albert.; Wang, L.; Harman, C.R.; Yang, P. 2016: MicroRNA expression profiling and functional annotation analysis of their targets modulated by oxidative stress during embryonic heart development in diabetic mice. Reproductive Toxicology 65: 365-374
Jurkovicova, D.; Lukackova, R.; Magyerkova, M.; Kulcsar, L.; Krivjanska, M.; Krivjansky, V.; Chovanec, M. 2015: MicroRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia. Neoplasma 62(6): 949-958
Lee, K.-P.; Shin, Y.J.; Kwon, K.-S. 2015: MicroRNA for determining the age-related myogenic capabilities of skeletal muscle. Bmb Reports 48(11): 595-596
Eisenberg, I.; Kotaja, N.; Goldman-Wohl, D.; Imbar, T. 2015: MicroRNA in Human Reproduction. Advances in Experimental Medicine and Biology 888: 353-387
Tagawa, H. 2015: MicroRNA in Malignant Lymphoma. Advances in Experimental Medicine and Biology 889: 41-50
Nankivell, B.J. 2015: MicroRNA in Transplantation: Small in Name only. Transplantation 99(9): 1754-1755
Kirchner, B.; Pfaffl, M.W.; Dumpler, J.; von Mutius, E.; Ege, M.J. 2016: MicroRNA in native and processed cow's milk and its implication for the farm milk effect on asthma. Journal of Allergy and Clinical Immunology 137(6): 1893-1895.E13
Inoue, M.; Jinnin, M.; Wang, Z.; Nakamura, K.; Inoue, K.; Ichihara, A.; Moriya, C.; Sakai, K.; Fukushima, S.; Ihn, H. 2016: MicroRNA level is raised in the hair shafts of patients with dematomyositis in comparison with normal subjects and patients with scleroderma. International Journal of Dermatology 55(7): 786-790
Huang, J.; Sun, C.; Wang, S.; He, Q.; Li, D. 2015: MicroRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells. Molecular Biosystems 11(7): 2051-2059
Schwickert, A.; Weghake, E.; Brüggemann, K.; Engbers, A.; Brinkmann, B.F.; Kemper, Börn.; Seggewiß, J.; Stock, C.; Ebnet, K.; Kiesel, L.; Riethmüller, C.; Götte, M. 2015: MicroRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements. Plos one 10(12): E0143993
Eggers, J.C.; Martino, V.; Reinbold, R.; Schäfer, S.D.; Kiesel, L.; Starzinski-Powitz, A.; Schüring, A.N.; Kemper, B.ör.; Greve, B.; Götte, M. 2016: MicroRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4. Reproductive Biomedicine Online 32(4): 434-445
Lourdusamy, A.; Rahman, R.; Smith, S.; Grundy, R. 2015: MicroRNA network analysis identifies miR-29 cluster as key regulator of LAMA2 in ependymoma. Acta Neuropathologica Communications 3: 26
Balci, S.; Ayaz, L.; Gorur, A.; Yildirim Yaroglu, H.; Akbayir, S.; Dogruer Unal, N.; Bulut, B.; Tursen, U.; Tamer, L. 2016: MicroRNA profiling for early detection of nonmelanoma skin cancer. Clinical and Experimental Dermatology 41(4): 346-351
Tana, C.; Giamberardino, M.Adele.; Cipollone, F. 2017: MicroRNA profiling in atherosclerosis, diabetes, and migraine. Annals of Medicine 49(2): 93-105
Macchiaroli, N.; Cucher, M.; Zarowiecki, M.; Maldonado, L.; Kamenetzky, L.; Rosenzvit, M.C. 2015: MicroRNA profiling in the zoonotic parasite Echinococcus canadensis using a high-throughput approach. Parasites and Vectors 8: 83
Luo, Z.; Liu, Y.; Chen, L.; Ellis, M.; Li, M.; Wang, J.; Zhang, Y.; Fu, P.; Wang, K.; Li, X.; Wang, L. 2015: MicroRNA profiling in three main stages during porcine spermatogenesis. Journal of Assisted Reproduction and Genetics 32(3): 451-460
Tatura, R.; Buchholz, M.; Dickson, D.W.; van Swieten, J.; McLean, C.; Höglinger, G.ün.; Müller, U. 2016: MicroRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP). Neurogenetics 17(3): 165-171
Mitra, R.; Sun, J.; Zhao, Z. 2015: MicroRNA regulation in cancer: one arm or two arms?. International Journal of Cancer 137(6): 1516-1518
Song, J.L.; Nigam, P.; Tektas, S.S.; Selva, E. 2015: MicroRNA regulation of Wnt signaling pathways in development and disease. Cellular Signalling 27(7): 1380-1391
Hudish, L.I.; Appel, B. 2014: MicroRNA regulation of neural precursor self-renewal and differentiation. Neurogenesis 1(1): E976018
Lopez-Anton, M.; Bowen, T.; Jenkins, R.H. 2015: MicroRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis. Biomed Research International 2015: 929806
Yu, Y.; Lü, X.; Ding, F. 2015: MicroRNA regulatory mechanism by which PLLA aligned nanofibers influence PC12 cell differentiation. Journal of Neural Engineering 12(4): 046010
Grosser, T. 2015: MicroRNA represses macromolecule. Blood 125(22): 3365-3366
Raschzok, N.; Reutzel-Selke, A.; Schmuck, R.B.; Tannus, L.M.; Morgul, M.H.; Dietel, C.; Leder, A.; Struecker, B.; Lippert, S.; Sallmon, H.; Schmelzle, M.; Bartels, M.; Jonas, S.; Pratschke, J.; Sauer, I.M. 2016: MicroRNA signatures in peripheral blood fail to detect acute cellular rejection after liver transplantation. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 21(8): 699-707
Rothschild, S.I. 2014: MicroRNA therapies in cancer. Molecular and Cellular Therapies 2: 7
Peng, H.; Park, J.K.; Katsnelson, J.; Kaplan, N.; Yang, W.; Getsios, S.; Lavker, R.M. 2015: MicroRNA-103/107 Family Regulates Multiple Epithelial Stem Cell Characteristics. Stem Cells 33(5): 1642-1656
Chen, X.-H.; Ling, X.-M.; Shi, S. 2015: MicroRNA-106a induces the proliferation and apoptosis of glioma cells through regulating JNK/MAPK pathway. European Review for Medical and Pharmacological Sciences 19(18): 3412-3417
Carvalheira, G.; Nozima, B.H.; Cerutti, J.M. 2015: MicroRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer. Oncotarget 6(29): 28357-28370
Song, N.; Ma, X.; Li, H.; Zhang, Y.; Wang, X.; Zhou, P.; Zhang, X. 2015: MicroRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes. Urologic Oncology 33(5): 205.E1
Pal, R.; Greene, S. 2015: MicroRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma. Plos one 10(9): E0137845
Gerresheim, G.K.; Dünnes, N.; Nieder-Röhrmann, A.; Shalamova, L.A.; Fricke, M.; Hofacker, I.; Höner Zu Siederdissen, C.; Marz, M.; Niepmann, M. 2017: MicroRNA-122 target sites in the hepatitis C virus RNA NS5B coding region and 3' untranslated region: function in replication and influence of RNA secondary structure. Cellular and Molecular Life Sciences: Cmls 74(4): 747-760
Huang, Y-F.; Zhang, Y.; Liu, C-X.; Huang, J.; Ding, G-H. 2016: MicroRNA-125b contributes to high glucose-induced reactive oxygen species generation and apoptosis in HK-2 renal tubular epithelial cells by targeting angiotensin-converting enzyme 2. European Review for Medical and Pharmacological Sciences 20(19): 4055-4062
Geng, Q.; Chen, H.; Ren, J.Y.; Song, J.X.; Li, S.F. 2014: MicroRNA-126 delivered by microparticles mediates intercellular signal transmission. Beijing da Xue Xue Bao. Yi Xue Ban 46(6): 894-898
Liu, Y.-J.; Fan, W.-J.; Bai, J.-Z. 2015: MicroRNA-126 expression and its mechanism of action in patients with systemic lupus erythematosus. European Review for Medical and Pharmacological Sciences 19(20): 3838-3842
Luo, P.; Fei, J.; Zhou, J.; Zhang, W. 2015: MicroRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells. Oncology Letters 9(5): 2225-2229
Gao, J.; Zhou, X.-L.; Kong, R.-N.; Ji, L.-M.; He, L.-L.; Zhao, D.-B. 2016: MicroRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway. Experimental and Molecular Pathology 100(1): 192-198
Han, H.; Li, W.; Shen, H.; Zhang, J.; Zhu, Y.; Li, Y. 2016: MicroRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect. Journal of Molecular Cell Biology 8(5): 400-410
Zhang, B.; Liu, T.; Wu, T.; Wang, Z.; Rao, Z.; Gao, J. 2015: MicroRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. International Journal of Biological Macromolecules 74: 111-118
Luo, Y.; Li, X.; Dong, J.; Sun, W. 2016: MicroRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(6): 7749-7755
Xiao, J.; Peng, F.; Yu, C.; Wang, M.; Li, X.; Li, Z.; Jiang, J.; Sun, C. 2014: MicroRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy. International Journal of Clinical and Experimental Pathology 7(11): 7442-7450
Zhao, W.; Zou, J.; Wang, B.; Fan, P.; Mao, J.; Li, J.; Liu, H.; Xiao, J.; Ma, W.; Wang, M.; Li, L.; Song, B. 2014: MicroRNA-140 suppresses the migration and invasion of colorectal cancer cells through targeting Smad3. Zhonghua Zhong Liu Za Zhi 36(10): 739-745
Dong, S.; Meng, X.; Xue, S.; Yan, Z.; Ren, P.; Liu, J. 2016: MicroRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2. American Journal of Translational Research 8(3): 1471-1481
Zhou, J.; Wu, S.; Chen, Y.; Zhao, J.; Zhang, K.; Wang, J.; Chen, S. 2015: MicroRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma. Experimental Biology and Medicine 240(7): 867-875
Takahara, K.; Ii, M.; Inamoto, T.; Nakagawa, T.; Ibuki, N.; Yoshikawa, Y.; Tsujino, T.; Uchimoto, T.; Saito, K.; Takai, T.; Tanda, N.; Minami, K.; Uehara, H.; Komura, K.; Hirano, H.; Nomi, H.; Kiyama, S.; Asahi, M.; Azuma, H. 2016: MicroRNA-145 Mediates the Inhibitory Effect of Adipose Tissue-Derived Stromal Cells on Prostate Cancer. Stem Cells and Development 25(17): 1290-1298
Sathyanarayanan, A.; Chandrasekaran, K.S.; Karunagaran, D. 2017: MicroRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Cellular Oncology 40(2): 119-131
Fujii, T.; Shimada, K.; Tatsumi, Y.; Hatakeyama, K.; Obayashi, C.; Fujimoto, K.; Konishi, N. 2015: MicroRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1. Bmc Cancer 15: 818
Han, J.; Sun, Y.; Song, W.; Xu, T. 2017: MicroRNA-145 regulates the RLR signaling pathway in miiuy croaker after poly(I:C) stimulation via targeting MDA5. Developmental and Comparative Immunology 68: 79-86
Zhang, Z.; Zhang, Y.; Sun, X.-X.; Ma, X.; Chen, Z.-N. 2015: MicroRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Molecular Cancer 14: 5
Sathyanarayanan, A.; Chandrasekaran, K.S.; Karunagaran, D. 2016: MicroRNA-146a inhibits proliferation, migration and invasion of human cervical and colorectal cancer cells. Biochemical and Biophysical Research Communications 480(4): 528-533
Zhang, S.-L.; Liu, L. 2015: MicroRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1. Experimental and Therapeutic Medicine 9(2): 579-584
Shen, X.; Li, J.; Liao, W.; Wang, J.; Chen, H.; Yao, Y.; Liu, H.; Ding, K. 2016: MicroRNA-149 targets caspase-2 in glioma progression. Oncotarget 7(18): 26388-26399
Li, J.; Zhang, S. 2016: MicroRNA-150 inhibits the formation of macrophage foam cells through targeting adiponectin receptor 2. Biochemical and Biophysical Research Communications 476(4): 218-224
Li, J.; Hu, L.; Tian, C.; Lu, F.; Wu, J.; Liu, L. 2015: MicroRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4. Bmc Molecular Biology 16: 24
Yu, F.; Lu, Z.; Chen, B.; Dong, P.; Zheng, J. 2015: MicroRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Diagnostic Pathology 10: 129
Cui, Y.; Zhao, J.; Yi, L.; Jiang, Y. 2016: MicroRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells. Plos one 11(6): E0156915
Thome, A.D.; Harms, A.S.; Volpicelli-Daley, L.A.; Standaert, D.G. 2016: MicroRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 36(8): 2383-2390
Arts, N.; Cané, S.; Hennequart, M.; Lamy, J.; Bommer, G.; Van den Eynde, B.ît.; De Plaen, E. 2015: MicroRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. Plos one 10(4): E0122517
Lee, D.E.; Brown, J.L.; Rosa, M.E.; Brown, L.A.; Perry, R.A.; Wiggs, M.P.; Nilsson, M.I.; Crouse, S.F.; Fluckey, J.D.; Washington, T.A.; Greene, N.P. 2016: MicroRNA-16 Is Downregulated During Insulin Resistance and Controls Skeletal Muscle Protein Accretion. Journal of Cellular Biochemistry 117(8): 1775-1787
Knudsen, K.Nguyen.; Nielsen, B.Schnack.; Lindebjerg, J.; Hansen, T.Frøstrup.; Holst, Ré.; Sørensen, F.Brandt. 2015: MicroRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution. Plos one 10(10): E0140503
Duan, X.; Zhang, T.; Ding, S.; Wei, J.; Su, C.; Liu, H.; Xu, G. 2015: MicroRNA-17-5p Modulates Bacille Calmette-Guerin Growth in RAW264.7 Cells by Targeting ULK1. Plos one 10(9): E0138011
Verduci, L.; Azzalin, G.; Gioiosa, S.; Carissimi, C.; Laudadio, I.; Fulci, V.; Macino, G. 2015: MicroRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1. Leukemia Research 39(4): 479-485
Liu, G.; Li, Y.; Gao, X.-G. 2016: MicroRNA-181a is upregulated in human atherosclerosis plaques and involves in the oxidative stress-induced endothelial cell dysfunction through direct targeting Bcl-2. European Review for Medical and Pharmacological Sciences 20(14): 3092-3100
Shao, J.-L.; Li, Z.-Z.; Wang, L.; Jiao, G.-L.; Zhou, Z.-G.; Sun, G.-D. 2016: MicroRNA-181b promotes migration and invasion of osteosarcoma cells by targeting N-myc downstream regulated gene 2. Nan Fang Yi Ke da Xue Xue Bao 36(3): 321-326
Wang, Y.; Zhao, X.; Wu, X.; Dai, Y.; Chen, P.; Xie, L. 2016: MicroRNA-182 Mediates Sirt1-Induced Diabetic Corneal Nerve Regeneration. Diabetes 65(7): 2020-2031
Feng, Y.A.; Liu, T.E.; Wu, Y. 2015: MicroRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression. Oncology Letters 10(2): 1197-1203
Zhang, C.; Liu, J.; Tan, C.; Yue, X.; Zhao, Y.; Peng, J.; Wang, X.; Laddha, S.V.; Chan, C.S.; Zheng, S.; Hu, W.; Feng, Z. 2016: MicroRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Oncotarget 7(8): 8783-8796
Lin, H-Chen.; Liu, S-Yun.; Yen, E-Yen.; Li, T-Kun.; Lai, I-Rue. 2017: MicroRNA-183 Mediates Protective Postconditioning of the Liver by Repressing Apaf-1. Antioxidants and Redox Signaling 26(11): 583-597
Cao, Z.; Zhang, N.; Lou, T.; Jin, Y.; Wu, Y.; Ye, Z.; Pan, J. 2014: MicroRNA-183 down-regulates the expression of BKCaβ1 protein that is related to the severity of chronic obstructive pulmonary disease. Hippokratia 18(4): 328-332
Su, Z.; Chen, D.; Li, Y.; Zhang, E.; Yu, Z.; Chen, T.; Jiang, Z.; Ni, L.; Yang, S.; Gui, Y.; Ye, J.; Lai, Y. 2015: MicroRNA-184 functions as tumor suppressor in renal cell carcinoma. Experimental and Therapeutic Medicine 9(3): 961-966
Jiang, H.; Zhang, J.; Du, Y.; Jia, X.; Yang, F.; Si, S.; Wang, L.; Hong, B. 2015: MicroRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator. Atherosclerosis 243(2): 523-532
Wang, L.; Liu, H. 2016: MicroRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(3): 4105-4113
Wu, F.; Huang, W.; Wang, X. 2015: MicroRNA-18a regulates gastric carcinoma cell apoptosis and invasion by suppressing hypoxia-inducible factor-1α expression. Experimental and Therapeutic Medicine 10(2): 717-722
Hu, W.; Li, M.; Hu, R.; Li, T.; Meng, X. 2015: MicroRNA-18b modulates insulin-like growth factor-1 expression in deer antler cell proliferation by directly targeting its 3' untranslated region. Dna and Cell Biology 34(4): 282-289
Krattinger, R.; Boström, A.; Schiöth, H.B.; Thasler, W.E.; Mwinyi, J.; Kullak-Ublick, G.A. 2016: MicroRNA-192 suppresses the expression of the farnesoid X receptor. American Journal of Physiology. Gastrointestinal and Liver Physiology 310(11): G1044-G1051
Zhao, C.; Qi, L.; Chen, M.; Liu, L.; Yan, W.; Tong, S.; Zu, X. 2015: MicroRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling. Experimental and Therapeutic Medicine 10(3): 1103-1108
Du, X.; Lin, L.I.; Zhang, L.; Jiang, J. 2015: MicroRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression. Oncology Letters 10(4): 2639-2643
Liu, X.; Duan, H.; Zhou, S.; Liu, Z.; Wu, D.; Zhao, T.; Xu, S.; Yang, L.; Li, D. 2016: MicroRNA-199a-3p functions as tumor suppressor by regulating glucose metabolism in testicular germ cell tumors. Molecular Medicine Reports 14(3): 2311-2320
Pan, Y.; Liang, H.; Chen, W.; Zhang, H.; Wang, N.; Wang, F.; Zhang, S.; Liu, Y.; Zhao, C.; Yan, X.; Zhang, J.; Zhang, C-Yu.; Gu, H.; Zen, K.; Chen, X. 2015: MicroRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs. Rna Biology 12(3): 276-289
Sinha, M.; Ghatak, S.; Roy, S.; Sen, C.K. 2015: MicroRNA-200b as a Switch for Inducible Adult Angiogenesis. Antioxidants and Redox Signaling 22(14): 1257-1272
Song, Z.; Liu, D.; Peng, Y.; Li, J.; Zhang, Z.; Ning, P.; Liu, Y. 2015: Microrna-203 Inducing Differentiation of Human Epidermal Stem cells into Sweat Gland cells in Vitro. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 29(3): 343-350
Obayashi, M.; Yoshida, M.; Tsunematsu, T.; Ogawa, I.; Sasahira, T.; Kuniyasu, H.; Imoto, I.; Abiko, Y.; Xu, D.; Fukunaga, S.; Tahara, H.; Kudo, Y.; Nagao, T.; Takata, T. 2016: MicroRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Oncotarget 7(7): 8223-8239
Han, H.; Chen, Y.; Cheng, L.; Prochownik, E.V.; Li, Y. 2016: MicroRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13. Oncotarget 7(13): 16409-16419
Zhang, Y.; Lei, W.; Yan, W.; Li, X.; Wang, X.; Zhao, Z.; Hui, J.; Shen, Z.; Yang, J. 2016: MicroRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase. Stem Cell Research and Therapy 7(1): 61
Feng, G.; Yan, Z.; Li, C.; Hou, Y. 2016: MicroRNA-208a in an early stage myocardial infarction rat model and the effect on cAMP-PKA signaling pathway. Molecular Medicine Reports 14(2): 1631-1635
Guo, L.; Zhao, J.; Qu, Y.; Yin, R.; Gao, Q.; Ding, S.; Zhang, Y.; Wei, J.; Xu, G. 2016: MicroRNA-20a Inhibits Autophagic Process by Targeting ATG7 and ATG16L1 and Favors Mycobacterial Survival in Macrophage Cells. Frontiers in Cellular and Infection Microbiology 6: 134
Xu, T.; Jing, C.; Shi, Y.; Miao, R.; Peng, L.; Kong, S.; Ma, Y.; Li, L. 2015: MicroRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases. Experimental and Therapeutic Medicine 10(2): 683-688
Chen, N.; Sui, B.D.; Hu, C.H.; Cao, J.; Zheng, C.X.; Hou, R.; Yang, Z.K.; Zhao, P.; Chen, Q.; Yang, Q.J.; Jin, Y.; Jin, F. 2016: MicroRNA-21 Contributes to Orthodontic Tooth Movement. Journal of Dental Research 95(12): 1425-1433
Lei, M.; Xie, W.; Sun, E.; Sun, Y.; Tian, D.; Liu, C.; Han, R.; Li, N.; Liu, M.; Han, R.; Liu, L. 2015: MicroRNA-21 Regulates Cell Proliferation and Migration and Cross Talk with PTEN and p53 in Bladder Cancer. Dna and Cell Biology 34(10): 626-632
He, Q.; Chen, Z.; Cabay, R.J.; Zhang, L.; Luan, X.; Chen, D.; Yu, T.; Wang, A.; Zhou, X. 2016: MicroRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncology 57: 15-20
Ilhan-Mutlu, A.ül.; Tezcan, G.ül.; Schoppmann, S.F.; Preusser, M.; Spyridoula, K.; Karanikas, G.; Birner, P. 2015: MicroRNA-21 expression is elevated in esophageal adenocarcinoma after neoadjuvant chemotherapy. Cancer Investigation 33(6): 246-250
Liu, Z.; Wang, J.; Guo, C.; Fan, X. 2015: MicroRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway. Biomedicine and PharmacoTherapy 69: 24-28
Wang, J.; Qiu, Y.; Shi, N.-W.; Zhao, J.-N.; Wang, Y.-C.; Jiang, H.; Qian, H.-B. 2016: MicroRNA-21 mediates the TGF-β1-induced migration of keratinocytes via targeting PTEN. European Review for Medical and Pharmacological Sciences 20(18): 3748-3759
Meng, Y.-B.; Li, X.; Li, Z.-Y.; Zhao, J.; Yuan, X.-B.; Ren, Y.; Cui, Z.-D.; Liu, Y.-D.; Yang, X.-J. 2015: MicroRNA-21 promotes osteogenic differentiation of mesenchymal stem cells by the PI3K/β-catenin pathway. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 33(7): 957-964
Amponsah, P.S.; Fan, P.; Bauer, N.; Zhao, Z.; Gladkich, J.; Fellenberg, J.; Herr, I. 2017: MicroRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer. Cancer Letters 388: 107-117
Zhao, X.; Lu, C.; Chu, W.; Zhang, Y.; Zhang, B.; Zeng, Q.; Wang, R.; Li, Z.; Lv, B.; Liu, J. 2016: MicroRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D. Dna and Cell Biology 35(11): 715-721
Wang, F.; Lv, P.; Liu, X.; Zhu, M.; Qiu, X. 2015: MicroRNA-214 enhances the invasion ability of breast cancer cells by targeting p53. International Journal of Molecular Medicine 35(5): 1395-1402
Long, L.-M.; He, B.-F.; Huang, G.-Q.; Guo, Y.-H.; Liu, Y.-S.; Huo, J.-R. 2015: MicroRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2. Oncology Letters 9(2): 645-650